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resumo 
 
 
Face ao uso disseminado e enorme potencial terapêutico das nanopartículas 
de prata (AgNPs), o estudo dos seus efeitos biológicos é um assunto relevante 
e atual. O trabalho apresentado nesta tese teve como objetivo aprofundar o 
conhecimento existente sobre o impacto das AgNPs no metabolismo celular, 
usando a metabolómica por espectroscopia de ressonância magnética nuclear 
(RMN). Os tipos celulares escolhidos para este estudo foram queratinócitos da 
epiderme humana, células de hepatoma humano e macrófagos sanguíneos, 
por serem relevantes, respetivamente, ao nível da entrada, acumulação e 
captação de nanopartículas no organismo. 
O Capítulo 1 introduz as principais propriedades das AgNPs, a sua atividade 
biológica e potencial toxicidade, e descreve a abordagem metabolómica, 
incluindo uma breve revisão bibliográfica das suas aplicações em 
nanotoxicologia. O âmbito e os objetivos desta tese são, também, 
apresentados. 
O Capítulo 2 descreve os métodos experimentais utilizados ao longo deste 
trabalho, incluindo a caracterização das AgNPs, os procedimentos usados na 
cultura celular e nos ensaios biológicos, a colheita e preparação de amostras, 
a análise por RMN e o tratamento estatístico dos dados. 
No Capítulo 3, a atividade metabólica e a composição dos três tipos de células 
usados neste trabalho (queratinócitos HaCaT, células de hepatoma HepG2 e 
macrófagos RAW 264.7) são descritas com base na análise por RMN dos 
sobrenadantes dos meios de cultura (exometaboloma) e dos extratos celulares 
polares e lipofílicos (endometaboloma). 
O Capítulo 4 apresenta a análise metabolómica das células HaCaT expostas a 
AgNPs de diferentes tamanhos (10, 30 ou 60 nm de diâmetro) e revestimentos 
(citrato, polietilenoglicol ou albumina de soro bovino). Verificou-se que o 
metaboloma celular foi afetado mesmo a concentrações subtóxicas de AgNPs, 
sugerindo: aumento da glicólise e glutaminólise, alteração na atividade do ciclo 
dos ácidos tricarboxílicos (TCA) e nos processos de produção e transferência 
de energia, degradação de proteínas, síntese de glutationa (GSH), 
modificações a nível das membranas e do equilíbrio osmótico. Apesar de 
muitas variações serem comuns a todas as nanopartículas testadas, as AgNPs 
de 10 nm causaram os efeitos mais distintos, nomeadamente no que diz 
respeito à glicólise e à síntese/utilização de GSH. Além disso, a exposição 
celular a prata iónica (Ag+) confirmou o importante papel dos iões prata no 
mecanismo de ação das AgNPs, enquanto a comparação com o peróxido de 
hidrogénio (H2O2) permitiu destacar os efeitos relacionados com o stress 
oxidativo. 
No Capítulo 5 são apresentadas as respostas metabólicas das células de 
fígado HepG2 a dois tipos de AgNPs, umas obtidas por redução química e 
estabilizadas em citrato e as outras obtidas por síntese verde na presença de 
um extrato vegetal (Cit30 e GS30, respetivamente), ambas com centros 
metálicos de 30 nm. Os resultados sugeriram adaptações metabólicas em 
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processos de produção de energia (metabolismo da glucose e sistema da 
fosfocreatina), autofagia e metabolismo lipídico, refletindo possivelmente a 
ativação de mecanismos de proteção. Ainda que os dois tipos de AgNPs 
tenham induzido muitos efeitos semelhantes, as Cit30 pareceram causar um 
maior impacto no ciclo TCA e na degradação de proteínas, enquanto as GS30 
aparentaram induzir uma diminuição mais forte na síntese de fosfolípidos. A 
assinatura metabólica da prata iónica foi bastante semelhante à das AgNPs, 
sugerindo, no entanto, uma menor capacidade das células expostas a Ag+ 
extracelular para lidar com o stress oxidativo. 
O Capítulo 6 descreve a avaliação do impacto das AgNPs Cit30 no 
metaboloma de macrófagos de murganho RAW 264.7, a concentrações 
subtóxicas (decréscimos de ~5 e 20% na viabilidade celular). As alterações 
encontradas apontaram para: estimulação da glicólise (a baixa concentração 
de exposição), reprogramação do ciclo TCA (resultando numa intensa 
produção de itaconato e succinato e numa marcada depleção de ATP, 
consistentes com uma resposta pro-inflamatória), ativação da gluconeogénese, 
promoção da síntese de GSH e acumulação de creatina/fosfocreatina. Foram, 
ainda, observadas variações possivelmente relacionadas com a 
osmorregulação e a modificação membranar. De notar que os macrófagos 
expostos a Ag+ mostraram características semelhantes aos expostos a AgNPs 
(por ex., aumento da glucose intracelular – gluconeogénese), mas também 
revelaram efeitos distintos, nomeadamente em metabolitos envolvidos no ciclo 
TCA, em processos de transferência de energia e no metabolismo lipídico. 
Adicionalmente, viu-se que o metaboloma dos macrófagos respondeu de 
maneira diferente à exposição a H2O2 (por ex., tendência para diminuição da 
glicólise e sem efeitos observados na ativação da gluconeogénese ou da 
síntese de GSH), indicando que muitos dos efeitos induzidos pelas AgNPs não 
foram necessariamente mediados por stress oxidativo. 
Finalmente, com base na integração dos resultados apresentados ao longo 
dos capítulos anteriores, as principais conclusões deste trabalho são 
apresentadas e discutidas no Capítulo 7. 
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abstract The wide dissemination and promising therapeutic potential of silver 
nanoparticles (AgNPs) make the study of their biological effects a relevant up-
to-date subject. The work presented in this thesis aimed at deepening current 
understanding of the impact of AgNPs on cell metabolism, using NMR 
metabolomics of cultured mammalian cells. Epidermis keratinocytes, hepatoma 
cells and blood macrophages, relevant, respectively, to nanoparticle entry, 
accumulation and uptake, have been selected for the study.  
Chapter 1 introduces the main properties of AgNPs, including their biological 
activity and toxicological potential, and describes the metabolomics approach, 
briefly reviewing its applications in the field of nanotoxicology. Also, the scope 
and aims of this thesis are presented. 
Chapter 2 covers the experimental methods adopted during the course of this 
work, including the sources and characterisation of AgNPs, the procedures 
used in cell culture and biological assays, sample collection and preparation 
methods, NMR analyses and statistical data treatment. 
In Chapter 3, the metabolic activity and composition of the three cell types used 
in this work (HaCaT keratinocytes, HepG2 hepatoma cells and RAW 264.7 
macrophages) are described based on the NMR analysis of culture medium 
supernatants (exometabolome) and polar/lipophilic cell extracts 
(endometabolome).  
Chapter 4 presents the metabolomic analysis of HaCaT skin cells exposed to 
AgNPs of different sizes (10, 30 or 60 nm in diameter) and coatings (citrate, 
polyethylene glycol or bovine serum albumin). The cellular metabolome was 
found to be affected even at sub-toxic concentrations of AgNPs, suggesting: 
upregulation of glycolysis and glutaminolysis, altered tricarboxylic acid (TCA) 
cycle activity, protein degradation, disruption of energy-producing pathways, 
glutathione (GSH) synthesis, membrane modification and changes in osmotic 
balance. Although several metabolic variations were common to all tested 
nanoparticles, the 10 nm AgNPs showed the most distinct effects, namely in 
regard to glycolysis and GSH synthesis/utilisation. Furthermore, cell exposure 
to ionic silver (Ag+) confirmed the major role of silver ions in AgNPs mode of 
action, while comparison with hydrogen peroxide (H2O2) allowed the effects 
related to oxidative stress to be highlighted. 
In Chapter 5, the metabolic responses of liver HepG2 cells to two types of 30 
nm AgNPs, obtained by chemical reduction and stabilised with citrate or 
produced by green synthesis in the presence of a plant extract (Cit30 and 
GS30, respectively) are presented. Sub-toxic concentrations of AgNPs were 
proposed to induce metabolic adaptations in energy production processes 
(glucose metabolism and the phosphocreatine system), autophagy and lipid 
metabolism, possibly reflecting the activation of metabolism-mediated 
protective mechanisms. Although the two types of AgNPs induced many 
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common effects, Cit30 appeared to have a greater impact on the TCA cycle 
and protein degradation, whereas GS30 seemed to induce stronger 
downregulation of phospholipid synthesis. The metabolic signature of Ag+ was 
largely similar to that of AgNPs, although suggesting a lower ability of cells 
exposed to extracellular Ag+ to cope with oxidative stress. 
Chapter 6 addresses the impact of Cit30 AgNPs on the metabolome of murine 
RAW 264.7 macrophages, at concentrations causing minimal (~5 and 20%) 
decreases in cell viability. Exposed cells were suggested to upregulate 
glycolysis (at the low exposure concentration), to reprogram the TCA cycle 
(resulting in marked production of itaconate and succinate and in ATP 
depletion, consistent with a pro-inflammatory response), to activate 
gluconeogenesis, to promote GSH synthesis, and to increase the 
creatine/phosphocreatine pool. Changes putatively related to osmoregulation 
and membrane modification were also observed. Notably, macrophages 
exposed to Ag+ showed common features to AgNPs-exposed cells (e.g. 
increased intracellular glucose suggesting gluconeogenesis), but also several 
distinct effects, for instance in metabolites involved in the TCA cycle, energy 
transfer processes or lipid metabolism. Furthermore, the cellular metabolome 
responded differently to H2O2 exposure (e.g. trend for downregulated 
glycolysis, no evidence of gluconeogenesis activation or of GSH upregulation), 
indicating that many of the AgNPs-induced effects were not necessarily 
mediated by oxidative stress.  
Finally, based on the integration of the results presented along the previous 
chapters, the main conclusions of this work are presented and discussed in 
Chapter 7. 
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Chapter 1 
 
1 
 
Chapter 1. Introduction 
1.1. Silver nanoparticles (AgNPs) 
Silver has been used throughout history for a large variety of applications, including 
the manufacture of currency coins, ornaments, jewellery, tableware and utensils. 
Furthermore, its healing and preservative properties have been known since primordial 
civilisations, as attested by the use of silver films for water preservation by the Phoenicians, 
or of silver powders as anti-disease agents by ancient Egyptians (Murphy et al., 2015). Over 
the last century, the engineering of silver into nanoparticles has further extended the myriad 
of applications for this noble metal. Today, silver nanoparticles (AgNPs) represent one of 
the classes of nanomaterials with largest production and commercialisation (Tran et al., 
2013). In particular, their well-documented antimicrobial properties has propelled their 
incorporation into numerous consumer goods, including plastics, textiles, cosmetics and 
food packaging materials, as well as in medical products, such as wound dressings, 
implants and catheters (Ge et al., 2014). Moreover, new therapeutic applications are 
increasingly being explored with a view to take advantage of other interesting biological 
properties of AgNPs, such as the antiviral or anticancer activities (Wei et al., 2015). On the 
other hand, given the high propensity for human exposure, there is a recognised need to 
better define the potential adverse effects of AgNPs to human health, and to understand 
their mechanisms of action in eukaryotic cells and higher organisms. In the following 
sections, the main physicochemical and biological properties of AgNPs as well as the 
current knowledge on their toxicity will be reviewed, aiming at establishing a sound and 
informed background that will aid in the interpretation of the results presented in this thesis. 
 
1.1.1. Synthesis and physicochemical properties of AgNPs 
AgNPs are nanoscale clusters of metallic silver (20-15000 atoms), with sizes 
typically below 100 nm in at least one dimension. They can be synthesised by numerous 
methods, usually divided into three main categories: chemical, physical and biological 
methods (Wei et al., 2015; Pinto et al., 2017). Chemical methods comprise the reduction of 
silver ions (Ag+) in aqueous or organic solutions, forming metallic silver (Ag0) atoms that 
subsequently form clusters, yielding colloidal silver in the nanometric range. In particular, 
the chemical synthesis of AgNPs can be achieved through chemical or electrochemical 
reduction, hydrothermal, microemulsion and photochemical methods (Pinto et al., 2017). 
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Physical methods include, among others, laser ablation, whereby AgNPs are synthesised 
through the ablation of metallic bulk materials by laser pulses, evaporation-condensation, 
and arc discharge between titanium electrodes in a silver nitrate solution (Pinto et al., 2017). 
Finally, biological synthetic routes for AgNPs make use of different organisms like bacteria, 
fungi, algae, yeasts or plants. These are generally safer and more economic than chemical 
or physical methods, since the solvent medium is preferably water, and the reducing and 
stabilising agents are non-toxic and environmentally friendly (Rajan et al., 2015; Rauwel et 
al., 2015). 
Depending on the fabrication method, AgNPs can present different shapes, 
including spheres, rods, wires and plates (Figure 1.1a), as well as various sizes. For 
instance, strong reducing agents usually produce small monodisperse particles, while weak 
reductants tend to generate larger polydisperse particles (Galdiero et al., 2011). 
 
 
Figure 1.1. a) Differently shaped AgNPs (nanoComposix, 2016a). b) Surface area:volume ratios of 
nanospheres, according to their diameter (nanoComposix, 2016a). c) Schematic representation of 
surface oxidation and dissolution of the oxide layer in AgNPs; reprinted with permission from (Li et 
al., 2012), Copyright © 2012 American Chemical Society. 
 
Since nanosized materials have a significant number of atoms on the surface, they 
are characterised by high surface area to volume ratio, which increases with decreasing 
nanoparticle size (Fig 1.1b). Consequently, the chemical reactivity and many of the physical 
properties of the nanoparticles, such as solubility and tendency to aggregate, are dominated 
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by the nature of the nanoparticle surface. Silver nanoparticles are characterised by the 
presence of an oxide layer (Ag2O) on the surface of the metallic core (Ag0) (Figure 1.1c), 
which dissolves under certain conditions to release silver ions (Ag+) (Li et al., 2010; Li et al., 
2012). Thus, it is not surprising that surface coating affects the dissolution behaviour of 
AgNPs (Li et al., 2012). The coating agent is also determinant for nanoparticle stabilisation 
and prevention of agglomeration, either through electrostatic (e.g. citrate coating) or steric 
interactions (e.g. polyvinylpyrrolidone (PVP) or polyethylene glycol (PEG) coating). 
Furthermore, it is important to stress that the surface of most nanoparticles is dynamic and 
strongly influenced by the local environment.  
Another size-dependent property of AgNPs is their ability to absorb and scatter light 
with great efficiency. This is due to the collective oscillation of conduction electrons on the 
metal surface when they are excited by incident light at specific wavelengths, producing the 
so called surface plasmon resonance (SPR). These unique optical properties allow AgNPs 
stability to be accurately monitored using UV-Vis spectroscopy (Zook et al., 2011). 
 
1.1.2. Biological properties of AgNPs 
Antibacterial activity 
Silver has been used as a bactericidal agent since ancient times, especially until the 
appearance of antibiotics. Then, the evolution of antibiotic-resistant strains of bacteria (Rai 
et al., 2012), led to a renewed interest in the antibacterial properties of silver, namely in the 
nanoparticulate form. AgNPs have shown high efficacy against a vast range of bacteria, 
including Gram negative bacteria, such as Escherichia, Vibrio or Pseudomonas, and Gram 
positive bacteria, such as Staphylococcus, Enterococcus or Bacillus, with reported 
minimum inhibitory concentrations (MIC) typically varying in the range 1-100 μg/mL (Tran 
et al., 2013). Moreover, the efficacy of AgNPs alone or in combination with antibiotics 
against several multidrug-resistant (MDR) strains (Rai et al., 2012) and the ability of AgNPs 
to prevent and disrupt bacterial biofilms (Franci et al., 2015), which can be responsible for 
serious infections, present a gateway for the development of new antibacterial therapies. 
The bactericidal activity of AgNPs is greatly influenced by their physicochemical 
properties, namely size, surface charge and shape. Smaller nanoparticles have been shown 
to possess stronger antibacterial activity than larger nanoparticles (Morones et al., 2005; 
Choi and Hu, 2008; Agnihotri et al., 2014), possibly due to their higher surface area and 
reactivity. In terms of surface charge, the strong electrostatic interactions between the 
Introduction 
 
4 
 
bacterial membrane and positively-charged AgNPs are probably responsible for the higher 
efficacy of these nanoparticles against Bacillus species, when comparing to negatively 
charged ones (El Badawy et al., 2011). The influence of shape has also been tested, 
revealing that silver nanoplates present higher bactericidal activity than spherical or rod-
shaped AgNPs (Pal et al., 2007; Sadeghi et al., 2012); this was proposed to be related to 
the NPs crystallographic surface structure, since the top basal plane of a truncated 
triangular nanoplate is a {111} facet, which is a high-atom-density surface that favours silver 
reactivity, whereas spherical and rod-shaped AgNPs are known to predominantly have 
{100} facets with a small percentage of {111} facets. 
Some works have attributed the antibacterial activity of AgNPs to intrinsic properties 
(Morones et al., 2005; Choi and Hu, 2008), while silver ions (Ag+), formed by oxidative 
dissolution of AgNPs or through the release of chemisorbed ions at the particles surface 
(Le Ouay and Stellacci, 2015), have been shown to play a key role in AgNPs toxicity (Xiu 
et al., 2012). Indeed, Xiu and co-workers found that the viability of E. coli was not affected 
under anaerobic conditions, in which dissolution to Ag+ did not occur, even when the 
concentration of AgNPs was much higher than the minimum lethal concentration measured 
under aerobic conditions. 
Even though the mechanism of silver interaction with bacterial cells is not fully 
understood, several processes are thought to be involved (Eckhardt et al., 2013), as 
illustrated in Figure 1.2. The direct physical damage to the cell membrane, resulting from 
attachment and penetration of AgNPs and Ag+ into the bacterial cell wall, can lead to 
increased cell permeability and subsequent cell death. In particular, it was proposed that 
membrane destabilisation could result in collapsed membrane potential, dissipation of 
proton motive force and depletion of intracellular ATP levels (Dibrov et al., 2002; Lok et al., 
2006). Furthermore, the uptake and intracellular accumulation of AgNPs and Ag+ (facilitated 
by membrane poration) enables their interaction with vital enzymes and phosphorous-
containing nucleobases, affecting major cell functions, such as cell division and DNA 
replication (Li et al., 2013b), resulting in bacterial apoptosis (Bao et al., 2015). Oxidative 
stress, with consequent damage to proteins, lipids and DNA, is another possible mechanism 
of AgNPs toxicity; high levels of reactive oxygen species (ROS) have been found in bacteria 
exposed to AgNPs (Kim et al., 2007; Park et al., 2009; Xu et al., 2012), and have been 
suggested to arise either from over-production, or from disruption of ROS-scavenging 
enzymatic and non-enzymatic systems, as recently reviewed (Rizzello and Pompa, 2014).  
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Figure 1.2. Scheme illustrating the proposed mechanisms of action on AgNPs on bacteria: 1A, 
diffusion; 1B, endocytosis; 2A, mitochondrial damage; 2B, direct generation of ROS; 2C, generation 
of ROS by damaged mitochondria; 3A, organelle damage via interaction with sulphur and phosphor 
groups; 3B, DNA damage via nucleotide oxidation; 3C, DNA and organelle damage via oxidative 
stress; 4A, electrostatic interaction of AgNPs with cell membrane; 4B, membrane damage (lipid 
oxidation) by Ag+ and ROS (Pinto et al., 2017). 
 
Antifungal activity 
The application of many antifungal medicines is often accompanied by toxicity and 
development of resistance (Sardi et al., 2013). Thus, AgNPs have appeared as alternative 
fungicidal agents, especially against Candida species, which are opportunistic pathogens 
in humans. The high anticandidal activity of AgNPs has been reported in several studies, 
with MIC values in approximately the same range as that of conventional antifungal agents 
(0.05 – 2 μg/mL) (Kim et al., 2009a; Panacek et al., 2009; Selvaraj et al., 2014; Bonilla et 
al., 2015). Moreover, AgNPs have been shown to inhibit the formation and bioactivity of 
Candida albicans biofilms (Li et al., 2014b; Lara et al., 2015; Longhi et al., 2015). It has 
been proposed that the antifungal mode of action of AgNPs against C. albicans involves 
the disruption of the cell membrane, with pore formation and subsequent inhibition of the 
normal budding process (Kim et al., 2009a). Nonetheless, the ultrastructural analysis of C. 
albicans, exposed to AgNPs and fluconazole, through high-resolution transmission electron 
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microscopy (HRTEM), did not show severe damage to cell membranes (Vazquez-Munoz et 
al., 2014). It showed, however, high extracellular accumulation of AgNPs, with release of 
Ag+, and intracellular biosynthesis of smaller AgNPs (through reduction by cell organic 
compounds). In another study, the increased ROS production in AgNPs-exposed C. 
albicans was related with mitochondria-dependent apoptosis and DNA fragmentation 
(Hwang et al., 2012).  
 
Antiviral activity 
Several works have demonstrated the activity of AgNPs against different viruses 
(Galdiero et al., 2011), such as those causing human immunodeficiency (Elechiguerra et 
al., 2005), herpes simplex (Baram-Pinto et al., 2009), hepatitis B (Lu et al., 2008), Dengue 
(Sujitha et al., 2015) and influenza (Xiang et al., 2011; Mori et al., 2013; Xiang et al., 2013). 
It has been suggested that the inhibition of viral infections by AgNPs could be due to an 
impaired attachment of viruses to host cells, resulting from the interaction of AgNPs with 
outer proteins in the viral envelope (Elechiguerra et al., 2005; Sun et al., 2008; Lara et al., 
2010). Nonetheless, in the presence of AgNPs, the Vaccinia virus was capable of adsorbing 
to cells but was prevented from entering (Trefry and Wooley, 2013). On the other hand, 
AgNP-treated tacaribe virus (TCRV) was more efficiently internalised into Vero cells than 
untreated TCVR (Speshock et al., 2010); in that work, viral RNA production (and thus virus 
replication) was found to be inhibited upon AgNPs treatment, leading the authors to suggest 
the potential use of AgNPs in vaccine products. 
 
Anti-inflammatory activity 
The anti-inflammatory properties of AgNPs have been demonstrated both in vitro 
and in vivo. Recently, biosynthesised AgNPs with antibacterial activity were shown to have 
a cytoprotective effect towards hydrogen peroxide (H2O2)-induced inflammation in murine 
macrophages (Manikandan et al., 2015). PVP-coated AgNPs also helped controlling 
inflammation triggered by a Chlamydia trachomatis infection in macrophages, through the 
regulation of several upstream surface receptors and downstream inflammatory pathway 
genes (Yilma et al., 2013). In another study, composites of AgNPs and dendrimers were 
shown to have synergistic anti-inflammatory activity in lipopolysaccharide-stimulated 
murine macrophages (Liu et al., 2014). Furthermore, in the presence of biogenic AgNPs, 
the production of pro-inflammatory cytokines by human keratinocytes exposed to UVB 
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radiation was decreased (David et al., 2014). Regarding in vivo studies, AgNPs were shown 
to reduce inflammation and/or accelerate healing in murine models of allergic airway 
diseases (Jang et al., 2012; Shin and Ye, 2012), a porcine model of contact dermatitis 
(Nadworny et al., 2008), postoperative peritoneal adhesion models (Wong et al., 2009; 
Zhang et al., 2014a) and a burn wound mouse model (Liu et al., 2014). 
 
Anticancer activity 
A recent review thoroughly describes the potential therapeutic applications of AgNPs 
in cancer (Wei et al., 2015). Angiogenesis, the formation of new blood vessels, is a critical 
process for tumour growth and spreading. It has been shown that AgNPs and a natural anti-
angiogenesis molecule, contributed almost equally to the inhibition of the formation of new 
blood microvessels induced by vascular endothelial growth factor (VEGF) (Gurunathan et 
al., 2009). Moreover, several studies have demonstrated the ability of AgNPs to directly kill 
tumour cells. As described in the following section, AgNPs can cause dose-dependent 
toxicity in mammalian cells, including oxidative stress and DNA damage, ultimately leading 
to cell death. In particular, apoptosis has been often highlighted as a main mechanism 
through which AgNPs exert their cytotoxic action against tumour cells (Gurunathan et al., 
2009; Krishnasamy et al., 2015; Gurunathan et al., 2015; Satapathy et al., 2015). Other 
potential applications of AgNPs in cancer treatment are based on their ability to sensitise 
tumour cells to radiation therapy (Lu et al., 2012; Swanner et al., 2015), and to show 
phototherapeutic properties under near-infrared (NIR) radiation (Boca et al., 2011; Mfouo-
Tynga et al., 2014). 
 
1.1.3. Toxicity of AgNPs towards mammalian cells 
While in some applications the cytotoxicity of AgNPs is a desirable feature, e.g. 
when envisaging the killing of tumour cells, the successful use of AgNPs, e.g. as 
antimicrobial agents, often requires low toxicity towards human cells. Therefore, there is a 
great need to understand the mechanisms of AgNPs toxicity and the influencing factors that 
modulate toxic effects. In recent years, numerous studies have been carried out to address 
the toxicological potential of AgNPs towards mammalian cultured cells, as will be briefly 
reviewed below.  
Several works have demonstrated that AgNPs can be readily taken up by various 
human-derived cell types, such as normal bronchial cells (Gliga et al., 2014), liver cells 
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(Song et al., 2012), epidermal keratinocytes (Monteiro-Riviere et al., 2013), mesenchymal 
stem cells (Greulich et al., 2011) and various tumour cell lines (Liu et al., 2010; Yu et al., 
2013b). Similarly to other nanomaterials (Zhao et al., 2011), the uptake of AgNPs has been 
shown to occur mainly through active pathways, namely clathrin- and caveolin-dependent 
endocytosis, macropinocytosis and phagocytosis, although involvement of energy-
independent uptake pathways has also been suggested (Jiang et al., 2014). Inside cells, 
AgNPs were often found to localise within membrane-bound structures, namely endosomes 
and lysosomes (Jiang et al., 2013; Milic et al., 2015; Gliga et al., 2014). Less frequently, 
AgNPs have also been found in the cell nuclei (AshaRani et al., 2009; Cronholm et al., 
2013). 
Silver nanoparticles have been found to negatively affect the viability of many cell 
types in a concentration- and time-dependent manner. Based mainly on mitochondrial 
metabolic activity (e.g. formazan-based MTT assay) or membrane leakage (e.g. LDH 
assay) endpoints, several studies have reported significant decreases in cell viability upon 
AgNPs exposure. Reported IC50 values (concentrations causing a 50% decrease in cell 
viability) typically ranged from a few μg/mL (e.g. HepG2 cells exposed to 5 nm AgNPs 
(Avalos et al., 2014)) to over 50 μg/mL (e.g. HaCaT cells exposed to 30 nm AgNPs 
(Mukherjee et al., 2012)). This variability likely reflects not only the diverse susceptibility of 
the different cell types to AgNPs, but also the variable physicochemical properties of the 
AgNPs tested. For instance, the size of AgNPs was often shown to have a major influence 
on biological outcomes. In the majority of cases, smaller particles were more cytotoxic than 
larger ones, with AgNPs sized below 40 nm generally causing much higher toxicity (Liu et 
al., 2010; Park et al., 2011; Prasad et al., 2013; Avalos et al., 2014; Wang et al., 2014; Gliga 
et al., 2014; Butler et al., 2015). The surface chemistry and shape of AgNPs were also 
highlighted as determinant to particle toxicity (Stoehr et al., 2011). 
DNA damage and chromosomal aberrations are other commonly reported outcomes 
of AgNPs exposure. In particular, DNA strand breaks and/or micronuclei formation have 
been observed in several AgNPs-exposed human cells, such as fibroblasts and 
glioblastoma cells (AshaRani et al., 2009), epidermal keratinocytes (Austin et al., 2011; 
Szmyd et al., 2012), renal cells (Kang et al., 2012), and white blood cells (Butler et al., 
2015). Induction of bulky DNA adducts (Foldbjerg et al., 2011) and increased levels of 8-
oxo-2'-deoxyguanosine (Jiang et al., 2013), a marker of oxidative DNA damage, have also 
been reported, summing up to recent alerting evidence on the mutagenic potential of AgNPs 
(Huk et al., 2014). Consistently with DNA damage, cell cycle arrest at the G2/M phase, to 
repair damaged DNA, has often been reported (AshaRani et al., 2009; Kang et al., 2012; 
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Song et al., 2012; Foldbjerg et al., 2012; Jiang et al., 2013; Xue et al., 2016). When cellular 
genetic material is damaged beyond repair, cells may initiate apoptotic cell death. Indeed, 
AgNPs have been shown to induce apoptosis in several human-derived cells (Piao et al., 
2011; Szmyd et al., 2012; Xue et al., 2016). Necrosis has also been reported to occur in a 
few studies with AgNPs, to an extent which depended on the cell type (Kim et al., 2012), as 
well as on the time of exposure, size and concentration of AgNPs (Kumar et al., 2015). 
The cells inability to cope with high levels of ROS and to counteract their harmful 
effects leads to oxidative stress. Many studies have proposed this condition to be the main 
mechanism underlying the cytotoxicity and genotoxicity of AgNPs. Indeed, ROS have been 
found to be significantly increased in several types of human cells exposed to AgNPs 
(Suliman et al., 2015; Avalos et al., 2014; Ahlberg et al., 2014; De Matteis et al., 2015). 
Additionally, exposure to AgNPs has been related to other markers of oxidative stress, 
namely lipid peroxidation, protein carbonylation, altered levels of reduced glutathione (GSH) 
and upregulated transcription of stress-related genes (Kim and Ryu, 2013). Together with 
studies showing that ROS scavengers could strongly reduce or eliminate AgNPs toxic 
effects (Hsin et al., 2008; Foldbjerg et al., 2011; Kim et al., 2011a; Kang et al., 2012), there 
is thus strong evidence for a major role of oxidative stress in AgNP-mediated toxicity. The 
causal relationship between AgNPs exposure and increased ROS is thought to be 
explained through multiple events (Foldbjerg et al., 2015): i) the AgNPs themselves and 
their oxidative dissolution to silver ions can directly generate free radicals (He et al., 2012; 
Ahlberg et al., 2014), ii) AgNPs (and/or liberated ions) can enhance ROS production by 
disrupting the mitochondrial electron transport chain, whereby escaped electrons are 
accepted by molecular oxygen and give rise to radical species, iii) antioxidant molecules 
may be depleted and antioxidant enzymes impaired by AgNPs (and/or liberated ions). On 
the other hand, a few studies have underlined the possible additional role of ROS-
independent mechanisms. For instance, Gliga and co-authors found no evidence of ROS 
production preceding DNA damage and postulated that this could be due to direct 
interaction of AgNPs with DNA repair pathways (Gliga et al., 2014). In another work, pre-
treatment of lung cells with a ROS scavenger prevented reduction of cell viability upon 
AgNPs administration but did not stop cell cycle changes, which appeared to be ROS-
independent (Chairuangkitti et al., 2013). 
The contribution of the particles per se and of released silver ions to AgNPs-
mediated toxicity has been a matter of controversy. While some studies attributed toxicity 
solely to Ag+ (Bouwmeester et al., 2011; Prasad et al., 2013), others suggested that Ag+ 
could not entirely account for the effects produced (Foldbjerg et al., 2011; Foldbjerg et al., 
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2012; Grosse et al., 2013; Sambale et al., 2015). Moreover, it has been reported that the 
influence of Ag+ on nanosilver toxicity decreased with increasing particle size (Pratsinis et 
al., 2013) and varied with the silver ion fraction in the AgNPs suspensions (Beer et al., 
2012). Recent works have provided key data to understand this interplay, by clearly 
distinguishing between the effects caused by extracellular and intracellular Ag+ (Cronholm 
et al., 2013; Gliga et al., 2014; De Matteis et al., 2015). Silver ions present in the external 
cell medium showed very low internalisation by cells and induced cell death through 
membrane damage (Cronholm et al., 2013; De Matteis et al., 2015). On the other hand, 
AgNPs were shown to be readily taken up by cells and to release Ag+ intracellularly, in a so 
called ‘Trojan horse’ effect. Indeed, by taking advantage of a recently developed 
chemosensor, De Matteis and co-authors could experimentally demonstrate the gradual 
release of Ag+ inside living cells (De Matteis et al., 2015). Thus, the intracellular dissolution 
of AgNPs, favoured by the acidic environment in the lysosomes and influenced by the 
physicochemical properties of the particles, appears to be a main driver of the AgNPs toxic 
effects on cells. 
While many reports have addressed the acute toxic effects of AgNPs towards 
various cultured cells, there is still insufficient knowledge on possible sub-toxic alterations 
of cell function, more representative of real exposure scenarios. Omics technologies, 
namely genomics, transcriptomics, proteomics and metabolomics, constitute a valuable 
approach in this respect, as they offer the possibility to detect unsuspected subtle changes 
in genes, transcripts, proteins or metabolites before cytotoxic events are detectable by 
conventional methods. In this thesis, metabolomics has been the approach elected to detect 
and aid interpreting biochemical events triggered by exposure to low concentration of 
AgNPs. Thus, the principles of this approach and the state-of-the-art concerning its 
applications in the field of nanotoxicology will be presented in subsequent sections of this 
chapter. Before that, a brief overview of cell metabolism is presented, focusing on some 
major metabolic pathways, as this information is relevant to interpret the results and 
metabolic hypotheses generated within this work. 
 
1.2. Brief overview of major cellular metabolic pathways 
Cellular metabolism can be viewed as a complex network of chemical reactions, 
catalysed by enzymes and strictly regulated, which allow organisms to grow and reproduce, 
maintain their structures, and respond to environmental changes (Nelson and Cox, 2004). 
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As represented in Figure 1.3, these reactions are organised into many inter-dependent 
metabolic pathways (Kanehisa et al., 2016). Some of those pathways are briefly reviewed 
below, due not only to their central importance to animal cells, but also to their particular 
relevance in the context of the results presented in this thesis. 
 
 
Figure 1.3. Diagram illustrating the integration of major metabolic pathways in animal cells. Pyruvate, 
from glycolysis, is either converted into lactate and released, or used to fuel the tricarboxylic acid 
(TCA) cycle. The TCA cycle can also be fuelled by several amino acids, which originate acetyl-CoA, 
pyruvate or cycle intermediates, or by acetyl-CoA resulting from fatty acid oxidation. Citrate, 
generated in the TCA cycle, and NADPH, from the pentose phosphate pathway (PPP), are then used 
for fatty acid synthesis. Finally, NADH and FADH2, produced in the TCA cycle and during fatty acid 
oxidation, contribute for ATP production from the electron transport chain. Green boxes, oxygen-
dependent pathways; blue boxes, oxygen-independent pathways. Adapted from (O'Neill et al., 2016). 
 
1.2.1. Glycolysis and gluconeogenesis 
Glycolysis is a ten-step process by which cells split one glucose molecule into two 
pyruvate molecules, yielding also two ATP and two NADH molecules (Figure 1.4a, left, 
green). It starts with the uptake of extracellular glucose and proceeds within the cell’s 
cytosol. At an initial phase, the six-carbon glucose molecule is phosphorylated to glucose-
6-phosphate, which is converted to fructose-6-phosphate; then, another phosphorylation 
occurs, forming fructose-1,6-bisphosphate, which is split in two three-carbon molecules, 
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glyceraldehyde-3-phosphate and dihydroxyacetone phosphate (later isomerised to 
glyceraldehyde-3-phosphate). In these steps, two molecules of ATP are consumed. Then, 
each molecule of glyceraldehyde-3-phosphate is oxidised and phosphorylated by inorganic 
phosphate (Pi) to form 1,3-bisphosphoglycerate. This reaction is accompanied by the 
reduction of NAD+ to NADH. The two molecules of 1,3-bisphosphoglycerate are then 
dephosphorylated in successive steps, with formation of four ATP molecules (substrate-
level phosphorylation), yielding two molecules of pyruvate. Pyruvate can subsequently be 
oxidised to yield the acetyl group of acetyl-coenzyme A, which enters the tricarboxylic acid 
(TCA) cycle, as part of cellular respiration (section 1.2.2). 
The glycolytic pathway is under tight enzymatic control, phosphofructokinase (PFK-
1) acting as the key regulatory and rate-limiting point of glycolysis (Berg et al., 2002). PFK-
1 is inhibited by ATP and activated by AMP, thus making glycolytic activity dependent on 
the cell energetic status. PFK-1 is also regulated by metabolites which signal the availability 
of building blocks for biosynthesis, being inhibited by citrate (generated in the TCA cycle) 
and long-chain fatty acids. On the other hand, fructose-2,6-bisphosphate is the most potent 
allosteric activator of PFK-1, being able to elevate enzymatic activity even when ATP levels 
are high. 
Although glycolysis is not highly efficient in energetic terms (net production of two 
ATP molecules per each glucose molecule oxidised), it plays essential roles in generating 
NADH molecules, used as electron carriers in multiple biochemical reactions, and in 
providing intermediates for biosynthetic purposes. Accordingly, rapidly proliferating cells 
(such as tumour cells) are often characterised by intense glycolytic activity (Mazurek, 2007). 
To maintain the glycolytic flux, cells must regenerate NAD+ from NADH. This can be 
accomplished in the mitochondria through the electron transport chain, or, especially when 
oxygen is in short supply, through the reduction of pyruvate into lactate, catalysed by the 
enzyme lactate dehydrogenase (LDH) – lactic acid fermentation (Figure 1.4a, bottom, 
purple). 
Another important pathway of glucose metabolism is gluconeogenesis, defined as 
the endogenous production of glucose from non-carbohydrate precursors, mainly lactate, 
certain amino acids and glycerol. These precursors are first converted into pyruvate, either 
directly (e.g. lactate and alanine) or through TCA cycle intermediates (e.g. oxaloacetate 
from aspartate), or enter the pathway at later stages (e.g. glycerol converted to 
dihydroxyacetone phosphate). Although many reactions in gluconeogenesis are the reverse 
of glycolytic steps, specific enzymes are needed to bypass the three irreversible reactions 
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of glycolysis (Figure 1.4a, right, blue). These are pyruvate carboxylase and 
phosphoenolpyruvate carboxykinase, required to form phosphoenolpyruvate from pyruvate, 
fructose-1,6-bisphosphatase, needed to hydrolyse the phosphate ester of fructose-1,6-
bisphosphate and form fructose-6-phosphate, and glucose-6-phosphatase, which catalyses 
the hydrolysis of glucose-6-phosphate into glucose. Gluconeogenesis and glycolysis are 
usually reciprocally regulated so that one pathway is minimally active while the other is 
highly active (Berg et al., 2002). 
 
Figure 1.4. a) Opposing pathways of glycolysis (left, green) and gluconeogenesis (right, blue), and 
lactic acid fermentation (bottom, purple). Circled grey numbers represent the enzymes catalysing 
each reaction: 1, hexokinase; 2, phosphohexose isomerase; 3, phosphofructokinase-1; 4, aldolase; 
5, triose phosphate isomerase; 6, glyceraldehyde-3-phosphate dehydrogenase; 7, phosphoglycerate 
kinase; 8, phosphoglycerate mutase; 9, enolase; 10, pyruvate kinase; 11, pyruvate carboxylase; 12, 
phosphoenolpyruvate carboxykinase; 13, fructose-1,6-bisphosphatase; 14, glucose-6-phosphatase; 
15, lactate dehydrogenase. b) Reactions of the TCA cycle. Enzymes are represented in grey. 
Adapted from (Nelson and Cox, 2004). 
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1.2.2. The TCA cycle and oxidative phosphorylation 
The TCA cycle is a series of eight enzyme-catalysed reactions which take place in 
the mitochondria and form a key part of cellular aerobic respiration (Figure 1.4b). Acetyl-
CoA from glycolysis-derived pyruvate, fatty acid oxidation, or amino acid metabolism, enters 
the TCA cycle by donating its acetyl group to the four-carbon oxaloacetate, forming the six-
carbon citrate, in a condensation reaction. Next, in reversible steps, citrate is dehydrated 
yielding cis-aconitate, which is hydrated to form isocitrate. The oxidative decarboxylation of 
isocitrate, requiring NAD(P)+ as the electron acceptor, then forms α-ketoglutarate, NAD(P)H 
and CO2. Another oxidative decarboxylation follows, in which α-ketoglutarate is converted 
to succinyl-CoA and CO2. In this step, NAD+ also acts as the electron acceptor. Then, 
succinate is reversibly formed through the hydrolysis of the thioester bond in succinyl-CoA. 
This reaction has intermediate steps where the enzyme is phosphorylated, and then the 
phosphoryl group is transferred to ADP/GDP to form ATP/GTP (substrate-level 
phosphorylation). Succinate is then reversibly oxidised to fumarate, and FADH2 is formed 
from FAD. Following the reversible hydration of fumarate to malate, the latter is finally 
oxidised to oxaloacetate, with production of NADH, in a reversible step.  
NADH and FADH2 are two major products of the TCA cycle, which transfer electrons 
to molecular oxygen (reducing it to water) in a set of membrane proteins known as the 
electron transport chain. This leads to the formation of a proton gradient across the inner 
mitochondrial membrane, which powers the synthesis of ATP. Overall, this process of 
oxidative phosphorylation generates 26 (or 28) of the 30 (or 32) ATP molecules formed 
when one glucose molecule is completely oxidised to carbon dioxide and water. Notably, 
the tight coupling between electron transfer (with recycling of electron donors back to the 
TCA cycle) and ADP phosphorylation to ATP ensures that the rate of the TCA cycle matches 
the need for ATP (Berg et al., 2002). 
The TCA cycle also has a role in anabolism, as it provides intermediates for 
biosynthesis, such as succinyl-CoA for the formation of porphyrins, α-ketoglutarate or 
oxaloacetate for the synthesis of amino acids, and citrate for the formation of fatty acids. 
This anabolic role is usually sustained by replenishment of TCA cycle intermediates by 
anaplerosis, mainly using amino acids as substrates, in order to keep the cycle operating. 
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1.2.3. The pentose phosphate pathway (PPP) 
The pentose phosphate pathway occurs in the cytosol, as a parallel branch of 
glycolysis, and comprises a linear oxidative portion and a cyclic non-oxidative phase (Figure 
1.5). The first step is the oxidative decarboxylation of glucose-6-phosphate, ultimately 
leading to: i) the formation of ribose-5-phosphate, used in the synthesis of nucleotides, 
coenzymes and nucleic acids, and ii) the generation of NADPH. This dinucleotide provides 
reducing equivalents for biosynthetic reactions (e.g. synthesis of fatty acids and sterols), as 
well as for regeneration of reduced glutathione (GSH) from its oxidised form (GSSG), in 
order to maintain an adequate cellular redox environment. The non-oxidative branch of the 
PPP consists of the reversible metabolism of five-carbon phosphosugars into 
phosphorylated three- and six-carbon sugars, which can be utilised by glycolysis. 
 
 
Figure 1.5 Schematic representation of the pentose phosphate pathway (PPP): in the oxidative 
phase, glucose-6-phosphate is dehydrogenated and decarboxylated by NADP-dependent enzymes, 
yielding NADPH and ribulose-5-phosphate which is then converted to ribose-5-phosphate, the 
precursor for nucleotides, coenzymes and nucleic acids; in the nonoxidative phase, ribulose 5-
phosphate is converted back to glucose 6-phosphate by a series of reactions catalysed mainly by 
transketolase and transaldolase. NADPH formed in the oxidative phase is used to recycle GSH from 
GSSG and to support reductive biosynthesis. Adapted from (Nelson and Cox, 2004). 
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1.2.4. Fatty acid synthesis and degradation 
Fatty acids are synthesised in the cytosol from acetyl-CoA and NADPH, in a series 
of reactions catalysed by fatty acid synthases. The precursors in fatty acid synthesis may 
derive from glycolysis, the TCA cycle and the pentose phosphate pathway. In particular, for 
the synthesis of straight chain fatty acids, citrate originated in the TCA cycle passes through 
the mitochondrial inner membrane, through the citrate-malate shuttle, into the cytosol where 
it is cleaved, regenerating acetyl-CoA along with oxaloacetate in an ATP-dependent 
reaction. Acetyl-CoA is then carboxylated to form malonyl-CoA, the committed step in fatty 
acid synthesis, catalysed by acetyl-CoA carboxylase and allosterically regulated (through 
activation by citrate and feedback inhibition by palmitoyl-CoA). Elongation of fatty acyl 
chains proceeds with condensation of an acyl group (e.g. from acetyl-CoA) activated by 
fatty acid synthase and two carbons derived from malonyl-CoA, with elimination of CO2. 
The nascent fatty acid chain is then reduced to an alcohol, dehydrated to create a double 
bond, and reduced to form a saturated product. The last four steps are repeated until, for 
example, palmitate, which is the precursor of other long-chain fatty acids, is synthesised. In 
the case of branched-chain fatty acid synthesis, branched-chain amino acids are used as 
substrates for elongation. Fatty acids are then used to generate lipids essential for cellular 
growth and proliferation, namely triacylglycerols and phospholipids. 
Fatty acid degradation takes place in the mitochondria and involves three stages: in 
the first, named β-oxidation, fatty acids are transported into the mitochondria, either by 
diffusion (short-chain fatty acids) or through conjugation with carnitine (medium- and long-
chain fatty acids), where they are oxidised to two-carbon fragments, yielding large amounts 
of acetyl-CoA, NADH and FADH2; then, if the supply of oxaloacetate is sufficient, the 
resulting acetyl-CoA is oxidised to CO2 in the TCA cycle. Alternatively, acetyl-CoA can give 
rise to ketone bodies; finally, the reduced electron carriers FADH2 and NADH produced 
during β-oxidation transfer electrons to O2 through the electron transport chain, for ATP 
generation (oxidative phosphorylation). The rate of fatty acid degradation is coupled to the 
need for ATP, as β-oxidation can continue only if NAD+ and FAD are regenerated, and is 
inhibited by malonyl-CoA, which prevents the translocation of fatty acids into mitochondria 
by inhibiting the formation of acyl carnitine. 
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1.3. Metabolomics in nanotoxicology 
1.3.1. The metabolomics approach 
Metabolomics entails the comprehensive analysis of the inventory of endogenous 
small molecules (molecular mass < 1000 Da) present in a biological system as a result of 
intermediary cellular metabolism (Nicholson et al., 1999; Fiehn, 2002). The general aim is 
to detect/quantify fluctuations in this inventory, the so called metabolome, upon a given 
stimulus/perturbation, such as a disease, a toxicant, a pharmaceutical drug or a 
nanomaterial. Being modulated by the complex interplay between gene expression, 
enzymatic activities and fluctuations in metabolic fluxes, the metabolome closely reflects 
the cell’s functional status. Hence, the comprehensive description of metabolite changes, 
through metabolomics, has the potential to reveal unforeseen deviations from homeostasis 
and to identify new endpoint markers of effect. Moreover, since a metabolite is the same 
chemical entity irrespective of its origin, metabolic profiles of cultured cells can potentially 
be correlated to those of animal tissues/biofluids, thus enabling in vitro-in vivo correlations 
to be proposed. 
The main analytical platforms used in metabolomic studies are nuclear magnetic 
resonance (NMR) spectroscopy and mass spectrometry (MS), the latter being usually 
coupled to liquid (LC) or gas chromatography (GC). These techniques enable the 
simultaneous detection of tens to hundreds of metabolites in complex mixtures like biofluids 
and tissue/cell extracts, providing a holistic approach which is clearly more powerful than 
the measurement of a few pre-established metabolites by classical biochemical methods 
(Lindon and Nicholson, 2008). Data treatment by multivariate statistics is then typically 
employed to deal with data complexity and search for consistent variation patterns or build 
classification models.  
MS-based methods are generally more sensitive than NMR, enabling the detection 
of metabolites present at sub-nanomolar concentrations (Wishart et al., 2013). However, 
the wider view of the metabolome offered by MS methods does not always translate into a 
significant gain in biochemical information, as the resulting data may be extremely complex 
and difficult to interpret. On the other hand, despite inherent sensitivity limitations, high 
resolution NMR shows unparalleled analytical reproducibility and the ability to provide 
unequivocal structural and quantitative information on a wide range of metabolites, present 
in the micromolar-milimolar range. In this work, metabolic profiling of cultured cells has been 
performed through NMR metabolomics. Thus, the basic principles of NMR spectroscopy, 
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as well as of the multivariate analysis and univariate statistical methods employed, will be 
reviewed below. 
 
NMR spectroscopy 
The theory of NMR is thoroughly covered in the literature (Ross et al., 2007; Keeler, 
2010; Zerbe and Jurt, 2014) and the aim of this subsection is not to provide an in depth 
account of NMR fundamentals and methods, but rather to briefly describe the basic 
principles underlying this technique. 
NMR is a phenomenon which occurs when the nuclei of certain atoms are immersed 
in a static magnetic field (B0) and exposed to a second oscillating magnetic field (B1). Not 
all nuclei experience this phenomenon, it depends on whether they possess a property 
called spin (I). Some nuclei carry a total spin (e.g. 1H, 2H, 13C, 15N, 19F, 31P) resulting in a 
magnetic moment µ = γ I h / 2π (where γ is the gyromagnetic ratio of the atomic nucleus), 
while others, with even number of protons and neutrons (e.g. 12C, 14C, 16O), do not, thus 
being undetectable by NMR spectroscopy. 
When nuclear spins with I = ½ (such as protons) are exposed to an external 
homogenous magnetic field B0, usually defined along z, the magnetic moments align 
parallel or anti-parallel with respect to B0, resulting in two spin states α and β with an energy 
difference ΔE. The α and β states are filled according to the Boltzmann distribution, resulting 
in a slight excess of α states at equilibrium (Nα/Nβ = eΔE/kT). This excess of α states gives 
rise to a macroscopic magnetic moment, the so called net magnetisation M0, aligned with 
the z axis. 
To detect an NMR signal, M0 is flipped into the xy plane by applying a radiofrequency 
(RF) magnetic field B1, orthogonal to z, for a defined time period (RF pulse). The 
magnetisation M will align along the x-direction and precess with a resonance frequency    
f0 = γ B0 / 2π. As soon as the RF pulse is turned off, the nuclear spins relax back to 
equilibrium according to two processes: i) the recovery of the magnetization along the z axis 
(longitudinal relaxation characterised by the time constant T1) and ii) the loss of phase 
coherence of spins precessing at different rates in the xy plane (transverse relaxation 
occurring with the time constant T2). Precession of magnetization in the xy plane induces 
an oscillating signal in the detection coil, the so called free induction decay (FID), which is 
then converted into a frequency domain signal by Fourier transformation (FT) (Figure 1.6). 
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Figure 1.6. Detection of an NMR signal: (left) a sample with many spins (>1012) is placed inside a 
strong external magnetic field B0 (orange) oriented along the z-direction. The sample is enclosed in 
a detection coil (green). At thermal equilibrium about one spin in every 10,000 contributes to a 
macroscopic magnetisation M0 shown in transparent red. After short application of a high-frequency 
B1 field (90º pulse, black bar at the left panel) the magnetisation is aligned along the x-axis of the 
rotating B1 field, and starts to precess around B0. Adapted from (Ross et al., 2007). 
 
Nuclei with different chemical environments (electronic cloud/chemical 
neighbourhood) will resonate at slightly different frequencies, giving rise to signals in 
different positions of the NMR spectrum. The frequency values are converted into chemical 
shifts (in parts per million), based on the frequency of a reference compound, so that 
chemical shifts are independent of B0 and data acquired at different field strength can be 
directly compared. 
The 1H chemical shifts of some characteristic functional groups are comprised within 
the relatively narrow range of 0-15 ppm: saturated hydrocarbons generally resonate 
between 1.0 and 4.0 ppm, whereas the olefinic protons appear in the region of 5.0-6.5 ppm 
and the resonances of aromatic protons are in the region of 6.5-10 ppm.  
Another important property of NMR signals is their splitting pattern, which reflects 
the interactions between neighbouring spins, via the electrons in the chemical bond – scalar 
or J coupling. For nuclei with I = ½, the multiplicity of the line splitting equals n + 1, where n 
is the number of non-equivalent nuclei in the neighbouring group. The line separation (in 
Hz) corresponds to the coupling constant (J) between the nuclei, which generally decreases 
as the number of bonds between the coupled nuclei increases.  
1H NMR is inherently quantitative, as the area under each signal is proportional to 
the number of protons that originate that signal. However, some conditions must be obeyed 
to perform absolute quantification, namely a sufficiently long delay between repetitions 
(scans) to allow the full relaxation of nuclear spins. In particular, a perfect linearity between 
the NMR signal and analyte concentration requires that the inter-scan delay (recycle time) 
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is larger than five times the longest T1 in the sample (Bharti and Roy, 2012). For most 
metabolites, T1 relaxation times are in the range 1-3 s (Ross et al., 2007), hence quantitative 
conditions require long acquisition times. This is often impractical due to time constraints 
and metabolomic studies typically rely on relative quantification of metabolites. 
The unambiguous identification of resonances in the 1H NMR spectrum of a 
biological sample, usually characterised by a rich, complex composition, requires the use 
of two-dimensional (2D) NMR methods. In general, these methods are based on the 
acquisition of a set of 1D spectra under incrementation of a t1 evolution delay (Figure 1.7a). 
Performing FT in respect to both t1 and t2 (acquisition time of each FID) produces a 2D map 
where the spectral amplitude is plotted as a function of two frequency dimensions. Among 
the most commonly employed 2D methods are homonuclear shift-correlation experiments 
(Figure 1.7b), namely correlation and total correlation spectroscopy (COSY and TOCSY, 
respectively). In 1H-1H TOCSY, additional cross peaks show up for pairs of spins which 
have a common coupling to another spin, through multistep transfer of the magnetization 
over a network of nuclei in a molecule. If the correlation is between different nuclei e.g. 1H 
and 13C, the experiment is called heteronuclear (Figure 1.7c). For instance, in a 1H-13C 
heteronuclear single quantum coherence (HSQC) spectrum, one dimension shows the 
chemical shift of 13C and the other the chemical shift of the directly bound 1H (correlated via 
the 1JCH coupling constant). Another frequently used 2D experiment is the J resolved (J-
res), where J-coupling information is separated into a second dimension from the chemical 
shifts (Ross et al., 2007). 
 
 
Figure 1.7 a) Diagram illustrating a basic 2D NMR experiment: a set of 1D spectra are acquired 
under incrementation of a t1 evolution delay, and FT is performed with respect to t1 and t2; b) 2D 
homonuclear correlation spectrum, where the off-diagonal cross peaks code for magnetization which 
was transferred by a selected interaction mechanism between two spins; c) 2D heteronuclear 
correlation spectrum, where proton magnetization was transferred to carbons (evolution along t1) and 
back to protons for detection along t2. Adapted from (Ross et al., 2007). 
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Multivariate analysis (MVA) 
Since each 1D NMR spectrum comprises a wide range of variables (metabolites) 
and numerous spectra are often acquired within a study, multivariate analysis (MVA) is 
required to reduce data complexity and extract meaningful biochemical information. 
Multivariate analysis (MVA) enables the multi-parametric evaluation of complex 
datasets, such as 1H NMR spectra from multiple samples, thus helping to unveil consistent 
differences between sample groups. A typical MVA workflow, similar to that used in this 
work, is shown in Figure 1.8. After appropriate data pre-treatment, which commonly 
includes signal alignment, normalisation and scaling procedures (Veselkov et al., 2009), the 
data are initially explored through unsupervised methods, such as principal component 
analysis (PCA), whereby no a priori information on sample groups is included.  
 
 
Figure 1.8. Typical workflow for the multivariate analysis of NMR data in metabolomic studies. 
 
PCA is a projection-based method which converts the multidimensional data table 
(in this case, a spectral matrix composed of samples or observations and variables) into a 
lower-dimensional matrix. In PCA, the original variables are converted into a set of 
uncorrelated (orthogonal) variables, called principal components (PCs: PC1, PC2,…PCn), 
thereby defining a lower n-dimensional space to represent the data. The PCs are linear 
combinations of the original variables computed so that PC1 accounts for most of the 
variance, PC2 for the 2nd largest variance and so on, always obeying the constraint that all 
PCs are orthogonal to each other. Hence, PCA allows samples (observations) to be 
distributed in a scores scatter plot according to the similarities and differences in their 
profiles. The influence (weight, w) of each variable on sample clustering is then given by 
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the loadings projection, knowing that the disposition of the observations in the scores plot 
is related to the disposition of the variables in the loadings plot (Figure 1.9).  
After initial data exploration, supervised methods (i.e. methods whereby information 
on class membership is included) may follow to build classification models and provide 
improved information on the variables accounting for sample separation. Partial least 
squares discriminant analysis (PLS-DA) is the most commonly used method for this 
purpose. PLS-DA assesses the relationship between the original data matrix X and a 
second matrix Y containing qualitative values which relate to sample class. The goal is to 
define new variables (latent variables, LVs) which model both the data matrix X and the 
correlation with Y, i.e. which maximise class discrimination. Similarly to PCA, the results of 
PLS-DA can be visualised through scores and loadings plots. Additionally, the loadings may 
be coloured as a function of variable importance to the projection (VIP) to highlight the most 
discriminant metabolites (with VIP > 1). 
 
Figure 1.9. Scheme representing principal component analysis (PCA), whereby the observations 
are projected into the space defined by the new reduced set of variables (principal components) 
obtained by linear combination of the original variables. Reprinted with permission from (Trygg et al., 
2007), Copyright © 2007 American Chemical Society. 
 
Given the very high ratio of variables to samples typically characterising the matrices 
used in metabolomic studies, PLS-DA models are prone to over-fitting and sample 
separation in the scores plot does not always correspond to consistent differences between 
the groups. A way to assess model robustness is through cross validation methods and 
permutation testing (Westerhuis et al., 2008). For instance, in Monte Carlo cross validation 
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(MCCV), used in this work, the data is randomly divided into calibration and validation sets, 
and internal cross validation of the calibration set is followed by prediction of class 
membership in the validation set (Xu and Liang, 2001). This process is repeated for a 
number of iterations (500-1000), each time with a randomly changed composition of the 
calibration and validation sets. The resulting confusion matrix can then be used to calculate 
sensitivity and specificity, which may be plotted in a receiver operating characteristic (ROC) 
space. Also, a chiefly important parameter to assess model robustness is the cross-
validated explained variance or predictive power (Q2), which represents the fraction of total 
variation of X and Y matrices that can be predicted by the extracted components; the closer 
Q2 is to 1 the more robust is the model.  
 
Univariate analysis 
Measurement of signal integrals to quantify the extent of specific metabolic 
variations is often performed in NMR metabolomics as a complement to MVA. The most 
simple and straightforward way to evaluate such extent is to calculate the percentage of 
variation (%var) between two groups (Equation 1.1, where  is the average value in a given 
group). This value should be accompanied by its respective error, which takes into account 
the standard deviation (s) and the number of samples (n) in each group (Equation 1.2). 
 
%var = 
  x 100    Equation 1.1. 
 
error (%) = 
	


	
(	×	×)(		)
 x 100  Equation 1.2. 
 
Another way to express the magnitude of variation between groups is through the 
calculation of the standardised mean difference or effect size (ES) (Berben et al., 2012). 
This parameter accounts for the standard deviations (s1 and s2) associated with the means 
compared ( and ) and the number of samples (n1 and n2). As shown in equation 1.3, 
the difference between the average of each group is divided by their pooled standard 
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deviation; df stands for degrees of freedom and corresponds to n1 + n2 - 2. The standard 
error (SE) of the standardised mean difference is then calculated according to Equation 1.4. 
In order to avoid a biased ES due to small sample numbers, a correction (J) can be applied 
by multiplying J (Equation 1.5) by the ES value. The same correction should also be applied 
to the SE. 
 
ES = 

(	)×(	)×
  Equation 1.3. 
SE =
× + (
)   Equation 1.4. 
J = 1 –  
×   Equation 1.5. 
 
Using the ES as a measure of the magnitude of variations is advantageous because 
not only it accounts for intra-group dispersion, as it is reasonably insensitive to sample size, 
thus providing more reliable comparison of small sample sets. According to Cohen and 
colleagues absolute effect sizes around 0.2, 0.5 and larger than 0.8 correspond to small, 
medium and large variations, respectively (Cohen, 1988). Thus, in this work, the criterion 
for considering a variation to be relevant was absolute ES > 0.8. 
Additionally, the p-value determined through the student t-test (or a non-parametric 
analogue like the Wilcoxon test) provides information on the statistical significance of the 
difference between the two means compared. The p-value expresses the probability of 
rejecting the null hypothesis (no difference between the means compared) at a pre-
established significance level. However, p-values are greatly influenced by sample size 
(Kalinowski and Fidler, 2010), decreasing with increasing number of samples compared. 
This means that an effect can be large, but fail to meet the often used p < 0.05 criterion if 
the sample size is small. 
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Correlation analysis 
The statistical correlation between two metabolites can be very helpful in identifying 
biochemical relationships. The Pearson correlation coefficient, r, gives an estimate of the 
degree of linear association between normally distributed variables, and is calculated 
through Equation 1.6, where x and y are metabolites, forming n pairs. Inverse correlation 
between variables is demonstrated through negative r values, -1 being the value for the 
maximum inverse association; conversely positive r values indicate positive correlations, 
with maximum at r = 1. 
 
r = 
∑ ( ! ̅)(#!#)	!$
∑ ( ! ̅)	!$ ∑ (#!#)	!$    Equation 1.6. 
 
It is also possible to correlate a single variable with all variables in a NMR spectral 
matrix, through statistical total correlation spectroscopy (STOCSY) (Cloarec et al., 2005). 
In NMR studies, this procedure is particularly helpful for the assignment of unknown 
resonances. Here, the correlation matrix C is computed from a set of sample spectra 
according to Equation 1.7, where X1 and X2 designate the autoscaled experimental matrices 
and n is the number of spectra. 
 
C =  
%   Equation 1.7. 
 
1.3.2. Considerations about NMR metabolomics of cultured mammalian cells 
Metabolomic studies of cultured mammalian cells have been growing exponentially 
over the last years, with applications reported in diverse areas like toxicology, drug testing, 
mechanistic understanding of diseases and pharmaceutical research (León et al., 2013). 
Compared to metabolomics of animal models or human subjects, in vitro cell 
metabolomics offers several advantages, such as a high control over experimental 
variables, less stringent ethical issues, lower costs and potentially lower biological variability 
(Čuperlović-Culf et al., 2010). On the other hand, the metabolomic analysis of cultured cells 
involves specific requirements that can be quite challenging. One critical issue is the 
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number of cells needed to obtain detailed metabolic information. Under common NMR 
acquisition conditions (500-600 MHz field strength, regular high resolution probe), a 
minimum of ~3-5 million cells per sample is typically required to detect a few tens of 
metabolites (Khoo and Al-Rubeai, 2007; Duarte et al., 2009a). Thus, in a study involving 
several experimental conditions and biological replicates of each condition, growing 
sufficiently high cell numbers can be a demanding task. This is probably one of the reasons 
why cell lines are more extensively used than primary cultures, as the first are much easier 
to grow and present nearly unlimited lifespan. Moreover, cell lines tend to have stable 
phenotypes which do not depend on donor characteristics, unlike primary cells, particularly 
those of human origin, which are characterised by high phenotypic variability (León et al., 
2013).  
 
Another important aspect when culturing adherent cells, is the method of 
detachment from the culture surface. A commonly used method consists of using trypsin, 
to cleave cell adhesion proteins, together with ethylenediaminetetraacetic acid (EDTA) to 
chelate calcium ions needed for integrin-mediated cell attachment. Although trypsinization 
is extensively used in routine cell culture, it has been argued that it alters the physiological 
state of cells, changing their metabolic profile (Teng et al., 2008). Moreover, depending on 
the cell type and the time required for trypsinization, this procedure has been shown to 
cause significant metabolite leakage by increasing cell membrane permeability (Dettmer et 
al., 2011). Another inconvenience regards the time-consuming steps that follow trypsin 
addition (washing and centrifugation), which can lead to metabolite modifications and 
further losses. An alternative approach consists of mechanically scraping the cells of the 
culture surface, after medium removal. In particular, direct scraping in the presence of the 
extraction solvent has been recommended as the harvesting procedure that maximises 
overall metabolite yield and enables rapid metabolism quenching (Teng et al., 2008; 
Dettmer et al., 2011; Garcia-Canaveras et al., 2011).  
The quenching (deactivation) of cellular metabolic activity at the time of sampling is 
critical to avoid fluctuations in metabolite levels during sample collection and processing, 
which could lead to misleading results. There are several ways to halt enzymatic activity, 
such as liquid nitrogen freezing, addition of ice-cold organic solvents or of quenching buffers 
(León et al., 2013). If cell integrity is to be preserved, the use of a cold isotonic saline solution 
(0.9% NaCl, 0.5ºC) is favoured (Dietmair et al., 2010).  
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When using NMR spectroscopy, cells can either be analysed directly or subjected 
to solvent extraction to obtain liquid metabolite mixtures. Direct analysis of whole cells can 
involve tube NMR (with inherent disadvantages of poor resolution and sample deposition 
over time) or high resolution magic angle spinning (HRMAS) NMR. This latter method allows 
well-resolved spectra of whole cells to be recorded (especially if cells have been lysed), 
providing simultaneous information on both small metabolites and macromolecular 
components (Duarte et al., 2009b). Also, it avoids losses or modifications possibly 
associated with extraction procedures, offering a closer representation of the real cellular 
composition and environment. On the other hand, quantification of metabolites from 
HRMAS spectra presents additional complexity, as the visibility of signals is not only 
dependent on metabolite abundance but also on their molecular mobility. For instance, 
while the lipid signals detected by HRMAS 1H NMR of cell pellets/suspensions correspond 
mainly to highly mobile neutral lipids in cytosolic droplets (Lutz et al., 2005), lipid extracts 
have a better chance to represent the entire cellular lipid pool, including membrane lipids. 
In addition, given the possibility of using an automatic sample changer for liquid samples, 
the NMR analysis of cell extracts is much faster than HRMAS of whole cells, which is 
especially important when high sample numbers are to be analysed. 
 
Cell extraction protocols reported in the literature vary in conditions like type of 
solvent and volume proportion, number of extraction cycles, duration of each cycle, 
temperature and homogenisation method (León et al., 2013). Given the diverse chemical 
nature of intracellular metabolites, there is no universal method capable of extracting the 
whole cellular content. Nevertheless, efforts have been made to establish the most efficient 
and reproducible extraction procedures which are compatible with the analytical platform to 
be used. In particular, different solvent mixtures have been extensively tested, including 
different proportions of water, acids and organic solvents (Dettmer et al., 2011; Martineau 
et al., 2011). Among the solvent mixtures compared, the one based on methanol, 
chloroform and water was highlighted as the most suitable for retrieving a higher number of 
metabolites from adherent mammalian cells and for achieving reliable and robust NMR 
metabolic profiles (Martineau et al., 2011). Also, this mixture allows the dual-phase 
extraction of both polar and lipophilic compounds, allowing their composition to be 
characterised separately. 
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In this work, after a careful literature review and some experimental tests (results 
not shown), we have decided to perform cell metabolomics by solution state NMR of cellular 
polar and lipophilic extracts, together with NMR of culture medium supernatants. The 
experimental details of sample collection and preparation are presented in Chapter 2. 
 
1.3.3. State-of-the-art of metabolomics applications in nanotoxicology 
Assessing the metabolic changes induced by nanomaterials on cellular or animal 
models, through NMR or MS-based metabolomics, is increasingly proving its value for 
revealing unforeseen biological effects and helping to understand the mechanisms of 
nanomaterials toxicity (Duarte, 2011; Lv et al., 2015). Indeed, the number of scientific 
papers reporting metabolomic applications in nanotoxicology has been continuously 
growing over the last years (Figure 1.10a). The earliest reports date back to 2008-2010 and 
used NMR analysis of animal (rats) biofluids to assess the systemic responses to the 
administration of copper (Lei et al., 2008), titanium dioxide (Bu et al., 2010) or iron oxide 
(Feng et al., 2010) nanoparticles. Subsequently, in 2011, the first papers describing the 
metabolic responses of cultured mammalian cells to nanomaterials were published (Figure 
1.10b). Both NMR spectroscopy and MS-based analytical platforms have been used in 
those studies (Figure 1.10c) and the complementarity of the various methods in revealing 
different aspects of the metabolome has often been highlighted.  
Among the nanomaterials addressed by metabolomics, titanium dioxide and silica 
nanoparticles were the ones most extensively studied (Figure 1.10d). This was probably 
due to their widespread industrial uses and incorporation into consumer products (thus 
causing increased occupational exposure), together with emerging biomedical applications. 
For similar reasons, the interest in AgNPs has intensified over the last years, as largely 
reflected by the work produced within this thesis (Carrola et al., 2016a; Carrola et al., 
2016b). 
Note, however, that before the commencement of this work, the information about 
the impact of silver nanoparticles on cell metabolism was very scarce. A preliminary study 
published in 2011 by Kim and co-authors examined the metabolic effects of AgNPs on 
cultured liver cells and suggested that the changes observed were mediated by oxidative 
stress and glutathione metabolism (Kim et al., 2011c). However, the lack of information on 
nanoparticle properties and exposure conditions, as well as of proper validation of metabolic 
changes, hampered solid conclusions from that work. As for in vivo metabolomics of AgNPs, 
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studies have focused on the environmental impact of these particles, using a terrestrial 
invertebrate earthworm (Li et al., 2015b) and a freshwater invertebrate (Li et al., 2015a) as 
model organisms. On the other hand, the investigation of mammalian models with a view 
to assess putative effects of AgNPs on human health, has been addressed in two studies, 
one confined to the analysis of rat urine (Hadrup et al., 2012) and the other, published by 
our group, comprehensively describing the metabolic effects of AgNPs on mice serum and 
several organ tissues (paper submitted). 
 
 
Figure 1.10. Published papers reporting metabolomic applications in nanotoxicology: a) total number 
of published papers, by year; b) distribution according to the model in study; c) distribution according 
to the analytical platform used; d) distribution according to the nanomaterial tested. Source: Web of 
Science, September 2016 (ThomsonReutersTM, 2016); search terms: (metabolomics or 
metabonomics) and (nanoparticles or nanomaterials). 
 
Other nanoparticles investigated through metabolomics included gold nanorods, 
several metal oxide nanoparticles, carbon nanotubes and graphene nanosheets (Figure 
1.10d). A summary list of metabolomic applications in nanotoxicology, using in vitro or in 
vivo animal models, is presented in Table 1.1. The biochemical findings of some of these 
works will be discussed, when pertinent, along with the results presented through Chapters 
4 to 6 of this thesis. 
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1.4. Scope and aims of this thesis 
There is compelling evidence that the interaction of nanomaterials with cell 
membranes or internal organelles may affect multiple pathways (e.g. oxidative stress 
regulation, inflammation, apoptosis, cell cycle), translating into molecular alterations at the 
gene/protein level (Klaper et al., 2014) and ultimately leading to changes in cell metabolism. 
This thesis aimed at deepening current understanding of the impact of AgNPs on cell 
metabolism and function, using a NMR-based metabolomics approach applied to cultured 
cells. Three cell models have been selected for the study, namely: i) human epidermis 
keratinocytes (HaCaT cells), as skin is a major entry portal for AgNPs, ii) human liver 
hepatoma (HepG2) cells, given the preferential accumulation of AgNPs in the liver and the 
role of hepatic cells in detoxification mechanisms, and iii) murine blood macrophages (RAW 
264.7), which actively participate in the uptake of nanoparticles from the bloodstream and 
in the modulation of inflammatory responses. Well-characterised, ultra-purified AgNPs have 
been used to enable meaningful relationships between nanoparticle properties and 
biological outcomes to be established.  
 
The specific objectives of this work were: 
- To comprehensively characterise the metabolic activity and intracellular 
metabolomes of the three cell types studied (keratinocytes, liver cells and macrophages).  
- To describe the changes in the exo- and endometabolome of cultured cells upon 
exposure to AgNPs, Ag+ and H2O2. 
- To obtain mechanistic insights into the modulation of cellular metabolism by AgNPs, 
particularly at sub-toxic concentrations.  
- To enlighten structure-activity relationships in respect to the influence of AgNPs size 
and surface coating. 
- To distinguish between AgNPs-specific effects and the effects due to Ag+ released 
from the oxidised nanoparticle surface.  
- To identify metabolic effects related to oxidative stress. 
- To contribute for the validation of cell metabolomics as a novel approach in the risk-
benefit assessment of nanomaterials. 
 
Chapter 2 
 
35 
 
Chapter 2. Materials and methods 
2.1. Silver nanoparticles: sources and characterisation 
Most AgNPs used in this work were purchased from a specialised supplier and were 
of high purity to avoid unwanted interferences in biological tests. Silver nanoparticles 
synthesised in-house by project collaborators (Dr C. Freire and co-workers) were also used. 
The physicochemical properties of all AgNPs were carefully checked and monitored 
throughout storage time, by different techniques, as described below. Nanoparticle 
characterisation was performed using the equipment available at CICECO (Universidade 
de Aveiro), with the assistance of project partners (Dr A.L. Daniel-da-Silva and co-workers). 
 
2.1.1. Sources of AgNPs 
Sterile, purified and endotoxin-free AgNPs (Biopure AgNPs 1.0 mg/mL), having 
either a citrate surface layer, with diameters of 10, 30 or 60 nm, or a methoxy(polyethylene 
glycol)-thiol coating (mPEG-SH 5 kDa), with diameters of 10 and 30 nm, were purchased 
from nanoComposix Europe (Prague, Czech Republic). Moreover, nanoparticles coated 
with bovine serum albumin (BSA) were prepared based on a procedure previously 
described (Beer et al., 2012). Briefly, 7 μL of a BSA solution (135 mg/mL) were added to 63 
μL of a commercial colloidal solution of citrate-stabilised 30 nm AgNPs (Biopure 1.0 mg/mL) 
and vortexed for 1 h at room temperature, protected from light, before overnight storage at 
4 ºC. 
Biogenic AgNPs were prepared by project collaborators through the reduction of 
silver nitrate with an aqueous extract of Eucalyptus globulus Labill. bark, as described in 
their published work, with minor modifications (Santos et al., 2014). In brief, autoclaved E. 
globulus extract was added to an AgNO3 aqueous solution (1 mM), at a 1:3 volume ratio, 
and allowed to react in a sealed container for 72 hours. Then, the nanoparticle suspension 
was centrifuged, and the supernatant was replaced with ultra-pure water, and centrifuged 
again. The final nanoparticle suspension was stored at 4 ºC, protected from light. 
 
2.1.2. Transmission Electron Microscopy (TEM) 
TEM is a powerful technique used for nanoparticle characterisation, since it allows 
the measurement of particle and/or grain size, size distribution, morphology, and crystal 
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structure (Rao and Biswas, 2009). In a transmission electron microscope, a focused beam 
of electrons is transmitted at a high acceleration voltage through a thin sample; images are 
formed from electron scattering resulting from the interaction between the sample and the 
electron beam. The contrast of the sample in relation to the background gives information 
on the size and shape of the nanoparticles.  
In this work, samples for TEM analysis were prepared by placing a drop of a diluted 
aliquot of AgNP colloidal solution on a copper support grid coated with an amorphous 
carbon film. The solvent was allowed to air dry at room temperature. Then, the morphology 
and size of AgNPs were assessed by TEM using a Hitachi H9000 NAR microscope (Hitachi 
High-Technologies Europe GmbH, Krefeld, Germany) operating at 300 kV. 
 
2.1.3. UV-Visible (UV-Vis) Spectroscopy  
UV-Vis spectroscopy enables a rapid and simple evaluation of AgNPs stability. The 
optical properties of AgNPs arise from oscillating electron clouds at the metal-solution 
interface in resonance with the incident electromagnetic radiation, termed surface plasmon 
resonance (SPR) (Liz-Marzán, 2006). The characteristic SPR absorbance peak (λmax) of 
AgNPs is observed at about 400 nm (Braun et al., 2013). However, this peak is strongly 
affected by particle size and aggregation state, leading to either a lower wavelength, for 
smaller particles, or to a band broadening accompanied by red shifting, for 
larger/agglomerated particles (Hassellov et al., 2008; MacCuspie, 2011). 
The optical spectra of AgNPs colloidal solutions were recorded using a Jasco V-560 
UV-Vis spectrophotometer, over a range from 300 to 900 nm, with a band width of 0.5 nm. 
1 mL solutions were prepared by adding AgNPs to either ultra-pure water or complete 
culture medium, to a final concentration of 10 μg/mL. Samples were incubated at 37 ºC, 
simulating cell culture conditions, for variable periods (0, 4, 24 or 48 h) before UV-Vis 
measurements. 
 
2.1.4. Dynamic Light Scattering (DLS) 
DLS is a commonly used technique for measuring the size of nanoparticles in 
solution. It is based on the ability of individual particles in solution to scatter light from a 
laser and on the fluctuating movements originating from the Brownian motion (Calzolai et 
al., 2012). Considering that larger particles diffuse slower than smaller particles, and taking 
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into account liquid viscosity and temperature, particle size can be calculated from the 
Stokes-Einstein equation (Equation 2.1), where Dh is the hydrodynamic diameter, k is the 
Boltzmann’s constant, T is the absolute temperature, η is the refractive index of the solvent, 
and D is the diffusion coefficient (Hassellov et al., 2008): 
 
&' = )*+,-    Equation 2.1. 
 
Another important parameter measured by DLS is the polydispersity index (PdI), 
which indicates the width of the particle size distribution. A PdI < 0.1 generally indicates 
monodispersity, while PdI values in the 0.1 – 0.4 range or > 0.4 reflect moderate or broad 
polydisperse size distributions, respectively (Nobbmann, 2014). 
Here, the Dh and the PdI of the nanoparticles were measured by DLS, using a 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Samples were prepared by adding 
AgNPs to 1 mL of either ultra-pure water or complete culture medium, to a final 
concentration of 10 μg/mL. Prior to analysis, samples were incubated at 37 ºC, simulating 
cell culture conditions, for variable periods (0, 4, 24 or 48 h). 
 
2.1.5. Zeta potential 
The surface charge of nanoparticles in solution can be measured through zeta 
potential analysis. The zeta potential typically ranges from +100 mV to -100 mV and is 
defined as the electric potential formed at the boundary of the electrostatic double layer of 
particles in solution as measured by electrophoresis (Hassellov et al., 2008). At values 
greater than +25 mV or less than -25 mV, the nanoparticle dispersion presents high stability 
due to electrostatic repulsion (nanoComposix, 2016b). 
In this work, the zeta potential was assessed by electrophoretic mobility, using a 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Samples of 10 μg/mL AgNPs were 
prepared in ultra-pure water or complete culture medium, and incubated at 37 ºC, simulating 
cell culture conditions, for variable periods (0, 4, 24 or 48 h). 
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2.1.6. Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
In order to quantify the amount of free ionic silver in AgNPs colloidal suspensions 
and study the Ag+ release behaviour in culture medium, we have used ICP-OES. Samples 
for ICP-OES were prepared by addition of 10 μL AgNPs (1.0 mg/mL) to 990 μL of either 
ultra-pure water or complete culture medium, incubated for variable periods (0, 4, 24 or 48 
h), followed by centrifugation at 40000 x g for 120 min at 4 ºC (in accordance with the 
manufacturer’s recommendations) to deposit the nanoparticles and separate the 
supernatant. Acid digestion of the supernatant was then performed by mixing 500 μL with 
100 μL of acids (HCl:HNO3 2:1 v/v) and 400 μL of ultrapure water (HCl from Merck, 
Darmstadt, Germany, and HNO3 from Panreac, Barcelona, Spain). The percentage 
dissolution of AgNPs to ionic silver was calculated as 100 x F x [Ag]/Ci, where F is the 
dilution factor, Ci the initial concentration of AgNPs and [Ag] the concentration of silver 
determined by ICP-OES. Silver quantification measurements were performed by ICP-OES 
at Laboratório Central de Análises (Universidade de Aveiro) by a specialised technician. An 
Activa M Radial spectrometer (Horiba Jobin Yvon, Kyoto, Japan), employing a charge 
coupled device (CCD) array detector, with a wavelength range of 166–847 nm and radial 
plasma view was used. Samples were introduced into the ICP plasma using an HF resistant 
sample introduction system including a Burgener nebuliser, a cyclonic spray chamber and 
a quartz torch with aluminium injector. 
 
2.2. Cell culture and biological assays 
2.2.1. Chemicals 
Dulbecco's modified Eagle's medium (DMEM), foetal bovine serum (FBS), 
antibiotics, L-glutamine, sodium pyruvate, phosphate buffer saline (PBS, pH 7.4) and 
trypsin-ethylenedieminetetraacetic acid (trypsin-EDTA) were purchased from Life 
Technologies (Carlsbad, CA, USA). Silver nitrate (AgNO3), hydrogen peroxide (H2O2), 
bovine serum albumin (BSA), sodium citrate, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), chloroform, methanol, 
sodium phosphate monobasic (NaH2PO4), sodium phosphate dibasic (Na2HPO4) and 
deuterium oxide containing 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt 
(D2O/TSP, 99.9 atom % D, 0.75 wt. % TSP) were obtained from Sigma-Aldrich (St. Louis, 
MO, USA). Polyethylene glycol (PEG, Mw 5 kDa) was purchased from Laysan Bio ® (Arab, 
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AL, USA). D2O (99.96%) and deuterated chloroform with 0.03% tetramethylsilane (TMS) 
were purchased from Euriso-top (Saint-Aubin, France). 
 
2.2.2. Cell lines 
Human epidermis keratinocytes (HaCaT) are a spontaneously immortalised 
epithelial cell line established from adult skin (Boukamp et al., 1988). This cell line maintains 
full epidermal differentiation capacity, has an approximate doubling time of 24 hours and 
can be propagated for more than 140 passages. The HaCaT cells used in this work were 
obtained from Cell Lines Service (Eppelheim, Germany).  
The human hepatoma cell line (HepG2) derives from a liver biopsy of a 15-year old 
Caucasian boy with a well-differentiated hepatocellular carcinoma (Aden et al., 1979). 
These cells have epithelial morphology comparable to liver parenchymal cells. HepG2 were 
obtained from European Collection of Authenticated Cell Cultures (ECACC) and supplied 
by Sigma Aldrich (St. Louis, MO, USA). 
Murine RAW 264.7 macrophages are a blood macrophage cell line isolated from the 
ascites of a tumour induced in a male BAB/14 mouse by the intraperitoneal injection of 
Abelson leukaemia virus (Raschke et al., 1978). When placed in mice, these cells are 
tumorigenic. In culture, RAW 264.7 grow very fast, with a doubling time of 12 h (Bancos 
and Tyner, 2014). The RAW 264.7 cells used in this work were gently provided by Dr Philipp 
Seib, University of Strathclyde, Glasgow, UK. 
 
2.2.3. Routine cell culture maintenance 
All cells were grown in high glucose DMEM supplemented with 10% FBS, 2 mM L-
glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin and 250 μg/mL fungizone, in 75 
cm2-flasks, at 37 ºC in 5% CO2 humidified atmosphere, until 80% confluency was reached. 
The medium of HepG2 cells additionally contained 1 mM sodium pyruvate, as this was 
recommended by the supplier and found to improve cell growth. 
Cells were then washed with PBS (pH 7.4), and either trypsinized (HaCaT and 
HepG2 cells) or gently scraped (RAW 264.7 macrophages). For trypsinization, cells were 
incubated with 0.25% trypsin/EDTA at 37 ºC in 5% CO2 humidified atmosphere, for 5 min; 
HaCaT cells were previously incubated with PBS/EDTA, at 37 ºC in 5% CO2 humidified 
atmosphere, for 10 min. After cell dislodging, trypsin was neutralised by adding complete 
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DMEM (twice the volume of trypsin/EDTA); cells were counted and re-seeded in complete 
DMEM. Cells were subcultured every 3 to 4 days. 
 
2.2.4. Cell viability assay 
Cell viability was measured through a colorimetric assay using the yellow-coloured 
tetrazolium salt (MTT) that is reduced by mitochondrial dehydrogenases of metabolically 
active cells, forming purple formazan crystals (Mosmann, 1983). Formazan accumulates 
inside viable cells, and thus the percentage of living cells can be estimated from the 
sample’s absorbance at 570 nm.  
 
HaCaT cells 
For the MTT assay, HaCaT cells were seeded in 96-well plates, at densities of 1.8 
x 104/cm2 or 1.5 x 104/cm2, for 24 and 48 h response curves, respectively. Twenty four hours 
later the medium was replaced with fresh medium containing: AgNPs (concentration range 
0.5-100 μg/mL), ionic silver (Ag+), added as AgNO3 (concentration range 0.5-2 μg/mL), H2O2 
(concentration range 50-500 μM), sodium citrate (50-400 μM), mPEG(-SH) (6-200 μg/mL) 
or BSA (10-200 μg/mL). After additional 24 h or 48 h, 50 μL of MTT (1 mg/mL) in PBS were 
added to each well, and incubated for 4 h at 37 ºC, 5% CO2 humidified atmosphere. MTT 
solution was then removed and 150 μL of DMSO were added to each well for formazan 
crystal solubilisation. The optical density of reduced MTT (formazan) was measured at 570 
nm in a microtiter plate reader (Synergy HT Multi-Mode, BioTek, Winooski, VT, USA) and 
the cell metabolic activity (MA) was calculated from Equation 2.2, where AbsEXP is the 
absorbance measured in exposed samples, AbsDMSO is the absorbance measured in wells 
containing only DMSO, and AbsCT is the absorbance measured for control cells (non-
exposed). Three independent assays, with three technical replicates each, were performed. 
 
MA =  
./012./03456./078./03456  x 100   Equation 2.2. 
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HepG2 cells 
Cells were seeded at a density of 5.6 x 104, in 96-well plates, and after 24 h the 
medium was replaced with fresh medium containing: AgNPs (concentration range 1-25 
μg/mL), ionic silver (Ag+), added as AgNO3 (concentration range 0.5-2 μg/mL), H2O2 
(concentration range 1-15 mM), sodium citrate (15 and 20 μM), or Eucalyptus globulus 
Labill. (EG) bark extract (0.20 and 0.50 mg/mL). After 24 h, the MTT assay proceeded as 
described for HaCaT cells. 
 
RAW 264.7 cells 
Cells were seeded at a density of 2.5 x 104, in 96-well plates, and after 24 h the 
medium was replaced with fresh medium containing: AgNPs (concentration range 10-150 
μg/mL), ionic silver (Ag+), added as AgNO3 (concentration range 1-7.5 μg/mL), H2O2 
(concentration range 50-500 μM), or sodium citrate (20 and 300 μM). After 24 h, the MTT 
assay proceeded as described for HaCaT cells. 
 
2.2.5. Reactive Oxygen Species (ROS) assay 
Intracellular ROS generation was assessed by flow cytometry with the probe 2’,7’-
dichlorodihydrofluorescein diacetate (DCFH2-DA, Sigma-Aldrich, St. Louis, MO, USA), 
according to the procedure previously described (Ferreira de Oliveira et al., 2014). In brief, 
cells were seeded in 6-well plates (at 1.2 x 104/cm2, 5.6 x 104/cm2, and 2.5 x 104/cm2, for 
HaCaT, HepG2 and RAW 264.7 cells, respectively) and after 24 h, the culture medium was 
replaced with medium containing AgNPs or H2O2, as well as Ag+ (from AgNO3) in the case 
of HepG2 and RAW 264.7 cells, at concentrations corresponding to IC20 and IC50 values. 
Additionally, HepG2 and RAW 264.7 cells were exposed to EG extract and citrate, 
respectively, at the maximum concentrations present in the AgNPs exposure. Following 
exposure, cells were washed with PBS and incubated in the dark with serum-free DMEM 
containing 10 μM DCFH2-DA, for 30 min, at 37 ºC. Then, after PBS washing and 
trypsinization (or scraping, in the case of RAW 264.7 macrophages), cells were collected 
for analysis in an Attune® Acoustic Focusing Cytometer (ThermoFisher Scientific, Waltham, 
MA). ROS formation was estimated from the mean fluorescence intensity (MFI) of DCF 
using the FlowJo software (Tree Star Inc., Ashland, OR, USA). 
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2.3. NMR metabolomics 
2.3.1. Cell culture and exposure for metabolomics 
HaCaT cells 
HaCaT cells were seeded at a density of 1.5 x 104 cells/cm2 onto 10 cm diameter 
Petri dishes and allowed to adhere for 24 h. Then, the medium was replaced by fresh 
complete medium containing: AgNPs at final concentrations of 10 μg/mL or 40 μg/mL, Ag+ 
(added as AgNO3) or H2O2, at the IC20 or IC50 concentrations (selected based on the cell 
viability results). Fresh medium without AgNPs was added to control cells. In addition, to 
account for possible effects of the coating substances, cells were also incubated with 
medium containing citrate, mPEG, mPEG-SH or BSA, at concentrations equivalent to those 
added when cells were exposed to coated AgNPs. At least three independent assays were 
performed. 
 
HepG2 cells 
Similarly, HepG2 cells were seeded at a density of 5.6 x 104/cm2 onto 10 cm 
diameter Petri dishes and allowed to adhere for 24 h. Then, the medium was replaced by 
fresh complete medium containing: AgNPs, Ag+ or H2O2, at the IC5 or IC20 concentrations 
(selected based on the cell viability results). Fresh medium without AgNPs was added to 
control cells. Furthermore, cells were also incubated with medium containing citrate or EG 
bark extract, at concentrations equivalent to those added when cells were exposed to 
AgNPs. Five independent assays were performed. 
 
RAW 264.7 cells 
RAW 264.7 macrophages were seeded at a density of 2.5 x 104/cm2 onto 10 cm 
diameter Petri dishes and allowed to grow for 24 h. Culture medium was then replaced by 
fresh complete medium containing: AgNPs, Ag+ or H2O2, at the IC5 or IC20 concentrations 
(selected based on the cell viability results). Fresh medium without AgNPs was added to 
control cells. Furthermore, cells were also incubated with medium containing citrate, at a 
concentration equivalent to that added when cells were exposed to the IC20 of AgNPs. Five 
independent assays were performed. 
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2.3.2. Sample collection 
Cell culture supernatants 
Medium aliquots were collected from each dish, centrifuged (1000 x g, 5 min) and 
the supernatant stored at -80 ºC until NMR analysis. Aliquots from medium without cells 
incubated in the same conditions as exposed cells, were also collected. At the time of 
analysis, 540 μL of thawed medium were mixed with 60 μL of D2O containing 0.25% TSP-
d4 and 550 μL of each sample were transferred into 5 mm NMR tubes.  
 
Cell extracts 
To collect cell samples, the remaining medium was aspirated and each dish was 
washed 2-4 times with PBS. Then, intracellular metabolites were extracted using a dual 
phase extraction, with methanol:chloroform:water (1:1:0.7), as adapted from (Teng et al., 
2008). Briefly, 650 μL of cold methanol 80% was added, to stop metabolic activity, and the 
cells were scraped off the dish and vortexed for 2 min in microcentrifuge tubes containing 
0.5 mm glass beads (150 mg), to aid cell breakage. Chloroform (260 μL) and chloroform + 
water (260 μL + 220 μL) were then added to each sample, each addition being followed by 
2 min vortexing, and the samples were left to rest on ice for 10 min. After centrifuging at 
2000 g for 15 min, and at 10000 g for 1 min, the upper aqueous phase (polar) and the lower 
organic phase (lipophilic) were carefully transferred into new vials, dried under vacuum and 
stored at -80 ºC. 
At the time of NMR analysis, dried polar extracts were reconstituted in 600 μL of 
deuterated phosphate buffer (100 mM, pH 7.4) containing 0.1 mM TSP, and 550 μL of each 
sample were transferred into 5 mm NMR tubes. 
Lipophilic extracts were reconstituted in deuterated chloroform containing 0.03% 
TMS. For NMR analysis, 550 μL of each sample were transferred into 5 mm NMR tubes. 
 
2.3.3. Acquisition and processing of NMR spectra 
1H NMR spectra of all samples were acquired on a Bruker Avance DRX-500 
spectrometer (Universidade de Aveiro, Rede Nacional de RMN, Portugal) operating at 
500.13 MHz for 1H observation, at 298 K, using 5 mm BBI or TXI Bruker probes. Standard 
1D 1H spectra with water suppression by presaturation during the relaxation delay (RD) and 
mixing time (tm) (pulse program ‘noesypr1d’ from Bruker library, RD-90º-t-90º-tm-90º-ACQ, 
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t being a short delay of 3 μs) were recorded for medium samples and polar extracts; for 
lipophilic extracts, 1D 1H spectra were acquired using a standard Bruker proton pulse 
sequence (‘zg’) with a 90º pulse. Acquisition time (ACQ) for each FID was set to 2.34 s and 
the relaxation delay to 4 s. Spectral processing was performed using Topspin 3.2 (Bruker 
Biospin, Rheinstetten, Germany). Each FID was zero-filled to 64 k points and multiplied by 
an exponential line-broadening window function (LB 0.30/1.00 Hz, for medium and polar 
extracts/lipophilic extracts) prior to Fourier transformation. Spectra were manually phased 
and baseline corrected, and chemical shifts were referenced internally to TSP/TMS 
(medium and polar extracts/lipophilic extracts). Typical acquisition and processing 
parameters for these 1D experiments are provided in Table 2.1. 
 
Table 2.1. Main parameters used for the acquisition and processing of 500 MHz 1D 1H NMR spectra 
of culture media, polar extracts, and lipophilic extracts, of HaCaT, HepG2 and RAW 264.7 cells. 
aBruker library 
 
Culture medium Polar extracts Lipophilic extracts 
Acquisition parameters 
Pulse programmea noesypr1d noesypr1d zg 
FID data points, TD 32768 32768 32768 
Number of scans 256 256 256 
Spectral width (ppm) 20.6557 14.0019 14.0019 
Relaxation delay, RD (s) 4 4 4 
Mixing time, tm (ms) 100 100  
Processing parameters 
Window function Exponential Exponential Exponential 
Spectrum data points, SI 65536 65536 65536 
Line broadening, LB (Hz) 0.30 0.30 1.00 
 
2D 1H-1H total correlation (TOCSY), 1H-13C heteronuclear single quantum correlation 
(HSQC) and J-resolved spectra were also registered for selected samples to assist spectral 
assignment. TOCSY spectra were recorded in phase-sensitive mode using time 
proportional phase incrementation (TPPI) and the MLEV 17 pulse sequence for the spin-
lock (clmlevprtp pulse programme from Bruker library); phase sensitive (echo/antiecho) 
HSQC spectra were recorded with inverse detection and carbon decoupling (invietgpsi 
pulse programme from Bruker library); J-resolved spectra were acquired with F2 decoupling 
(jresgpprqf pulse programme from Bruker library). 2D spectral processing was also 
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performed using Topspin 3.2 (Bruker Biospin, Rheinstetten, Germany). The acquired FIDs 
were zero-filled to the spectrum data points (SI) shown in Table 2.2 and multiplied by a sine-
bell-squared/sine-bell function (qsine/sine) prior to FT and phasing. J-resolved spectra were 
tilted (45º) to provide orthogonality of the chemical shift and coupling constant axes were 
subsequently symmetrised about the F1 axis. In all spectra, chemical shifts were calibrated 
internally to TSP/TMS (medium and polar extracts/lipophilic extracts). Typical acquisition 
and processing parameters for these 2D experiments are provided in Table 2.2. 
 
Table 2.2. Main parameters used for the acquisition and processing of 500 MHz 2D NMR spectra of 
culture media, polar extracts, and lipophilic extracts, of HaCaT, HepG2 and RAW 264.7 cells. aBruker 
library 
 
Culture medium/Polar extracts/Lipophilic extracts 
Acquisition parameters 
Experiments 1H-1H TOCSY 1H-13C HSQC J-resolved 
Pulse programmea clmlevprtp invietgpsi jresgpprqf 
FID data points [F1] 160 128 40 
FID data points [F2] 2048 2048 8192 
Number of scans 64 120 64 
Spectral width [F1] (ppm) 16.0214 172.8503 0.0868 
Spectral width [F2] (ppm) 16.0214 9.9974/9.5395/12.0161 12.6549 
Relaxation delay, RD (s) 1.5 2 2 
Mixing time, D9 (ms) 80   
Processing parameters 
Window function qsine/qsine qsine/qsine sine 
Spectrum data points [F1], SI 1024 256 128 
Spectrum data points [F2], SI 4096 2048 16384 
Line broadening [F1], LB (Hz) 0.30  0.30 
Line broadening [F2], LB (Hz)   0.50 
 
2.4. Multivariate and statistical analysis of NMR spectra 
2.4.1. Data pre-treatment 
Full resolution 1H NMR spectra were converted to matrices of n observations 
(samples, in rows), and m variables (peak intensities, in columns), in Amix-Viewer 3.9.15 
(Bruker BioSpin, Rheinstetten, Germany). Selected regions comprising solvent signals 
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(water in polar extracts and culture media, chloroform in lipophilic extracts), culture media 
traces in polar extracts, and other contaminants (ethanol, methanol), were excluded from 
data matrices. Spectra (rows in data matrices) were normalised by total spectral area to 
compensate for differences in the number of cells, and then aligned in MATLAB version 
7.9.0 (The MathWorks, Inc., Natick, MA, USA), using recursive segment-wise peak 
alignment (Veselkov et al., 2009) to minimise chemical shift variations. Data matrices were 
uploaded in SIMCA-P 11.5 (Umetrics, Umeå, Sweden), where variables were mean centred 
(subtraction by average value), and scaled to unit variance (UV, each column divided by its 
standard deviation). 
 
2.4.2. Principal Component Analysis (PCA) and Partial Least Squares – Discriminant 
Analysis (PLS-DA) 
PCA and PLS-DA were applied to mean centred and UV scaled data, in the SIMCA-
P software, with a default seven-fold internal cross validation, from which Q2 and R2 values, 
respectively reflecting predictive capability and explained variance, were extracted. Results 
from PCA and PLS-DA were visualised in scores scatter plots. PLS-DA model robustness 
was further assessed by Monte Carlo cross validation (MCCV) with 500 iterations and 
permutation testing (class membership randomly assigned), in an in-house software 
developed by Dr António Barros. The distribution of Q2 values and the receiver operating 
characteristic (ROC) maps, representing the true positive rate (TPR or sensitivity) as a 
function of the false positive rate (FPR or 1-specificity), were recovered from MCCV applied 
to both original and permuted models. PLS-DA models were considered valid when: in the 
ROC map, permuted classes fell along the line of no discrimination (TPR = FPR), and true 
models presented high sensitivity and specificity; in the Q2 histogram, there was minimal 
overlap between classes, and median Q2 was > 0.5 for true models.  
The PLS-DA loadings plots were back-transformed by multiplying the loading weight 
w by the standard deviation of each variable, and coloured according to variable importance 
to the projection (VIP) using the R-statistical software (R Foundation for Statistical 
Computing, Vienna, Austria). 
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2.4.3. Spectral integration and univariate statistical analysis 
Selected signals in the normalised 1D spectra were integrated using the Amix-
Viewer software. In cases of significant overlap, spectral deconvolution was employed, 
using a variable Gaussian/Lorentzian curve fitting, with a default line width of 1 Hz. 
For each metabolite, the percentage of variation and respective error were 
calculated, along with the effect size (ES), corrected for small sample numbers, and 
respective standard error, according to equations 1.1-1.5 (Chapter 1). Metabolites 
presenting variations with absolute ES larger than 0.8 (and with standard error < ES) were 
expressed in a heatmap coloured as a function of the percentage of variation, using the R-
statistical software. Moreover, the statistical significance of the difference between the 
means of two groups (control and exposed) was assessed using the two-sample t-test or 
the non-parametric Wilcoxon rank sum test with continuity correction, and considering the 
False Discovery Rate (FDR)-corrected p values (confidence level 95%) (Benjamini and 
Hochberg, 1995). 
 
2.4.4. Correlation analysis  
In order to assign unknown resonances or to confirm the presence of specific 
metabolites, statistical total correlation spectroscopy (STOCSY) analysis was applied to 
spectral matrices containing samples where those resonances were found to vary. Selected 
signals (driver peaks) were correlated to the full spectral matrix, in the Matlab software, and 
the correlation coefficients were used to colour the median spectrum, resulting in a 1D 
STOCSY plot (Cloarec et al., 2005). 
Correlation analysis was also performed to seek biochemical relations among 
metabolite variations. To this end, matrices with metabolite integrals were imported to the 
Matlab software, where the Pearson correlation coefficients (r), and respective significance, 
were calculated. A threshold of |r| > 0.75, with p < 0.005, was applied. The obtained 
correlation values are mentioned throughout this report when relevant. 
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Chapter 3. Metabolite profiling of cultured cells: keratinocytes 
(HaCaT), hepatoma cells (HepG2) and macrophages (RAW 264.7) 
3.1. Background and aims 
This chapter describes the basal metabolic activity and composition of the three cell 
lines used in this work: human keratinocytes (HaCaT), human hepatoma cells (HepG2) and 
murine macrophages (RAW 264.7). High resolution 1H NMR spectroscopy was used to 
obtain the spectral profiles of culture medium supernatants, as well as of polar and lipophilic 
cell extracts, providing detailed information on both the exometabolome and 
endometabolome of each cell type. This information is crucial to interpret the metabolic 
effects induced by silver nanoparticles, presented in subsequent chapters. 
 
Metabolite identification was strongly supported by recording two-dimensional (2D) 
experiments, namely: i) 1H-1H TOCSY, which revealed intramolecular coupling networks 
(spin systems), ii) 1H-13C HSQC, useful to show 1H-13C connectivities and confirm the 
assignment of singlets or of highly overlapped multiplets, and iii) J-resolved spectra, 
characterised by reduced spectral complexity and clearer information on signal multiplicity. 
The statistical correlation between 1D spectra, using the STOCSY method (Cloarec et al., 
2005), was also used to probe molecular or biochemical correlations, further aiding spectral 
assignment. Additionally, the identity of some signals was confirmed by spiking the sample 
of interest with pure reference compounds and observing the increase in the corresponding 
resonances. The chemical shift, signal multiplicity and coupling pattern information retrieved 
from 1D and 2D spectra was then matched to the reference spectra available in different 
databases. The main databases consulted were Bruker BBIOREFCODE-2-0-0 database 
(Bruker Biospin, Rheinstetten, Germany), HMDB (Wishart et al., 2013) and 
BioMagResBank (Ulrich et al., 2008). Also, spectral assignment relied on existing literature 
reports for HepG2 cells (Bayet-Robert et al., 2010; Ruiz-Aracama et al., 2011; Li et al., 
2015c; Zheng et al., 2015) and for RAW 264.7 macrophages (Santini et al., 2004; Stuckey 
et al., 2005; Strelko et al., 2011), while, to our knowledge, the NMR metabolic profile of 
HaCaT cells was newly reported within the framework of this thesis (Carrola et al., 2016a).  
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3.2. Metabolic activity of cells assessed by the NMR analysis of culture 
media 
During in vitro incubation, cells take up nutrients from the culture medium and 
excrete metabolic products. Thus, the variations in the medium composition provide 
valuable information on cellular metabolic activity. Figure 3.1 shows the 1H NMR spectra of 
acellular medium and of HaCaT cells conditioned medium, collected after 24 h incubation. 
Corresponding 2D spectra, used for spectral assignment, are shown in Figure 3.2. 
 
 
Figure 3.1. 500 MHz 1H NMR spectra of culture media: comparison between acellular medium (red) 
and culture medium supernatant from HaCaT control cells (black), grown for 24 hours. Signals are 
numbered in accordance with Table 3.1. *ethanol. 
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Figure 3.2. Expansions of a) 1H-1H TOCSY, b) 1H-13C HSQC, and c) J-resolved spectra of culture 
medium from HaCaT control cells. Signals are numbered in accordance with Table 3.1. *ethanol. 
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The same medium (DMEM with 10% FBS) was used for growing all cell types, 
although in the case of HepG2 cells, the medium was further supplemented with sodium 
pyruvate (1 mM), as this was specifically recommended by the cell line supplier and found 
to greatly enhance cell growth. The impact of pyruvate addition on the results will be 
addressed later on. All organic nutrients listed in the medium formulation (Table S3.1) were 
detected in the NMR spectrum, although some vitamins (e.g. pyridoxine, thiamine), present 
at concentrations below 20 μM, showed only very weak signals in the 1D spectrum, 
hindering unambiguous identification or any quantitative analysis. Some compounds arising 
from medium supplementation with 10% FBS, such as glutamate, organic acids, fructose 
and allantoin, were also unequivocally identified. Moreover, a few metabolites not present 
in complete acellular medium were identified, reflecting their excretion from cells. This was 
the case of 2-oxoisoleucine and α-ketovaline, resulting from the catabolism of branched 
chain amino acids, or of itaconate, detected only in the RAW 264.7 conditioned medium. 
The full list of metabolites detected in the NMR spectra of complete culture medium, used 
to grow the three cell lines, is shown in Table 3.1. 
 
Table 3.1. Assignment of resonances in the NMR profile of culture media from HaCaT, HepG2, and 
RAW 264.7 cells. Multiplicity: s, singlet; d, doublet; t, triplet; m, multiplet; dd, doublet of doublets. 
No. Compound δ 1H in ppm (multiplicity, assignment)/ 
δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
1 Acetate 1.92 (s, β-CH3)/26.0    
2 N-acetylaspartate 2.04 (s, CH3)/24.7; 2.51 (dd, β-CH2); 
2.68 (dd, β’-CH2); 4.40 (dd, α-CH) 
   
3 Alanine (Ala) 1.49 (d, β-CH3)/18.9; 3.78 (q, α-CH)    
4 Allantoin 5.39 (s, CH)    
5 Arginine (Arg) 1.69 (m, γ-CH2)/26.7; 1.92 (m, β-
CH2)/30.9; 3.24 (t, δ-CH2)/43.2; 3.78 (α-
CH) 
   
6 Aspartate (Asp) 2.66 (dd, β-CH); 2.81 (dd, β’-CH); 3.90 
(dd, α-CH) 
   
7 Citrate 2.53 (d, α, β-CH2); 2.70 (d, α’, β’-CH2)    
8 Choline 3.21 (s, N(CH3)3)/56.5; 3.53 (m, 
CH2(NH)); 4.07 (m, CH2(OH)) 
   
9 Creatine 3.04 (s, CH3); 3.93 (s, CH2)    
10 Cysteine (Cys) 3.08 (m, β-CH2); 3.91 (dd, α-CH)    
11 Formate 8.46 (s, CH)    
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No. Compound δ 1H in ppm (multiplicity, assignment)/ 
δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
12 α-Fructose 3.66 (m, C1H)/65.3; 3.64, 3.86 (m, 
C6H)/72.3; 3.99 (m, C4H)/71.8; 4.04 (dd, 
C5H)/65.9; 4.11 (m, C3H)/78.1 
   
13 β-Fructose 3.57 (m, C1H)/66.5; 3.64, 3.79 (m, 
C6H)/70.2; 3.82 (m, C5H)/82.9; 4.10 (dd, 
C4H); 4.11 (m, C3H)/76.7 
   
14 Fumarate 6.52 (s, CH)    
15 α-Glucose 3.40 (m, C4H)/72.3; 3.55 (dd, C2H)/74.0; 
3.71 (m, C3H)/75.5; 3.83 (m, C6H)/63.2; 
3.85 (m, C5H)/74.2; 5.24 (d, C1H)/94.8 
   
16 β-Glucose 3.26 (dd, C2H)/76.8; 3.41 (m, C4H)/72.3; 
3.47 (m, C5H)/78.6; 3.49 (t, C3H)/78.4; 
3.74 (m, C6H)/63.4; 3.90 (dd C6’H)/63.4; 
4.66 (d, C1H)/98.6 
   
17 Glutamate (Glu) 2.06 (m, β-CH)/29.7; 2.13 (m, β’-
CH)/29.7; 2.35 (m, γ-CH2)/36.2; 3.73 (t, 
α-CH)/57.2 
   
18 Glutamine (Gln) 2.14 (m, β-CH2)/29.6; 2.45 (m, γ-
CH2)/33.7; 3.68 (t, α-CH)/55.9 
   
19 Glycine (Gly) 3.57 (s, α-CH2)/44.2    
20 Histidine (His) 3.22 (m, β-CH2); 7.03 (s, C4H, ring); 
7.74 (s, C2H, ring) 
   
21 Isoleucine (Ile) 0.94 (t, δ-CH3)/13.8; 1.01 (d, β'-
CH3)/17.4; 1.26 (m, γ-CH2)/27.2; 1.48 
(m, γ’-CH2)/27.2; 1.98 (m, β-CH)/38.7; 
3.68 (d, α-CH)/62.0 
   
22 Itaconate 3.18 (m, α-CH2); 5.38 (m, β-CH); 5.86 
(m, β’-CH) 
  
 
23 Ketoleucine 0.93 (d, δ-CH3); 2.09 (m, γ-CH); 2.65 (d, 
β-CH2) 
   
24 α-Ketovaline 1.12 (d, γ-CH3); 3.01 (dq, β-CH)    
25 Lactate 1.33 (d, β-CH3)/22.8; 4.12 (q, α-CH)/71.3    
26 Leucine (Leu) 0.96 (d, δ-CH3)/23.7; 0.97 (d, δ'-
CH3)/24.9; 1.70 (m, γ-CH)/27.0; 1.72 (m, 
β-CH2)/42.4; 3.74 (t, α-CH) 
   
27 Lysine (Lys) 1.47 (m, γ-CH2)/24.2; 1.73 (m, δ-
CH2)/29.2; 1.92 (m, β-CH2)/32.9; 3.03 (t, 
ε-CH2)/41.9; 3.76 (t, α-CH) 
   
28 Methionine (Met) 2.14 (s, β-CH2); 2.16 (t, β-CH2); 2.65 (t, 
γ-CH2); 3.80 (t, α-CH) 
   
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No. Compound δ 1H in ppm (multiplicity, assignment)/ 
δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
29 myo-Inositol 3.29 (t, C5H)/77.1; 3.54 (C1H, 
C3H)/73.8; 3.63 (dd, C4H, C6H)/75.2; 
4.07 (t, C2H)/74.9 
   
30 Niacinamide 7.60 (dd, N5, ring); 8.26 (dd, N4, ring); 
8.72 (dd, N6, ring); 8.95 (s, N2, ring) 
   
31 2-Oxoisoleucine 0.89 (t, δ-CH3); 1.10 (d, β'-CH3); 1.45 (m, 
γ-CH2); 1.70 (m, γ’-CH2); 2.93 (m, β-CH) 
   
32 Pantothenate 0.90 (s, CH3); 0.92 (s, CH3); 2.42 (t, α-
CH2); 3.39 (d, CH2); 3.43 (q, β-CH2); 
3.51 (d, CH2); 3.98 (s, CH) 
   
33 Phenylalanine (Phe) 3.14 (m, β-CH); 3.27 (dd, β'-CH); 4.00 
(m, α-CH); 7.33 (d, C2H, C6H, 
ring)/131.9; 7.39 (d, C4H, ring); 7.43 (t, 
C3H, C5H, ring)/131.7 
   
34 Proline (Pro) 2.01 (m, γ-CH2); 2.07 (m, β-CH); 2.35 
(m, β'-CH); 3.35 (dt, δ-CH); 3.42 (dt, δ'-
CH); 4.13 (dd, α-CH) 
   
35 Pyroglutamate 2.04 (m, β-CH2)/27.7; 2.41 (m, γ-
CH2)/32.2; 2.51 (m, β’-CH2)/27.7; 4.17 
(dd, α-CH)/61.0 
   
36 Pyruvate 2.38 (s, β-CH3)    
37 Serine (Ser) 3.83 (dd, α-CH); 3.96 (m, β-CH2)    
38 Succinate 2.41 (s, CH2)/36.8    
39 Threonine (Thr) 1.34 (d, γ-CH3)/22; 3.59 (d, α-CH)/63.1; 
4.20 (m, β-CH)/69.0 
   
40 Tryptophan (Trp) 3.31 (dd, β-CH); 3.48 (dd, β’-CH); 4.05 
(dd, α-CH); 7.21 (t, C5H, ring); 7.29 (t, 
C6H, ring); 7.31 (s, C2H, ring); 7.55 (d, 
C7H, ring); 7.74 (d, C4H,ring) 
   
41 Tyrosine (Tyr) 3.07 (m, β'-CH); 3.21 (m, β-CH); 3.96 
(m, α-CH); 6.91 (d, C3H, C5H, 
ring)/118.6; 7.20 (d, C2H, C6H, 
ring)/133.6 
   
42 Valine (Val) 0.99 (d, γ-CH3)/ 19.5; 1.05 (d, γ'-
CH3)/20.7; 2.26 (m, β-CH)/31.7; 3.62 (d, 
α-CH)/63.0 
   
 
The quantitative analysis of variations in medium metabolites upon cellular 
incubations was then carried out based on NMR signal integration. The results obtained for 
each cell type are shown graphically in Figure 3.3, where negative bars represent 
metabolites consumed by cells and positive bars represent metabolites excreted by cells. 
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Figure 3.3. Variations in metabolites consumed (negative bars) and excreted (positive bars) by a) 
HaCaT, b) HepG2, and c) RAW 264.7 cells, as assessed through comparison of acellular culture 
media and culture medium supernatants from control cells, grown for 24 (white bars) or 48 hours 
(black bars); d) summary heatmap for the three cell types colour-coded as a function of %variation 
in 24 h cell medium relatively to acellular medium. *p-value < 0.05; ** FDR-corrected p-value < 0.05. 
Three-letter code used for amino acids. 
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HaCaT cells (Figure 3.3a) consumed mainly glucose, glutamine, leucine, isoleucine 
and choline and excreted several organic acids (mainly lactate and pyruvate, together with 
smaller amounts of formate, acetate and fumarate), ketoacids, alanine, glutamate and 
allantoin. As expected, the variations in relation to acellular medium were greater in the 48 
h cell conditioned medium than in the 24 h medium. In the case of HepG2 cells (Figure 
3.3b), a substantial difference was that pyruvate, used to supplement the culture medium, 
was consumed by cells. Several other substrates were also used, namely glutamine, 
glucose, choline and amino acids (including branched chain and aromatic amino acids). 
The main products released were organic acids (mainly lactate and formate), ketoacids, 
alanine and glutamate. As for the RAW 264.7 macrophages (Figure 3.3c), the most 
noticeable difference in metabolite balances was the excretion of itaconate, not seen for the 
other cell types. 
To conduct a more thorough comparison of the metabolic activity of the three cell 
types, the magnitude of variations in the 24 h conditioned media in relation to the acellular 
media was expressed in a colour-coded table (Figure 3.3d). Taking the consumption of 
glucose as a measure of glycolytic activity, macrophages appeared to be the most glycolytic 
cell line. This is in agreement with early works showing that macrophages readily convert 
glucose to lactate at high rates, mainly in order to generate glycolytic intermediates for 
biosynthetic purposes (Newsholme et al., 1987; Newsholme et al., 1996). HepG2 cells, in 
turn, are also known for their dominant glycolytic metabolism (Miccheli et al., 2006b; 
Loiseau et al., 2009), consistent with the ‘Warburg’ phenotype of tumour cells (Mazurek, 
2007). However, it should be noted that, in the present work, the HepG2 medium 
supplementation with pyruvate could have reduced the need for glucose uptake. 
Glutamine was also consumed from the culture medium, especially by HepG2 and 
RAW 264.7 cells. High glutamine consumption by HepG2 cells is consistent with the 
decreased activity of glutamine synthetase and increased activity of glutaminase in 
hepatocellular carcinoma (Matsuno and Goto, 1992). Likewise, it has also been reported 
that glutamine is utilised at high rates by macrophages and other isolated immune cells 
(Newsholme et al., 2003). The consumption of other amino acids was also clear, again with 
varying magnitudes for the different cell lines. For instance, HepG2 consumed more 
branched chain amino acids than the other cell types, while methionine was more avidly 
consumed by macrophages.  
In regard to the excretion patterns of the three cell types, there were a few distinctive 
features. For instance, allantoin (a product of purine catabolism, namely of uric acid 
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oxidation) was detected only in the HaCaT conditioned medium. On the other hand, the 
HepG2 conditioned medium showed much higher levels of alanine and glutamate (likely 
reflecting the high glycolytic and glutaminolytic activity of these cells), as well as of ketoacids 
derived from branched chain amino acids catabolism. Finally, the macrophage conditioned 
medium showed distinctly high levels of acetate, citrate and itaconate, possibly in relation 
to the TCA cycle activity. Acetate may arise from citrate through the action of citrate lyase, 
while itaconate has been shown to be generated in macrophages by the decarboxylation of 
the citrate-derived metabolite cis-aconitate (Strelko et al., 2011).  
 
Overall, it should be noted that the metabolic activities of the three cell lines may 
reflect not only their different genetic backgrounds and enzymatic profiles, but also 
differences in cell confluence state, proliferation rate and cell cycle distribution, as these 
factors are all known to affect cellular metabolism (Miccheli et al., 2006a; Miccheli et al., 
2006b; Valverde et al., 2006). Importantly, the culture conditions were strictly maintained 
for all experiments performed with each cell line, to ensure that the biological responses to 
silver nanoparticles were not biased by variations in experimental conditions. 
 
3.3. Intracellular polar metabolites 
Typical 1H NMR spectra of polar extracts from HaCaT, HepG2, and RAW 264.7 cells 
are shown in Figure 3.4 (a, b, and c, respectively). For each cell type, concentrated samples, 
prepared from at least 4 polar extracts, have been used to record 2D experiments, to aid 
spectral assignment. As an example, Figure 3.5 shows expansions of a) 1H-1H TOCSY, b) 
1H-13C HSQC, and c) J-resolved spectra of a polar extract from HaCaT cells. Table 3.2 lists 
the compounds present in the polar extracts of each cell type, identified by matching 1D 
and 2D spectral data to reference spectra, as explained before. A total of 51 compounds 
have been identified. 
In the low-frequency region (δ 0-3 ppm), the spectra of cellular polar extracts showed 
resonances from several amino acids (e.g. branched chain amino acids, threonine, alanine, 
glutamate, glutamine, methionine, aspartate), and organic acids (e.g. lactate, acetate, 
pyruvate, succinate). Moreover, the reduced form of the tripeptide glutathione (GSH) was 
also clearly detected in both 1D and 2D spectra, while the oxidised form (GSSG) could only 
be distinguished in 2D spectra.  
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Figure 3.4. 500 MHz 1H NMR spectra of polar extracts from a) HaCaT, b) HepG2, and c) RAW 264.7 
control cells, grown for 24 hours. Signals are numbered in accordance with Table 3.2. 
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Figure 3.5. Expansions of a) 1H-1H TOCSY, b) 1H-13C HSQC, and c) J-resolved spectra of a polar 
extract from HaCaT control cells. Signals are numbered in accordance with Table 3.2. 
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Table 3.2. Assignment of resonances in the NMR profile of polar extracts from HaCaT, HepG2, and 
RAW 264.7 cells. Multiplicity: s, singlet; d, doublet; t, triplet; m, multiplet; dd, doublet of doublets. 
No. Compound δ 1H in ppm (multiplicity, assignment) 
/ δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
1 Acetate 1.92 (s, β-CH3)/26.0    
2 N-Acetylaspartate 2.02 (s, CH3)/24.6; 2.50 (dd, β-CH2); 
2.70 (dd, β’-CH2); 4.39 (dd, α-CH) 
 
 
 
3 ADP 4.22 (m, C5’H, ribose); 4.38 (m, C4’H, 
ribose); 4.61 (m, C2’H, ribose); 6.15 (d, 
C1’H, ribose)/89.4; 8.28 (s, C8, ring); 
8.54 (s, C2, ring) 
   
4 Alanine  1.49 (d, β-CH3)/18.9; 3.78 (q, α-CH)    
5 β-Alanine 2.56 (t, β-CH2); 3.18 (t, α-CH2)    
6 γ-Aminobutyrate 1.89 (m, β-CH2); 2.31 (t, α-CH2); 3.00 (t, 
γ-CH2) 
 
 
 
7 Arginine 1.69 (m, γ-CH2); 1.92 (m, β-CH2); 3.24 (t, 
δ-CH2); 3.78 (α-CH) 
   
8 Aspartate 2.69 (dd, β-CH); 2.82 (dd, β’-CH); 3.90 
(dd, α-CH) 
   
9 ATP 4.22 (m, C5’H, ribose); 4.29 (m, C5’’H, 
ribose); 4.41 (m, C4’H, ribose)/86.8; 4.62 
(m, C2’H, ribose)/72.9; 6.15 (d, C1’H, 
ribose)/89.4; 8.28 (s, C2, ring); 8.55 (s, 
NH, ring) 
   
10 Betaine 3.27 (s, CH3)/56.1; 3.90 (s, CH2)/68.6    
11 Citrate 2.53 (d, α, β-CH2); 2.67 (d, α’, β’-CH2)    
12 Choline 3.21 (s, N(CH3)3); 3.53 (m, CH2(NH)); 
4.07 (m, CH2(OH)) 
   
13 Creatine 3.04 (s, CH3)/39.6; 3.93 (s, CH2)/56.6    
14 Formate 8.46 (s, CH)    
15 Fumarate 6.52 (s, CH)    
16 α-Glucose 3.40 (m, C4H)/72.3; 3.55 (dd, C2H)/74.0; 
3.71 (m, C3H)/75.5; 3.83 (m, C6H)/63.2; 
3.85 (m, C5H)/74.2; 5.24 (d, C1H)/94.8 
   
17 β-Glucose 3.26 (dd, C2H)/76.8; 3.41 (m, C4H)/72.3; 
3.47 (m, C5H)/78.6; 3.49 (t, C3H)/78.4; 
3.74 (m, C6H)/63.4; 3.90 (dd C6’H)/63.4; 
4.66 (d, C1H)/98.6 
   
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No. Compound δ 1H in ppm (multiplicity, assignment) 
/ δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
18 Glutamate 2.06 (m, β-CH2)/29.7; 2.13 (m, β’-
CH2)/29.7; 2.35 (m, γ-CH2)/36.2; 3.75 (α-
CH)/57.4 
   
19 Glutamine 2.14 (m, β-CH2)/29.6; 2.45 (m, γ-
CH2)/33.7; 3.76 (α-CH)/57.2 
   
20 Glutathione, oxidised 
(GSSG) 
2.16 (m, β-CH2, Glu)/29.1; 2.53 (m, γ-
CH2, Glu)/34.2; 2.97 (m, β-CH2, 
Cys)/41.4; 3.31 (m, β-CH2, Cys’)/41.4; 
3.78 (α-CH, Gly)/46.1; 3.78 (α-CH, 
Glu)/56.8; 4.77 (m, α-CH, Cys)/55.2 
   
21 Glutathione, reduced 
(GSH) 
2.17 (m, β-CH2, Glu)/29.1; 2.56 (m, γ-
CH2, Glu)/34.2; 2.96 (m, β-CH2, 
Cys)/28.4; 3.78 (α-CH, Gly)/46.1; 3.78 
(α-CH, Glu)/56.8; 4.57 (m, α-CH, 
Cys)/58.5; 8.37 (NH, Gly); 8.56 (NH, 
Cys) 
   
22 Glycerophosphocholine 3.235 (s, N(CH3)3)/56.6; 3.68 (β'-
CH2(N))/68.6; 4.33 (m, α'-CH2(P)/62.2 
 
 
 
23 Glycine 3.57 (s, α-CH2)/44.2    
24 Histidine 3.22 (m, β-CH2); 7.11 (s, C4H, ring); 
7.92 (s, C2H, ring) 
   
25 β-Hydroxybutyrate 1.20 (d, γ-CH3); 2.30 (dd, CH2); 2.42 (dd, 
CH2); 4.16 (m, CH) 
   
26 myo-Inositol 3.29 (t, C5H)/77.1; 3.54 (C1H, 
C3H)/73.8; 3.63 (dd, C4H, C6H)/75.2; 
4.07 (t, C2H)/74.9 
   
27 Isoleucine 0.94 (t, δ-CH3)/13.8; 1.01 (d, β'-
CH3)/17.4; 1.26 (m, γ-CH2)/27.2; 1.48 
(m, γ’-CH2)/27.2; 1.98 (m, β-CH)/38.7; 
3.68 (d, α-CH)/62.0 
   
28 Itaconate 3.16 (m, α-CH2)/44.9; 5.38 (m, 
CH2)/124.8; 5.83 (m, CH2’)/124.8 
  
 
29 α-Ketoglutarate 2.44 (t, β-CH2); 3.00 (t, γ-CH2)    
30 Lactate 1.33 (d, β-CH3)/22.8; 4.12 (q, α-CH)/71.3    
31 Leucine 0.96 (d, δ-CH3)/23.7; 0.97 (d, δ'-
CH3)/24.9; 1.70 (m, γ-CH)/27.0; 1.72 (m, 
β-CH2)/42.4; 3.74 (t, α-CH) 
   
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No. Compound δ 1H in ppm (multiplicity, assignment) 
/ δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
32 Lysine 1.47 (m, γ-CH2); 1.73 (m, δ-CH2); 1.92 
(m, β-CH2); 3.03 (t, ε-CH2); 3.76 (t, α-
CH) 
   
33 Malate 2.38 (dd, β'-CH); 2.67 (dd, β-CH); 4.30 
(dd, α-CH) 
   
34 Methionine 2.14 (s, β-CH2); 2.16 (t, β-CH2); 2.65 (t, 
γ-CH2); 3.86 (t, α-CH) 
   
35 NAD+ 4.23 (m, A5’); 4.36 (m, A4’); 4.39 (m, 
A4’/N5’); 4.42 (dd, N3’); 4.50 (m, A3’); 
4.54 (m, N2’); 6.04 (d, N1’); 6.10 (d, A1’); 
8.18 (s, A2); 8.19 (N5); 8.43 (s, A8); 8.83 
(d, N4); 9.14 (d, N6); 9.34 (s, N2) 
   
36 Pantothenate 0.90 (s, CH3); 0.92 (s, CH3); 2.42 (t, α-
CH2); 3.39 (d, CH2); 3.43 (q, β-CH2); 
3.51 (d, CH2); 3.98 (s, CH) 
   
37 Phenylalanine 3.14 (m, β-CH); 3.27 (dd, β'-CH); 4.00 
(m, α-CH); 7.33 (d, C2H, C6H, 
ring)/131.9; 7.39 (d, C4H, ring); 7.43 (t, 
C3H, C5H, ring)/131.7 
   
38 Phosphocholine 3.226 (s, N(CH3)3)/56.6; 3.62 (m, N-
CH2)/69.3; 4.17 (m, PO3-CH2)/60.7 
   
39 Phosphocreatine 3.05 (s, CH3); 3.95 (s, CH2)/63.2    
40 Proline 2.01 (m, γ-CH2); 2.07 (m, β-CH); 2.35 
(m, β'-CH); 3.35 (dt, δ-CH); 3.42 (dt, δ'-
CH); 4.13 (dd, α-CH) 
   
41 Pyroglutamate 2.04 (m, β-CH2); 2.41 (m, γ-CH2); 2.51 
(m, β’-CH2); 4.17 (dd, α-CH) 
   
42 Pyruvate 2.38 (s, β-CH3)    
43 Serine 3.85 (dd, α-CH); 3.98 (m, β-CH2)    
44 Spermidine 1.82 (m, β, β'-CH2); 2.15 (m, γ, γ'-CH2); 
3.12 (m, α, α'-CH2) 
   
45 Succinate 2.41 (s, CH2)    
46 Taurine 3.26 (t, S-CH2)/50.3; 3.43 (t, N-CH2)/37.9    
47 Threonine 1.34 (d, γ-CH3)/22; 3.59 (d, α-CH)/63.1; 
4.26 (m, β-CH)/68.0 
   
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No. Compound δ 1H in ppm (multiplicity, assignment) 
/ δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
48 Tyrosine 3.07 (m, β'-CH); 3.21 (m, β-CH); 3.96 
(m, α-CH); 6.91 (d, C3H, C5H, 
ring)/118.6; 7.20 (d, C2H, C6H, 
ring)/133.6 
   
49 UDP 4.23 (m); 4.27 (m); 4.40 (t); 4.44 (t); 5.97 
(s); 5.98 (d); 8.00 (d) 
   
50 UTP 5.97 (s); 5.99 (d);7.98 (d)    
51 Valine 0.99 (d, γ-CH3)/19.5; 1.05 (d, γ'-
CH3)/20.7; 2.28 (m, β-CH)/31.7; 3.62 (d, 
α-CH)/63.0 
   
 
In the mid-frequency region (δ 3-5.5 ppm), additional intracellular metabolites 
detected included creatine, phosphocreatine, choline-containing compounds, taurine, myo-
inositol, and glucose. In the high-frequency region (δ 5.5-10 ppm), the signals detected 
were assigned mainly to aromatic amino acids (tyrosine, phenylalanine), organic acids 
(fumarate and formate) and nucleotides (ADP, ATP, UDP, UTP and NAD+). The assignment 
of nucleotides was confirmed through spiking with reference compounds. 
 
Most metabolites were present in all cell types, although in varying relative amounts. 
Still, a few qualitative differences were noticed. Acetylated amino acids were found in 
HepG2 cells, but not in HaCaT or RAW 264.7 cells. In particular, N-acetylaspartate was 
clearly identified in the HepG2 J-resolved spectrum, through a singlet at 2.02 ppm and two 
doublets of doublets at 2.50 and 2.70 ppm, not present in the spectra of the other cell types. 
Furthermore, another N-acetylated amino acid, with a singlet at 2.01 ppm, was detected in 
HepG2 cells, but its unambiguous identification was not possible. On the other hand, 
glycerophosphocholine, clearly identified in keratinocytes and macrophages through the N-
-trimethyl singlet (3.23 ppm) and the scalar-coupled methylene protons (3.68 and 4.33 
ppm), was not detectable in HepG2 cells. Furthermore, betaine and itaconate were found 
in RAW 264.7 macrophages, but not in the other cell types. The assignment to itaconate 
was confirmed through statistical correlation between 1D spectra (STOCSY), as shown in 
Figure 3.6.  
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Figure 3.6. STOCSY confirming the assignment of itaconate in RAW 264.7 cells; driver peak 5.86 
ppm. 
 
3.4. Lipophilic metabolites 
The NMR analysis of lipophilic extracts, obtained by dual phase extraction of cells, 
enabled the cellular lipid pool to be characterised. Figure 3.7 shows typical 1H NMR spectra 
of lipophilic extracts from HaCaT, HepG2 and RAW 264.7 cells. Two-dimensional 
experiments (1H-1H TOCSY, 1H-13C HSQC, and J-resolved) have also been recorded for 
each cell type, as exemplified in Figure 3.8 for a HepG2 lipophilic extract. Spectral 
assignment relied primarily on matching the chemical shift information derived from 1D and 
2D spectra to previous literature reports (Casu et al., 1991; Adosraku et al., 1994; 
Oostendorp et al., 2006; Mannina et al., 2008; Ruiz-Aracama et al., 2011). Moreover, 1H 
NMR spectra of a few standard lipids have been recorded in-house. The different lipid 
species identified and their corresponding NMR resonances are listed in Table 3.3.  
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Figure 3.7. 500 MHz 1H NMR spectra of lipophilic extracts from a) HaCaT, b) HepG2, and c) RAW 
264.7 control cells, grown for 24 hours. Signals are numbered in accordance with Table 3.3. 
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Figure 3.8. Expansions of a) 1H-1H TOCSY, b) 1H-13C HSQC, and c) J-resolved spectra of a lipophilic 
extract from HepG2 control cells. Signals are numbered in accordance with Table 3.3. 
Chapter 3 
 
67 
 
Table 3.3. Assignment of resonances in the NMR profile of lipophilic extracts from HaCaT, HepG2, 
and RAW 264.7 cells. Multiplicity: s, singlet; d, doublet; t, triplet; m, multiplet; dd, doublet of doublets. 
No. Compound δ 1H in ppm (multiplicity, assignment)/ 
δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
1 Cholesterol 0.68 (s, CH3-18)/11.8; 
0.86/0.87 (2xd, CH3-26/ CH3-27)/22.7; 
0.91 (d, CH3-21)/18.6; 
1.01 (s, CH3-19)/19.4; 
1.05-1.19 (m, multiple protons)/39.7; 
1.42-1.55 (m, multiple protons)/31.8; 
1.78-1.88 (m, multiple protons); 
2.00 (m, multiple protons); 
2.26 (m, CH2-4); 
3.48-3.57 (m, CH-3)/71.8; 
5.35 (m, CH-6)/122.02 
   
2 Cholesterol ester 1.02 (s, CH3-19); 
1.57 (m, multiple protons); 
1.84 (m, CH2-2); 
2.31 (m, CH2-4); 
4.62 (m, CH-3) 
   
3 Diglycerides (DG) 3.71, 4.27 (glyceryl CH2 sn1/sn3); 
5.08 (glyceryl CH sn2) 
   
4 Fatty acyl chains 
(mainly in 
phospholipids) 
0.88 (t, CH3(CH2)n)/14.1; 
1.25 (m, (CH2)n)/22.8/29.6/31.8; 
1.55-1.65 (m, -CH2-CH2CO)/24.8/27.0; 
1.98-2.09 (m, -CH2CH=)/27.0; 
2.25-2.35 (m, -CH2COOR)/34.1; 
2.77-2.87 (m, =CHCH2CH=)/25.6; 
5.35 (m, -HC=CH-)/130.1 
   
5 Free fatty acids 0.97 (t, CH3(CH2)n); 
1.63 (m, -CH2-CH2CO); 
2.05 (m, -CH2CH=); 
2.35 (t, -CH2COOH); 
2.77 (t, =CHCH2CH=) 
   
6 Phosphatidylcholine 
(PTC) 
3.35 (s, N(CH3)3)/54.7; 
3.82 (CH2-N)/66.7; 
3.99 (glyceryl CH2 sn3)/63.5; 
4.12, 4.38 (glyceryl CH2 sn1)/62.8; 
4.40 (CH2-OP)/59.4; 
5.22 (glyceryl CH sn2)/70.4 
   
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No. Compound δ 1H in ppm (multiplicity, assignment)/ 
δ 13C in ppm 
Cell type 
   HaCaT HepG2 RAW 
7 Phosphatidylethanol-
amine (PTE, diacyl 
form) 
3.18 (s, CH2-N)/40.7; 
3.55 (glyceryl CH2 sn1)/71.6; 
3.92 (glyceryl CH2 sn3)/63.9; 
4.12 (CH2-OP)/62.7; 
5.22 (glyceryl CH sn2)/70.4 
   
8 PTE plasmalogen  
(PTE, plasmenyl form) 
1.27 ((CH2)n); 
1.99 (-CH=CH-CH2); 
3.90 (glyceryl CH2 sn3); 
4.34 (glyceryl CH2 sn1); 
5.15 (glyceryl CH sn2); 
5.91 (-CH=CH-) 
   
9 Sphingomyelin (SM) 3.34 (s, N(CH3)3); 
5.45 (-CH=CH-); 
5.70 (-CH=CH-) 
   
10 Triglycerides (TG) 4.12, 4.28 (glyceryl CH2 sn1/sn3)/62.0; 
5.27 (glyceryl CH sn2)/68.9 
 
 
 
 
The main contributors to the lipophilic profile were the signals of cholesterol and 
phosphatidylcholine, two major components of cell membranes. Cholesterol was easily 
identified through its characteristic singlet at 0.68 ppm, arising from C18, and several other 
resonances (Table 3.3). Phosphatidylcholine was positively identified through the intense 
singlet at 3.35 ppm, arising from the N(CH3)3 headgroup, and a number of other signals, 
namely those from CH2-N and CH2-OP protons, glyceryl protons, and fatty acyl chains. The 
latter comprise methyl (CH3), methylene (CH2), olefinic (CH=CH) and allylic (CH2-CH=) 
protons, which largely overlap within different fatty acids, producing broad, complex spectral 
signals.  
Other membrane phospholipids, namely phosphatidylethanolamine and 
sphingomyelin, were also identified based on their typical chemical shifts (Table 3.3). 
Phosphatidylethanolamine comprised both the diacyl and plasmenyl forms, distinguishable 
through their glyceryl sn-2 proton resonances. Additionally, smaller amounts of neutral 
lipids, namely cholesterol esters, free fatty acids, diglycerides and triglycerides were also 
detected, especially in HepG2 cells. Indeed, the characteristic glyceryl sn-1 and sn-3 proton 
resonances of triglycerides (4.12 and 4.28 ppm) were not found in the spectra of HaCaT 
nor RAW 264.7 cells. Other differences between the three cell types in terms of their lipid 
composition could be highlighted through the consideration of signal ratios (Table 3.4). 
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HepG2 cells were characterised by a higher proportion of neutral lipids in relation to 
membrane phospholipids, likely reflecting the storage of lipid reserves in the form of 
cytosolic droplets typically seen in liver cells (Gao and Goodman, 2015). Moreover, HepG2 
lipids showed, on average, higher chain lengths (greater (CH2)n/CH3 ratio) and higher 
degree of unsaturation (CH=CH/CH3 ratio), while HaCaT keratinocytes showed the highest 
relative amount of polyunsaturated fatty acids (=CH-CH2-CH=/CH=CH ratio).  
 
Table 3.4. Lipid ratios in HaCaT, HepG2, and RAW 264.7 cells, as obtained by integration of NMR 
signals in the spectra of lipophilic extracts. Data is expressed as mean ± standard deviation, of at 
least 3 samples. PL, phospholipids; FA, fatty acyl; PUFA, polyunsaturated fatty acyl chains. 
 Neutral lipids/PL 
FA chain length 
[(CH2)n/CH3] 
FA unsaturation 
[CH=CH/CH3] 
PUFA 
[=CH-CH2-CH=/CH=CH] 
HaCaT 0.16±0.03 4.13±0.16 0.86±0.07 0.48±0.00 
HepG2 0.27±0.04 4.80±0.32 1.08±0.08 0.32±0.01 
RAW 0.12±0.01 4.70±0.53 0.79±0.08 0.33±0.01 
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Supplementary information to Chapter 3 
Table S3.1. Dulbecco's Modified Eagle Medium (DMEM) formulation, from GIBCO®. 
Components Molecular 
Weight 
Concentration 
(mg/L) 
Concentration 
(mM) 
Amino acids 
   
Glycine 75 30 0.4 
L-Arginine hydrochloride 211 84 0.398 
L-Cystine 2HCl 313 63 0.201 
L-Histidine hydrochloride-H2O 210 42 0.2 
L-Isoleucine 131 105 0.802 
L-Leucine 131 105 0.802 
L-Lysine hydrochloride 183 146 0.798 
L-Methionine 149 30 0.201 
L-Phenylalanine 165 66 0.4 
L-Serine 105 42 0.4 
L-Threonine 119 95 0.798 
L-Tryptophan 204 16 0.0784 
L-Tyrosine disodium salt dihydrate 261 104 0.398 
L-Valine 117 94 0.803 
Vitamins 
   
Choline chloride 140 4 0.0286 
D-Calcium pantothenate 477 4 0.00839 
Folic Acid 441 4 0.00907 
Niacinamide 122 4 0.0328 
Pyridoxine hydrochloride 204 4 0.0196 
Riboflavin 376 0.4 0.00106 
Thiamine hydrochloride 337 4 0.0119 
i-Inositol 180 7.2 0.04 
Inorganic Salts 
   
Calcium Chloride (CaCl2) (anhyd.) 111 200 1.8 
Ferric Nitrate (Fe(NO3)3•9H2O) 404 0.1 0.000248 
Magnesium Sulfate (MgSO4) (anhyd.) 120 97.67 0.814 
Potassium Chloride (KCl) 75 400 5.33 
Sodium Bicarbonate (NaHCO3) 84 3700 44.05 
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Components Molecular 
Weight 
Concentration 
(mg/L) 
Concentration 
(mM) 
Sodium Chloride (NaCl) 58 6400 110.34 
Sodium Phosphate monobasic (NaH2PO4-H2O) 138 125 0.906 
Other Components 
   
D-Glucose (Dextrose) 180 4500 25 
Phenol Red 376.4 15 0.0399 
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Chapter 4. Metabolomic analysis of human keratinocytes (HaCaT 
cells) exposed to silver nanoparticles of different sizes and 
coatings 
4.1. Background and aims 
In this chapter, the impact of silver nanoparticles (AgNPs) on the endo- and 
exometabolome of human epidermal keratinocytes (HaCaT cell line) is addressed. AgNPs 
present in skin care and wound healing products are able to penetrate across the skin 
barrier and translocate into the epidermis, especially if the skin barrier is damaged (for 
example, due to inflammation) (Vogt et al., 2014). HaCaT cells have several morphological 
and functional features of normal epidermal keratinocytes, thus being a relevant in vitro 
model for studying the biological effects of AgNPs. Indeed, previous studies have used 
HaCaT cells to test the cytotoxic effects of AgNPs. The results, were, however, highly 
variable with respect to cellular uptake, cytotoxicity and genotoxicity. For instance, Lu and 
co-workers found that 30 nm citrate-stabilised silver nanospheres and PVP-coated 
nanoprisms could enter HaCaT cells and accumulate in the nucleus, but were not cytotoxic 
and did not appear to affect DNA integrity up to 100 μg/mL and 48 h exposure (Lu et al., 
2010). In contrast, other studies have shown that PVP-coated AgNPs with metallic core 
diameters of 25 nm (Zanette et al., 2011) or 70 nm (Vogt et al., 2014), resuspended Ag 
nanopowder (< 100 nm) (Mukherjee et al., 2012) and 50 nm citrate-stabilised AgNPs 
(Comfort et al., 2014) were cytotoxic to HaCaT keratinocytes (IC50 near or below 50 μg/mL). 
The different properties of the tested AgNPs, as well as the different incubation times and 
endpoints assessed, are likely to account for these discrepancies. As mentioned in section 
1.1 of the Introduction, the physicochemical properties of AgNPs (size, shape, surface 
chemistry and charge) are known to impact their biological outcomes. Thus, in this work, a 
panel of six well-characterised AgNPs, varying in size and coating, has been selected to 
systematically study the structure-activity relationships of metabolic changes induced in 
HaCaT cells. The nanoparticles tested included citrate-stabilised AgNPs with diameters of 
10, 30 and 60 nm (here designated as Cit10, Cit30 and Cit60, respectively), AgNPs coated 
with polyethylene glycol (PEG), sized 10 and 30 nm (PEG10 and PEG30), and AgNPs 
coated with bovine serum albumin (BSA), sized 30 nm (BSA30). The choice of the coating 
agents was based on their low inherent toxicity and on their relevance in the context of 
AgNPs behaviour in a biological environment. Citrate is one of the most commonly used 
reductants, stabilising AgNPs by electrostatic repulsion, and yielding negatively charged 
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particles (Tolaymat et al., 2010). PEG, a polymer of ethylene oxide, stabilises the AgNPs 
and minimises their agglomeration by steric hindrance (Luo et al., 2005); PEG is known for 
its ability to prevent protein adsorption and promote extended circulation, being frequently 
used in the pharmaceutical industry (Xu et al., 2007). BSA has also been previously shown 
to provide great colloidal stability to AgNPs dispersions (MacCuspie, 2011); it is a protein 
with large homology to the human serum albumin, encountered by the AgNPs as soon as 
they enter the bloodstream, having less stringent biosafety requirements than the human 
protein. In addition to the AgNPs mentioned above, silver ions (Ag+ from AgNO3) and 
hydrogen peroxide (H2O2) were also added to HaCaT cells and their metabolic effects 
evaluated, with a view to better understand the role of ionic silver and oxidative stress in 
AgNPs toxicity. 
 
4.2. Physicochemical properties of the AgNPs tested 
The main properties of aqueous colloidal solutions of the AgNPs used in this work 
are summarised in Table 4.1. Transmission electron microscopy (TEM) (Figure S4.1) 
showed that AgNPs were approximately spherical in shape, with mean diameters agreeing 
with those indicated by the manufacturer. The wavelength of the maximum absorbance 
peak in the UV-Vis spectra also matched the expected values, increasing with particle size. 
Regarding the DLS measurement of hydrodynamic diameters (Dh), with the exception of 
Cit10 and PEG10, all aqueous colloidal solutions of nanoparticles showed PdI values below 
0.3, indicating reasonably monodisperse distributions. Therefore, the Z-average size, 
obtained from the light scattering intensity distribution, was considered for comparison of 
particle sizes. In the case of 10 nm nanoparticles, accurate DLS measurements were 
hindered by the reduced light scattering typical of small particles, and the values presented 
in Table 4.1 correspond to rough estimates of average sizes. The Dh of citrate-coated 
nanoparticles was slightly above the diameter of the inorganic core, whereas this difference 
was greater for PEG and BSA coatings, as expected based on the larger size of these 
molecules compared to citrate. As to the zeta potential, citrate-stabilised particles carried a 
strongly negative surface charge (ζ -29 to -43 mV) while the surface of the PEG- and BSA-
stabilised nanoparticles was less negative (ζ -12 to -18 mV, Table 4.1). Ionic silver was 
quantified in these colloidal solutions by ICP-OES and found to be below 4% for all 
nanoparticles, except in the case of PEG10, which showed a high amount of free Ag+ (19%), 
likely because this suspension had been stored for over 6 months at the time of the ICP 
measurement. Note, however, that the PEG10 AgNPs used in biological and metabolomics 
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assays had been stored for much shorter time (< 1 month) and should not have such high 
amounts of free ionic silver. 
 
Table 4.1. Physicochemical properties of the AgNPs used in this work, dispersed in ultrapure distilled 
water. Cit10, Cit30 and Cit60 stand for citrate-coated AgNPs with nominal diameters of 10, 30 and 
60 nm, respectively; PEG10 and PEG30 are AgNPs coated with polyethylene glycol, sized 10 and 
30 nm, respectively; BSA30 designates 30 nm AgNPs coated with bovine serum albumin. 
AgNP D (nm)a D (nm)b Dh (nm)c PdIc ζ (mV)d λmaxe 
(nm) 
%Ag+f 
 
Cit10 9.3±1.8 11.0±2.4 25.1±3.6 0.42-0.52 -34.5±3.3 386 0.93±0.02 
Cit30 32.7±4.8 29.1±3.9 43.3±0.5 0.25-0.26 -42.7±2.7 408 3.32±0.04 
Cit60 59.6±5.8 59.0±6.9 63.4±0.4 0.13-0.14 -29.2±3.9 427 0.16±0.01 
PEG10 9.8±2.0 7.8±3.7 40.6±3.9 0.26-0.37 -14.3±1.0 396 19.14±0.70 
PEG30 31.8±3.2 26.8±5.3 62.1±0.5 0.15-0.16 -12.1±0.5 411 0.63±0.01 
BSA30 n.a. 26.3±4.4 75.6±0.7 0.15-0.21 -18.4±0.7 409 1.92±0.01 
aDiameter indicated by the manufacturer; bDiameter measured by TEM; cHydrodynamic diameter 
and polydispersity index (PdI) measured by DLS; dZeta potential assessed by electrophoretic 
mobility; eWavelength of maximum absorbance peak in the UV-Vis spectrum; fPercentage of ionic 
silver in the AgNPs suspension (10 μg/mL). Standard deviations calculated for Dh, ζ and %Ag+ 
correspond to 3 replicate measurements. n.a. Not available (NPs coated with BSA in-house). 
 
The behaviour of AgNPs in cell culture medium (DMEM with 10% FBS) was 
assessed by monitoring Dh and ionic silver release over time (Figure 4.1a and 4.1b, 
respectively). The Cit10 nanoparticles, for which DLS measurements were inherently less 
accurate, showed a sudden increase in Dh to ~150 nm, as soon as they were placed in the 
culture medium, and the PdI values were greater than 0.3, indicating large dispersion in 
particle size. Together with the significant broadening of the respective UV-Vis absorption 
spectra (not shown), these observations suggest the formation of variable-sized 
agglomerates, induced by the high ionic strength of the culture medium. The more reactive 
surface and the less effective protection of small nanoparticles by FBS proteins (Shannahan 
et al., 2013) may have accounted for this effect. The Dh of Cit30 and Cit60 nanoparticles 
progressively increased with incubation time (up to 94 and 119 nm, respectively), likely due 
to the displacement of citrate and the formation of a protein corona, as shown by others 
(Bolea et al., 2014; Hansen and Thunemann, 2015). Agglomeration did not seem significant 
for these particles, based on the rather monodisperse Dh peaks (PdI < 0.3) and the small 
red shift (by 10-20 nm) in the UV-Vis absorbance maxima, which could be due to changes 
in the local dielectric constant surrounding the nanoparticles as a result of protein binding 
(Zook et al., 2011). Regarding PEG-coated nanoparticles, while PEG10 appeared to form 
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variable-sized agglomerates, the Dh of PEG30 did not vary much upon incubation in culture 
medium, showing that PEG provided high colloidal stability to these particles. BSA30 
AgNPs showed moderate variations in Dh, which increased to 103 nm at 48 h, suggesting 
that additional coating with FBS proteins could have occurred. 
 
Figure 4.1. a) Hydrodynamic diameter (Dh) of different AgNPs in ultrapure water and in culture 
medium (DMEM + 10% FBS) at 0, 4, 24 and 48 h incubations. # PdI > 0.3 or poor quality of results 
(as reported by the DLS instrument); b) Amount (%) of ionic silver (Ag+) in suspensions of different 
AgNPs in water and in culture medium (0, 4, 24 and 48 h incubations). 
 
Regarding ionic silver release (Figure 4.1b), the highest rate of dissolution was 
observed for Cit10, in agreement with the premise that smaller metal nanoparticles show 
enhanced ion release due to increased specific surface area and curvature (Butler et al., 
2015). Thus, the formation of agglomerates of Cit10, suggested to occur based on the DLS 
data, was less determinant to the dissolution than the primary size, consistently with the 
observations of others (Zhang et al., 2011; Gliga et al., 2014). In the case of PEG10, there 
was a decrease in the amount of free ionic silver as soon as the suspension was added to 
culture medium; this could possibly be due to the formation of insoluble silver salts with 
medium ions (e.g. AgCl) which remained in the centrifugation pellet and were not quantified. 
Then, during incubation in culture medium, there was an additional release of Ag+ up to 
11%. As for the other nanoparticles, there was a progressive Ag+ release over time, 
reaching maximum values of 7-10%. Notably, the Ag+ release profiles of Cit30, PEG30 and 
BSA30 AgNPs were similar, showing that coating had little influence on nanoparticle 
dissolution. 
 
4.3. Viability of HaCaT cells exposed to AgNPs, Ag+ and H2O2 
The dose-response curves of HaCaT cells exposed to each AgNP type for 24 h, as 
obtained by the MTT assay, are depicted in Figure 4.2. Equivalent results for the 48 h 
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exposures are presented in Figure S4.2. All nanoparticles caused dose-dependent 
decreases in cell viability, except for the 24 h exposure to PEG30 which did not affect cell 
viability in a significant way up to the maximum concentration tested (100 μg/mL). Among 
the citrate-coated AgNPs, Cit30 were the most cytotoxic, with IC50 values around 40 μg/mL, 
at both 24 and 48 h. 
 
 
Figure 4.2. Viability (%) of HaCaT cells, measured by the MTT assay, after 24 h of exposure to 
AgNPs: a) Cit10, b) Cit30, c) Cit60, d) PEG10, e) PEG30 and f) BSA30. Data was acquired by project 
partners Verónica Bastos and Tiago Pedrosa (CESAM, UA), and is expressed as mean ± standard 
deviation of three independent assays with three replicates each (n 9). Calculated IC50 value shown 
only when it fell within the concentration range tested. Statistically significant (p < 0.05) differences 
relatively to controls are indicated by *. 
 
The lower cytotoxicity of Cit10 compared to the other citrate-coated nanoparticles 
contradicted previous reports which noted an inverse correlation between nanoparticle size 
and toxicity (Liu et al., 2010; Park et al., 2011). However, in the present work, the above 
mentioned agglomeration of Cit10 in culture medium could have limited the cellular uptake 
of these nanoparticles and, consequently, their damaging effects. The cells exposed to 
PEG-coated AgNPs decreased their viability down to 60 % (for 48 h exposure to 100 μg/mL 
PEG10), with an apparent inverse correlation between size and toxicity. As for BSA30, their 
IC50 concentration was 35 μg/mL at 24 h and 25 μg/mL at 48 h. However, this larger 
cytotoxicity of BSA30 could be partially related with the toxicity of the coating protein in 
itself. As shown in Figure S4.3, neither citrate nor PEG decreased cell viability at the 
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maximum concentrations possibly present when citrate- or PEG-coated AgNPs were 
administered to cells (up to 21 μg/mL citrate or 8 μg/mL PEG). On the other hand, BSA 
caused a statistically significant decrease in cell viability down to ~80% at the highest 
concentration tested (200 μg/mL), which is the BSA concentration present in ~15 μg/mL of 
BSA30. Furthermore, it should be recalled that the specific surface chemistry and charge 
may influence the extent of nanoparticle uptake and interaction with cell membranes, and 
thus nanoparticle toxicity (Caballero-Diaz et al., 2013; Chunyan and Valiyaveettil, 2013; 
Kaur and Tikoo, 2013). As to the ionic silver released extracellularly, it may have contributed 
to toxicity but did not have a determinant effect on cell viability, in agreement with the 
findings of others (Caballero-Diaz et al., 2013; Gliga et al., 2014). 
 
The effect of Ag+, administered as AgNO3, on cell viability is expressed in the dose-
response curve shown in Figure 4.3a. Exposure to 1.0-1.5 μg/mL Ag+ for 24 h caused a 
steep decrease in cell viability (IC50 1.26 ± 0.02 μg/mL), agreeing with previous results 
reported for HaCaT cells (Zanette et al., 2011) and other cell types (Kim et al., 2009b; Liu 
et al., 2010). This much higher toxicity of Ag+ compared to the same concentration of silver 
given as AgNPs has also been reported by others (Beer et al., 2012; Cronholm et al., 2013; 
Caballero-Diaz et al., 2013; Butler et al., 2015). It has been argued that, while AgNPs enter 
cells by endocytosis releasing Ag+ intracellularly (Cronholm et al., 2013; Gliga et al., 2014), 
Ag+ from AgNO3 is not as readily taken up by cells and induces toxicity via extracellular 
mechanisms causing cell membrane damage (Cronholm et al., 2013). 
 
 
Figure 4.3. Viability (%) of HaCaT cells, measured by the MTT assay, after 24 h of exposure to: a) 
Ag+, and b) H2O2. Data was acquired by project partners Verónica Bastos and Tiago Pedrosa 
(CESAM, UA), and is expressed as mean ± standard deviation of three independent assays with 
three replicates each (n 9). Statistically significant (p < 0.05) differences relatively to controls are 
indicated by *. 
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The cytotoxicity of H2O2 was also assessed; the dose-response curve for 24 h 
exposure is shown in Figure 4.3b. H2O2 is a nonradical ROS which is usually generated 
from any source of oxidative stress and can easily transform into more reactive oxygen 
radicals, leading to the propagation of cellular oxidative damage. Upon exposure to 
increasing concentrations of H2O2, cells progressively showed decreasing viability, down to 
less than 20% at 500 μM, the IC50 value being calculated as 143 ± 6 μM. An approximate 
result was obtained by Ramanauskienė and colleagues that calculated the IC50 value of 
H2O2 in HaCaT cells as 183.7 ± 20.4 μM (Ramanauskienė et al., 2015). 
 
4.4. Generation of reactive oxygen species (ROS) 
Intracellular ROS generation was measured in HaCaT cells exposed to either Cit30 
AgNPs or H2O2, at IC20 and IC50 concentrations (Figure 4.4). ROS levels showed a dose-
dependent increase with exposure to both chemicals. In particular, Cit30 induced a 
significant 1.4 fold increase in ROS at 24 h exposure, which was not sustained at 48 h, for 
which the ROS levels, although still slightly elevated, approached those of controls. 
Exposure to H2O2 for 24 h caused an increase in ROS generation similar to that observed 
for AgNPs, which was further enhanced at 48 h. 
 
Figure 4.4. Intracellular generation of reactive oxygen species (ROS), at 24 and 48 h exposure to 
Cit30 AgNPs or H2O2. The data are expressed as mean ± standard deviation of three independent 
assays with three replicates each (n 9). Statistically significant (p < 0.05) differences relatively to 
controls are indicated by *. 
 
4.5. Metabolic variations induced by AgNPs in HaCaT cells 
In order to assess the impact of AgNPs on cell metabolism, HaCaT cells were 
exposed to the six nanoparticle types described above (Table 4.1), at two concentration 
levels, and their metabolic profiles compared to those of control cells. The dose-response 
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behaviour of Cit30 (Figure 4.2b) was taken as reference to select the two concentrations 
used for all nanoparticles: a lower value of 10 μg/mL, corresponding to a small reduction in 
cell viability (~15-20%), and a higher value of 40 µg/mL, which was the estimated IC50 
concentration at 24 h. Cell viability data for the other nanoparticles at these concentrations, 
calculated from the dose-response curves shown above, is summarised in Table S4.1. 
Three sets of spectra – culture medium supernatants, polar cell extracts, and lipophilic cell 
extracts – were then subjected to multivariate analysis and spectral integration, to reveal 
the metabolic changes induced by each type of AgNPs. 
 
Analysis of the culture medium enabled the assessment of the metabolic activity of 
cells. The main cell-mediated extracellular changes upon exposure to AgNPs are 
summarised in Figure 4.5a. Glucose consumption and lactate excretion, reflective of 
glycolytic activity, were not greatly different between control and exposed cells. On the other 
hand, the excretion of pyruvate generally decreased (although less markedly for Cit60), 
while that of citrate increased in a few cases. Furthermore, HaCaT cells exposed to AgNPs 
generally intensified the consumption of glutamine and significantly increased the excretion 
of glutamate. Other metabolites with altered extracellular levels included formate, acetate 
and allantoin (Figure 4.5a and Supplementary Table S4.2). 
Additionally, it has been verified whether the quantitative variations in the culture 
medium could be due to direct interactions with AgNPs or Ag+, since compounds like some 
amino acids have been reported to form complexes with both silver forms (Blaske et al., 
2013; Shi et al., 2014). However, no significant differences in the spectra of acellular media 
with or without AgNPs/Ag+ were found, apart from an increase in citrate in the medium 
incubated with citrate-coated AgNPs. Still, this increase had lower magnitude than upon 
cellular incubation, thus indicating that at least part of the citrate released in the presence 
of AgNPs arose from cell metabolism rather than from the nanoparticles surface. 
 
The polar cell extracts, which contained tens of small hydrophilic metabolites (as 
described in Chapter 3), showed marked changes in their composition upon exposure to all 
nanoparticle types. Indeed, the PCA scores scatter plots (Figure 4.6, left) showed 
reasonable separation between control and exposed samples, and PLS-DA discriminated 
these two groups with high predictive power (Q2 ≥ 0.7), producing scores plots with a clear 
separation along LV1 (Figure 4.6, centre). The robustness of such discrimination was 
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confirmed through Monte Carlo cross validation (MCCV) and permutation testing (results 
shown in Figure S4.4). 
 
 
Figure 4.5. Heatmap of the main metabolite variations in a) culture media, b) polar extracts, and c) 
lipophilic extracts, from HaCaT cells exposed to different AgNP types (at 10 and 40 μg/mL), coloured 
according to % variation in relation to controls. * Uncorrected p-value < 0.05; ** FDR-corrected p-
value < 0.05. Three letter code used for amino acids; Cr, creatine; PCr, phosphocreatine; GSH, 
reduced glutathione; PC, phosphocholine; GPC, glycerophosphocholine; m-Ino, myo-inositol; PTC, 
phosphatidylcholine; PTE, phosphatidylethanolamine; FA, fatty acyl; PUFA, polyunsaturated fatty 
acyl chains. 
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Inspection of PLS-DA loadings (Figure 4.6, right), which qualitatively show the 
leading metabolites responsible for sample discrimination, provided immediate assessment 
of the main similarities and differences between the metabolic effects produced by the six 
nanoparticle types. For instance, GSH showed intensely coloured negative loadings for the 
models pertaining to 30 and 60 nm AgNPs (suggesting increased levels in exposed cells), 
while it was not highlighted as an important variation in cells exposed to 10 nm AgNPs. 
Lactate, on the other hand, appeared to be increased mainly in cells exposed to 10 nm 
nanoparticles. Furthermore, several metabolites apparently decreased in exposed cells 
(positive loadings), such as (phospho)creatine and choline compounds, showed different 
relative importance among the various nanoparticles. 
The magnitude and significance of differences in individual metabolites, at each 
nanoparticle concentration and exposure time (compared to controls) were then assessed 
through spectral integration to enable a more detailed analysis of metabolic variations. The 
results were summarised in a heatmap colour-coded as a function of % variation in relation 
to controls (Figure 4.5b and Supplementary Table S4.3). Only the metabolites with an 
absolute effect size greater than 0.8, accepted as representative of a large effect (Berben 
et al., 2012), were included. The intracellular levels of pyruvate, lactate and succinate, 
involved in glycolysis and the tricarboxylic acid (TCA) cycle, were affected upon exposure 
to most AgNPs: pyruvate decreased (except in cells exposed to PEG30, where it did not 
vary); lactate increased, especially in cells exposed to PEG10 (showing no variation with 
exposure to Cit30 or BSA30); and succinate increased, except in PEG30-exposed cells (no 
change). Several amino acids varied significantly upon exposure to AgNPs: glutamine, 
glutamate and aspartate were generally decreased, except in cells exposed for 48 h to the 
high concentration of Cit10 (no change); glycine was also consistently decreased while 
alanine decreased to a lesser extent (only with Cit30 and BSA30); β-alanine had a variable 
behaviour; lysine, methionine, aromatic and branched chain amino acids generally 
increased, although less markedly in cells exposed to some nanoparticles (Cit60, PEG30 
and BSA30). Furthermore, the energy-related amino acid derivatives creatine and 
phosphocreatine decreased consistently in most exposed cells; only Cit10 were seen to 
cause a less marked decrease in creatine. Another prominent variation regarded the levels 
of GSH: this antioxidant molecule was generally increased, except in cells exposed to the 
high dose of the 10 nm nanoparticles, where it showed no variation (with Cit10) or a 
decrease (with PEG10). Choline-containing compounds were another family of metabolites 
affected by AgNP exposure, with phosphocholine and glycerophosphocholine generally 
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decreasing upon exposure to all nanoparticle types. Finally, decreasing trends in myo-
inositol were also observed for all nanoparticles. 
 
 
Figure 4.6. Multivariate analysis of 1H NMR spectra from polar extracts of HaCaT control cells and 
cells exposed to different AgNP types, namely a) Cit10, b) Cit30, c) Cit60, d) PEG10, e) PEG30 and 
f) BSA30 AgNPs: PCA and PLS-DA scores scatter plots (left and centre, respectively) and LV1 
loadings w (right), coloured as a function of variable importance to the projection (VIP). BCAA, 
branched chain amino acids; for other metabolite codes, vide legend of Figure 4.5. 
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The analysis of lipophilic cell extracts, composed mainly of membrane lipids (section 
3.4 of Chapter 3), revealed a few, moderate changes upon exposure to AgNPs. Indeed, 
multivariate methods hardly distinguished control from exposed cells based on their lipid 
profile, resulting in poorly validated PLS-DA models (Figures S4.5 and S4.6). Accordingly, 
most lipid signals assessed through spectral integration (cholesterol, fatty acyl chains and 
phospholipids) showed slight variations (Figure 4.5c and Supplementary Table S4.4). The 
most noticeable changes were the decreases in phosphatidylcholine and in 
phosphatidylethanolamine caused by BSA30 AgNPs. 
 
4.6. Metabolic variations induced by the coating substances alone 
In parallel with the assessment of AgNPs effects, the coating substances alone 
(citrate, PEG(-SH) and BSA) were also evaluated for their ability to affect the cellular 
metabolome, at concentrations approximately matching those estimated to be present in 
coated AgNPs suspensions added to cells. The results revealed that the HaCaT profile was 
not greatly affected by the presence of the coating substances alone. The high 
concentration of citrate caused small (< 10%) decreases in intracellular glutamate and 
pyruvate and no changes in the medium composition (besides the expected increase in 
citrate levels). PEG(-SH) did not cause any significant intracellular changes and the only 
variations seen in the medium were decreases in the aromatic amino acids phenylalanine 
and tryptophan, possibly reflecting the direct interaction between the free polymer and these 
compounds. BSA induced a less than 10% decrease in intracellular glycerophosphocholine 
and no variation in the medium. It should also be noted that although statistically significant 
(p < 0.05), the intracellular variations just mentioned were clearly less marked than those 
observed for the same metabolites in the presence of AgNPs (all above 10%). 
 
4.7. Metabolic variations induced by Ag+ in HaCaT cells 
The metabolic effects of extracellular Ag+, administered as AgNO3, at IC20 and IC50 
concentrations, to match the viability of cells resulting from exposure to Cit30 AgNPs, were 
assessed. The extracellular metabolome of cells exposed to Ag+ presented a few 
differences in comparison to control cells (Figure 4.7a and Supplementary Table S4.5). 
Cells exposed to Ag+ excreted less lactate in relation to controls and appeared to consume 
citrate from the medium (whereas citrate was released by cells exposed to AgNPs). 
Chapter 4 
 
85 
 
Glutamine consumption and glutamate excretion were increased, although to a lesser 
extent than seen for AgNPs. Another difference was seen for extracellular allantoin, which 
showed opposite variations upon exposure to the IC20 and IC50 concentrations of Ag+. 
 
 
Figure 4.7. Heatmap of the main metabolite variations in a) culture media, b) polar extracts, and c) 
lipophilic extracts, from HaCaT cells exposed to Cit30, Ag+, and H2O2, at the IC20 and IC50, coloured 
according to % variation in relation to controls. * Uncorrected p-value < 0.05; ** FDR-corrected p-
value < 0.05. Three letter code used for amino acids; Cr, creatine; PCr, phosphocreatine; GSH, 
reduced glutathione; PC, phosphocholine; GPC, glycerophosphocholine; m-Ino, myo-inositol; PTC, 
phosphatidylcholine; PTE, phosphatidylethanolamine; FA, fatty acyl; PUFA, polyunsaturated fatty 
acyl chains. 
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Regarding the polar intracellular profiles, HaCaT cells exposed to Ag+ showed 
several differences relatively to control cells, allowing for the two sample classes to be 
clearly discriminated through multivariate analysis. The respective PLS-DA scores and 
loadings are shown in Figure 4.8. The main discriminant features (higher VIP) were in fact 
common to some of those identified for the nanoparticles: GSH (increased in cells exposed 
to Ag+), glycine, creatine and phosphocholine (decreased in cells exposed to Ag+). A more 
thorough comparison between Ag+ and Cit30 AgNPs was then performed based on signal 
integrals, as summarised in the heatmap shown in Figure 4.7b (numerical values in 
Supplementary Table S4.6). The intracellular metabolic signature of Ag+ was remarkably 
similar to that of AgNPs; still, a few differences were noted. Succinate, which increased in 
cells exposed to the high concentration of Cit30, did not vary with Ag+. In regard to amino 
acids, the main differences were in glutamine (lesser intracellular decrease upon exposure 
to Ag+) and lysine (decreased levels in Ag+-exposed cells). Moreover, while 
phosphocreatine consistently decreased with AgNPs exposure, incubation with Ag+ caused 
a decrease in this metabolite only at 24 h, increasing thereafter at 48 h. 
 
 
Figure 4.8. Multivariate analysis of 1H NMR spectra from polar extracts of HaCaT control cells and 
cells exposed to Ag+: PCA and PLS-DA scores scatter plots (left and centre, respectively) and LV1 
loadings w (right), coloured as a function of variable importance to the projection (VIP). PLS-DA was 
validated by Monte-Carlo cross validation (MCCV), resulting in true models with median Q2 0.65 and 
classification rate 93.4%; permuted models resulted in median Q2 -0.15 and classification rate 54.8%. 
For metabolite codes, vide legend of Figure 4.7. 
 
Analysis of the lipophilic fractions revealed that only the higher Ag+ concentration 
induced marked changes in the levels of lipids (Figure 4.7c and Supplementary Table S4.7). 
In particular, cholesterol, phosphatidylcholine, phosphatidylethanolamine and 
polyunsaturated fatty acyl chains were significantly decreased in cells exposed to the IC50 
concentration of Ag+ for 24 h. 
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4.8. Metabolic variations induced by H2O2 in HaCaT cells 
The changes in the exometabolome of H2O2-exposed cells are summarised in 
Figure 4.7a and Supplementary Table S4.5 (columns on the right). There was a trend for 
decreased glucose consumption and lactate excretion, already suggested for Ag+, but much 
clearer with H2O2, especially at the 48 h exposure to the IC50 concentration. The excretion 
of pyruvate was also decreased, in a concentration and time-dependent way, similarly to 
the effect induced by AgNPs/Ag+. A major difference regarded the use of glutamine by cells 
exposed to H2O2: the extracellular levels of this amino acid either remained unchanged (at 
the IC20) or increased (at the IC50), indicating that, unlike AgNPs or Ag+, H2O2 did not induce 
higher glutamine consumption. On the other hand, glutamate excretion did increase, but at 
a lesser magnitude than for AgNPs or Ag+. Additionally, H2O2 caused cells to excrete less 
acetate and formate, and to release allantoin. 
 
Analysis of polar extracts from cells exposed to H2O2 allowed several intracellular 
metabolic effects to be highlighted and compared to those of AgNPs and Ag+. The 
discrimination of H2O2-exposed cells from controls was not as robust as for AgNPs or Ag+, 
as it was apparent from the corresponding PLS-DA scores plot (Figure 4.9, left) and the 
lower Q2 value (0.35). This was mainly due to the lesser impact of the low H2O2 
concentration, since, when only high concentration samples were included in the PLS-DA 
model (not shown), the respective Q2 improved to 0.7. The loadings explaining sample 
discrimination due to H2O2 exposure (Figure 4.9, right) highlighted as main variations: 
increases in branched chain amino acids, glutamine and methionine, together with 
decreases in lactate, glutamate, aspartate, creatine and myo-inositol. These and other 
variations were confirmed through spectral integration (results summarised in Figure 4.7b 
and Supplementary Table S4.6). 
Comparing the effects of H2O2 and AgNPs/Ag+, a clear difference was seen for 
intracellular lactate, which decreased upon exposure to H2O2, contrarily to the observation 
made for some AgNPs. Other striking differences regarded glutamine, increased in H2O2-
exposed cells, and GSH, which was unaltered or slightly elevated in cells exposed to the 
IC20 concentration of H2O2, but decreased in cells exposed to the IC50 concentration, 
especially at 24 h. Furthermore, phosphocholine and glycerophosphocholine also showed 
distinct variations with H2O2, by increasing their levels at 48h.  
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Figure 4.9. Multivariate analysis of 1H NMR spectra from polar extracts of HaCaT control cells and 
cells exposed to H2O2: PCA and PLS-DA scores scatter plots (left and centre, respectively) and LV1 
loadings w (right), coloured as a function of variable importance to the projection (VIP). For metabolite 
codes, vide legend of Figure 4.7. 
 
Regarding the lipophilic fractions, H2O2 induced significant changes only in 
phosphatidylethanolamine, which increased upon exposure to the IC20 concentration and 
decreased when cells were exposed to the IC50 concentration (Figure 4.7c and 
Supplementary Table S4.7). 
 
4.9. Discussion of metabolic variations in HaCaT cells 
The integrated analysis of the changes presented in the above sections allowed the 
impact of AgNPs on major cellular metabolic pathways to be proposed and the influence of 
nanoparticles properties on those changes to be discussed. Figure 4.10 shows a schematic 
diagram of the putative effects on glycolysis and the TCA cycle. Glucose consumption and 
lactate excretion were not greatly affected in exposed cells, implying no major impact on 
glycolytic activity. Still, intracellular lactate was increased in a few cases, especially in cells 
exposed to the PEG-coated 10 nm nanoparticles, suggesting that lactic acid fermentation 
(converting glycolytic pyruvate into lactate) could be enhanced in these cells. Indeed, 
pyruvate levels (intracellular and extracellular) were decreased, similarly to the observation 
made by others in HaCaT cells exposed to TiO2 nanoparticles (Tucci et al., 2013). 
Furthermore, increases in citrate excretion and intracellular succinate may be indicative of 
an altered TCA cycle activity, whereas the strong intracellular decreases in some amino 
acids, namely glutamine, glutamate, aspartate and glycine, could mean that they were being 
used up by exposed cells to replenish TCA cycle intermediates. The increased use of 
glutamine was also corroborated by its increased consumption from the culture medium. 
When entering cells, glutamine is converted to glutamate, which can in turn be excreted as 
an effective way to get rid of cytosolic hydrogen (Mazurek, 2007); excretion of glutamate 
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was indeed observed after AgNP exposure. Furthermore, glutamate can feed the TCA cycle 
by conversion into α-ketoglutarate or aspartate (which in turn transforms into oxaloacetate). 
Hence, our results suggest that exposed cells generally increased glutaminolysis and other 
amino acid catabolic routes to help sustain the TCA cycle. As for other changes in amino 
acids metabolism, the increased intracellular levels of lysine, methionine, branched chain 
and aromatic amino acids (especially prominent in cells exposed to Cit10, Cit30 and 
PEG10) could be indicative of protein degradation. In fact, mobilisation of branched chain 
and/or aromatic amino acids from protein has also been suggested to be involved in the 
response of different cell types to gold nanorods (Zhang et al., 2013) or silica nanoparticles 
(Feng et al., 2013). 
 
Figure 4.10. Schematic diagram of the putative effects of AgNPs (red arrows), Ag+ (green arrows), 
and H2O2 (blue arrows), on glycolysis and the TCA cycle of HaCaT cells. Dashed arrows indicate |% 
variation| < 10%; thick arrows indicate |% variation| > 50%; *40 μg/mL, at 48 h. 
 
The intracellular levels of creatine and phosphocreatine were generally decreased 
in exposed cells (with Cit10 producing a lesser impact on creatine levels). These 
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metabolites are part of the so-called PCr/Cr-shuttle or circuit (Figure 4.11), which is used 
for temporal and spatial energy buffering (Schlattner et al., 2006). Phosphocreatine is a 
reusable high energy phosphate reservoir, which can be broken down by the enzyme 
creatine kinase (CK) into creatine and inorganic phosphate, the latter being used to form 
ATP. As the phosphocreatine system is known to be particularly important in situations of 
high metabolic demand, when the rate of ATP use exceeds its generation by other metabolic 
pathways (Wallimann et al., 1992), the observed decreases suggest that this system is 
activated upon exposure to AgNPs, possibly to cope with impaired energy production 
through the TCA cycle and oxidative phosphorylation. 
 
 
Figure 4.11. Schematic diagram of the creatine (Cr)/phosphocreatine (PCr) system and its 
association with ATP-producing processes (oxidative phosphorylation or glycolysis) and ATP-
consuming processes (maintenance of ATP/ADP ratios). Arrows indicate effects caused by Cit30 
(red arrows), Ag+ (green arrows), and H2O2 (blue arrows). CK: creatine kinase. Adapted from 
(Schlattner et al., 2006). 
 
Another noticeable change in the endometabolome of HaCaT cells regarded the 
levels of reduced glutathione (GSH). Four of the nanoparticles tested (sized 30 or 60 nm) 
induced higher GSH levels; as for the 10 nm nanoparticles, GSH was increased only upon 
exposure to the low concentration (10 μg/mL), showing no variation upon exposure to 40 
μg/mL of Cit10, and decreased levels in cells exposed for 48 h to 40 μg/mL of PEG10. GSH 
is a sulfhydryl-containing tripeptide (γ-Glu-Cys-Gly) with a key role in the cell's defence 
system against oxidative stress, either by directly binding and reducing ROS or by serving 
as a cofactor for some antioxidant enzymes. Induction of oxidative stress, through 
excessive ROS accumulation, is regarded as a main mechanism by which AgNPs exert 
toxicity and cause different types of cellular injury, such as membrane lipid peroxidation, 
DNA damage and apoptosis (Kim and Ryu, 2013). Thus, the ability of cells to preserve the 
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GSH-mediated defence is critical for cellular redox homeostasis, GSH levels being an 
indication of such ability. Several studies have reported AgNPs exposure to cause GSH 
depletion in different cell types, including keratinocytes, and have interpreted this 
observation as arising from inhibition of GSH synthesising enzymes or increased 
conversion to the oxidised form (GSSG) (Kim and Ryu, 2013; Mukherjee et al., 2012). On 
the other hand, GSH was shown to increase upon exposure of fibroblasts, liver and renal 
epithelial cells to AgNPs, suggesting the triggering of a protective mechanism for coping 
with nanoparticle-mediated oxidative stress (Arora et al., 2009; Kang et al., 2012). 
Accordingly, Kang et al. have demonstrated that exposure of human renal cells to AgNPs 
increased the expression of GSH synthesising enzymes and raised GSH levels, likely in 
relation to activation of Nrf2 transcription factor signalling, since in Nrf2 knockdown cells 
GSH levels did not increase, resulting in DNA damage and growth arrest (Kang et al., 2012). 
Thus, the increase in GSH observed here upon exposure to most AgNPs could reflect the 
upregulation of GSH synthesis (also supported by decreases in precursor amino acids) to 
avoid oxidative damage. Another possibility is that GSH is being more intensely recycled 
from GSSG, using the reducing power of NADPH. As the major source of NADPH in animal 
cells is the pentose phosphate pathway (PPP) (Fujii et al., 2011), assessment of fluxes 
through this pathway could be important to verify this hypothesis. In our group, this has 
been attempted by using the stable isotope tracer [2-13C]glucose and quantifying the lactate 
isotopomers which result from glucose metabolism through glycolysis ([2-13C]lactate) or the 
PPP ([3-13C] and [1,3-13C]lactate). The results (not shown) suggested that the contribution 
of PPP for total glucose expenditure was indeed significantly increased by approximately 
25% in HaCaT cells exposed to Cit30 AgNPs at the IC20 concentration. Therefore, either if 
the increased GSH pool arises from upregulated de novo synthesis, intensified recycling, 
or both, it reflects the strong antioxidant capacity characterising skin keratinocytes 
(Mukherjee et al., 2012; D’Errico et al., 2007). On the other hand, the different GSH 
variations induced by Cit10 and PEG10 could mean that GSH was not as much 
synthesised/recycled or that it was more extensively used to neutralise ROS, leading to an 
overall depletion. Measurement of ROS levels upon exposure to the different types of 
nanoparticles, together with the assessment of enzymes involved in GSH synthesis and 
recycling, would be needed to test these hypotheses. 
Other alterations in AgNPs-exposed cells comprised decreased levels of 
phosphocholine, glycerophosphocholine and myo-inositol. A similar variation in choline-
containing compounds has also been reported in macrophages exposed to iron oxide 
nanoparticles and may be reflective of cell membrane modification and/or proliferation 
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arrest, as these metabolites are important constituents of membrane lipids (Feng et al., 
2010). The decrease in myo-inositol may also be related to phospholipid (namely 
phosphoinositides) turnover and/or reflect the role of this metabolite in osmoregulation and 
detoxification pathways, as suggested in several studies addressing the metabolic response 
of cultured cells to low molecular weight drugs (Knijn et al., 2005; Triba et al., 2010; Lamego 
et al., 2014). 
Taken together, metabolomics results have shown that HaCaT cells adapt their 
metabolism to cope with the presence of AgNPs, even at concentrations inducing minimal 
changes in cell viability. Hence, metabolic reprogramming seemed to be independent of 
AgNPs direct cytotoxic effects, corroborating previous findings (Chen et al., 2014). Several 
metabolic variations were commonly seen across all the tested AgNPs; however, a few 
changes were more prominent or even exclusive for some of the nanoparticles, suggesting 
that their different size and coating (and respective aggregation and dissolution behaviours) 
influenced the cells metabolic responses. In particular, the 10 nm AgNPs showed the most 
distinct behaviour in terms of variations related to glycolysis and GSH metabolism. 
 
The similarity of metabolic signatures found for Cit30 AgNPs and Ag+ (Figure 4.7) 
indicates that ionic silver plays a major role in AgNPs toxicity. Still, a few differences could 
be noted; mainly, Ag+ appeared to cause a lesser impact on the TCA cycle (citrate excretion 
and intracellular succinate not increased) and glutaminolysis (less expressive medium 
glutamine consumption and intracellular use); on the other hand, catabolic routes involving 
the use of extracellular citrate and intracellular lysine could be activated upon exposure to 
Ag+. Another distinct variation regarded phosphocreatine levels, which increased in cells 
exposed to Ag+ for 48 h, suggesting some recovery in energy metabolism, not seen with 
AgNPs. Additionally, Ag+ elicited much stronger changes in cellular lipids, causing 
prominent decreases in cholesterol and membrane phospholipids. 
 
Hydrogen peroxide is a nonradical ROS which is usually generated from any source 
of oxidative stress and can easily transform into more reactive oxygen radicals, leading to 
the propagation of cellular oxidative damage. In agreement with other studies (Alia et al., 
2005; Liu et al., 2012a; Jiang et al., 2014), there was an increase in intracellular ROS levels 
upon exposure to H2O2 (Figure 4.4). Interestingly, the magnitude of this increase was very 
similar to that driven by Cit30 AgNPs at concentrations inducing an equivalent decrease in 
cell viability, thus confirming the important role of ROS-mediated effects in AgNPs toxicity. 
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Nevertheless, when taking a closer look at metabolite variations, several differences were 
detected in the way H2O2 affected cell metabolism, compared to AgNPs (Figures 4.7). For 
instance, H2O2 appeared to inhibit glycolysis, based on lower glucose consumption and 
lactate production and excretion. This is consistent with other studies reporting reduced 
glycolytic flux in mammalian cells challenged with H2O2 (Brand et al., 1999; Colussi et al., 
2000; Kuehne et al., 2015). Another major difference regarded the variation of glutamine; 
with H2O2, cells did not appear to intensify glutaminolysis (as they did when exposed to 
AgNPs/Ag+). Thus, the upregulation of this pathway is likely a ROS-independent effect. As 
for the variation in GSH, the effect of H2O2 was similar to that of PEG10 (but not the other 
nanoparticles): there was a decrease in GSH levels at the higher concentration of exposure, 
suggesting that GSH synthesis/recycling did not compensate its use. Finally, the cellular 
response to H2O2 also differed from AgNPs in the variation of choline-containing 
compounds (phosphocholine and glycerophosphocholine). As these metabolites are 
constituents of membrane phospholipids, it is possible that their decreased levels may be 
indicative of reduced cell proliferation and lower membrane turnover, whereas their 
increase, observed in cells exposed to H2O2 for 48 h, may reflect membrane degradation. 
A similar finding of increased choline levels was reported for mesenchymal stem cells 
exposed to H2O2 (Kim et al., 2011b). Exposure to H2O2 further caused a more marked 
increase in the intracellular levels of branched chain and aromatic amino acids, suggesting 
more extensive protein degradation. Other effects, common to AgNPs, included the 
decreases in myo-inositol, creatine and phoshocreatine, agreeing with literature reports on 
the cellular responses to H2O2 (Brand et al., 1999; Straadt et al., 2010). 
 
Overall, we can conclude that although the metabolic signatures of AgNPs, Ag+ and 
H2O2 in HaCaT cells have several features in common, there are some important 
differences in the way these stimuli affect glucose and amino acid metabolism, oxidative 
balance and cell membranes. 
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Supplementary information to Chapter 4 
 
Figure S4.1. TEM images (left) and particle size histograms (right) of the AgNPs used in this work. 
Data acquired at CICECO (UA) by Dr A. L. Daniel-da-Silva and co-workers. 
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Figure S4.2. Viability (%) of HaCaT cells, measured by the MTT assay, after 48 h of exposure to 
AgNPs: a) Cit10, b) Cit30, c) Cit60, d) PEG10, e) PEG30 and f) BSA30. Data was acquired by project 
partners Verónica Bastos and Tiago Pedrosa (CESAM, UA), and is expressed as mean ± standard 
deviation of three independent assays with three replicates each (n 9). Calculated IC50 value shown 
only when it fell within the concentration range tested. Statistically significant (p < 0.05) differences 
relatively to controls are indicated by *. 
 
 
Figure S4.3. Viability (%) of HaCaT cells, measured by MTT assay, after 24 h of exposure to: a) 
citrate, b) PEG-SH and c) BSA. Data was acquired by project partners Verónica Bastos and Tiago 
Pedrosa (CESAM, UA), and is expressed as mean ± standard deviation of three independent assays 
with three replicates each (n 9). Statistically significant (p < 0.05) differences relatively to controls 
are indicated by *. 
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Figure S4.4. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models obtained for polar extracts’ data from controls cells and cells exposed to: a) 
Cit10, b) Cit30, c) Cit60, d) PEG10, e) PEG30 and f) BSA30 AgNPs. TPR: true positive rate; FPR: 
false positive rate; Sens: sensitivity; Spec: specificity; CR: classification rate. 
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Figure S4.5. Multivariate analysis of 1H NMR spectra from lipophilic extracts of control cells and cells 
exposed to different AgNP types, namely a) Cit10, b) Cit30, c) Cit60, d) PEG10, e) PEG30 and f) 
BSA30 AgNPs: PCA and PLS-DA scores scatter plots (left and centre, respectively) and LV1 
loadings w (right), coloured as a function of variable importance to the projection (VIP). 
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Figure S4.6. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models obtained for lipophilic extracts’ data from controls cells and cells exposed to: 
a) Cit10, b) Cit30, c) Cit60, d) PEG10, e) PEG30 and f) BSA30 AgNPs. TPR: true positive rate; FPR: 
false positive rate; Sens: sensitivity; Spec: specificity; CR: classification rate. 
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Table S4.1. Viability (%) of HaCaT cells, after 24 or 48 h of exposure to 10 and 40 μg/mL of Cit10, 
Cit30, Cit60, PEG10, PEG30, and BSA30 AgNPs, estimated based on curve fitting of data measured 
by the MTT assay, by project partners Verónica Bastos and Tiago Pedrosa (CESAM, UA). 
Concentration 10 μg/mL 40 μg/mL 
Time 24 h 48 h 24 h 48 h 
Cit10 102.9% 84.4% 101.7% 61.3% 
Cit30 89.7% 94.5% 48.0% 44.6% 
Cit60 88.1% 58.1% 81.8% 53.5% 
PEG10 91.6% 88.9% 83.7% 71.5% 
PEG30 103.5% 84.2% 103.5% 72.0% 
BSA30 90.9% 73.3% 46.6% 32.3% 
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Table S4.5. Main metabolite variations in the culture media of HaCaT cells exposed to IC20 and IC50 
of Cit30 AgNPs, Ag+, and H2O2, for 24 or 48 h, in relation to culture medium of control cells, expressed 
as % variation (%var) and respective error (±), effect size (ES), p-value (p), and FDR-adjusted (FDR) 
p-value. The variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|) were 
considered null. PyroGlu, pyroglutamate, for other metabolite codes, vide legend of Figure 4.7. 
  Cit30 Ag+ H2O2 
 IC20 IC50 IC20 IC50 IC20 IC50 
Time (h) 24 48 24 48 24 48 24 48 24 48 24 48 
Glucose 
%var 0 14.26 0 0 0 0 3.58 10.02 0 9.91 3.97 18.84 
±  10.26     1.49 6.54  5.83 1.64 4.49 
ES 0 0.85 0 0 0 0 1.25 0.95 0 1.06 1.41 2.54 
p  0.2999     0.0449 0.2196  0.1952 0.0975 0.0434 
FDR  0.8341     0.0945 0.3819  0.4879 0.3486 0.1609 
Pyruvate 
%var 0 -28.89 0 -37.57 0 -22.43 -33.52 -46.62 -18.97 -34.29 -39.64 -66.89 
±  11.48  9.96  12.39 14.63 14.54 14.50 19.04 11.39 12.97 
ES 0 -1.92 0 -3.04 0 -1.33 -1.40 -2.70 -0.94 -1.42 -2.32 -4.02 
p  0.0462  0.0340  0.1115 0.0295 0.0074 0.2243 0.1111 0.0279 0.0061 
FDR  0.3694  0.2549  0.3637 0.0715 0.0492 0.7436 0.4324 0.2323 0.0701 
Lactate 
%var 0 0 0 0 0 0 -19.49 -19.19 0 -22.49 -26.31 -44.23 
±       9.97 15.91  15.28 9.37 11.94 
ES 0 0 0 0 0 0 -1.14 -0.89 0 -1.08 -1.81 -2.85 
p       0.0669 0.2450  0.1895 0.0521 0.0274 
FDR       0.1216 0.4083  0.4879 0.2323 0.1368 
Citrate 
%var 0 39.35 47.40 69.67 0 -5.36 -9.25 -24.39 -2.10 -7.38 -3.53 -8.36 
±  14.63 15.29 2.06  2.83 4.50 10.10 1.13 2.97 1.52 2.76 
ES 0 1.47 1.41 16.37 0 -1.27 -1.00 -2.09 -1.23 -1.68 -1.53 -1.61 
p  0.1492 0.0789 4.6e-5  0.1743 0.0846 0.0914 0.1587 0.0938 0.1178 0.0870 
FDR  0.6514 0.7888 0.0018  0.4101 0.1254 0.2031 0.7052 0.4324 0.3486 0.2176 
Gln 
%var -5.63 -23.59 -5.04 -23.30 -4.44 -9.96 -11.41 -16.64 0 0 0 5.96 
± 3.22 5.18 3.65 4.70 1.21 1.70 8.00 8.53    0.72 
ES -1.01 -3.37 -0.84 -3.66 -2.44 -4.03 -0.97 -1.38 0 0 0 4.20 
p 0.1476 0.0149 0.2186 0.0265 0.0253 0.0091 0.2019 0.0889    0.0114 
FDR 0.9291 0.1989 0.8184 0.2549 0.2370 0.1142 0.2884 0.2031    0.0914 
Glu 
%var 23.04 120.04 29.60 127.62 18.61 47.26 24.90 95.87 5.33 21.41 7.67 43.67 
± 6.38 4.59 4.96 3.87 2.77 4.06 5.62 5.08 2.26 5.30 2.37 5.13 
ES 2.07 10.67 3.06 13.16 4.02 6.16 2.39 8.64 1.50 2.38 2.36 4.40 
p 0.0234 0.0002 0.0045 0.0009 0.0128 0.0034 0.0064 0.0015 0.1025 0.0235 0.1220 0.0061 
FDR 0.9291 0.0066 0.0909 0.0172 0.2370 0.1142 0.0562 0.0195 0.6967 0.3042 0.3486 0.0701 
PyroGlu 
%var 0 0 0 0 10.96 5.15 23.94 27.25 10.56 7.56 10.42 11.64 
±     3.05 2.21 8.98 9.53 4.41 2.19 5.98 1.93 
ES 0 0 0 0 2.22 1.48 1.16 1.48 1.49 2.17 1.47 4.27 
p     0.0640 0.1141 0.0525 0.0568 0.1433 0.0496 0.3366 0.0480 
FDR     0.3325 0.3637 0.1000 0.1607 0.7052 0.3395 0.5853 0.1609 
Ala 
%var -5.46 0 -4.27 -6.40 -2.11 0 -3.94 -13.80 0 0 -3.87 -14.79 
± 2.81  2.94 4.47 1.72  1.98 6.70   1.78 4.44 
ES -1.09 0 -0.83 -0.97 -0.81 0 -1.10 -1.40 0 0 -1.33 -2.23 
p 0.1347  0.2163 0.2143 0.2869  0.0786 0.0778   0.1158 0.0456 
FDR 0.9291  0.8184 0.6195 0.6751  0.1254 0.1946   0.3486 0.1609 
Met 
%var 0 0 0 0 0 -7.99 -10.80 -18.56 0 -3.54 0 -11.66 
±      4.87 5.33 9.21  2.83  4.20 
ES 0 0 0 0 0 -1.12 -1.00 -1.72 0 -0.83 0 -2.50 
p      0.2225 0.0824 0.1498  0.3146  0.1950 
FDR      0.4684 0.1254 0.2723  0.5389  0.3545 
Pro 
%var 0 0 0 0 0 0 36.68 33.88 0 0 0 0 
±       7.22 10.37     
ES 0 0 0 0 0 0 2.20 1.53 0 0 0 0 
p       0.0029 0.0581     
FDR       0.0393 0.1607     
Acetate 
%var 0 0 0 0 -9.64 -9.85 0 0 -11.93 -12.64 -16.01 -18.99 
±     3.57 3.16   4.26 3.99 2.01 4.29 
ES 0 0 0 0 -1.85 -2.14 0 0 -1.94 -2.21 -4.80 -2.94 
p     0.0634 0.0741   0.0652 0.0304 0.0038 0.0195 
FDR     0.3325 0.3295   0.6967 0.3042 0.1533 0.1303 
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  Cit30 Ag+ H2O2 
 IC20 IC50 IC20 IC50 IC20 IC50 
Time (h) 24 48 24 48 24 48 24 48 24 48 24 48 
Formate 
%var 6.65 11.24 20.58 22.44 0 0 0 0 0 -8.29 -18.74 -16.96 
± 4.53 6.23 3.50 4.13      6.93 5.53 9.54 
ES 0.96 1.12 3.46 3.19 0 0 0 0 0 -0.82 -2.14 -1.43 
p 0.2344 0.1628 0.0039 0.0382      0.2843 0.0352 0.2333 
FDR 0.9291 0.6514 0.0909 0.2549      0.5389 0.2323 0.4058 
Allantoin 
%var 0 0 0 0 27.78 29.33 -17.69 -20.47 20.58 35.78 24.78 31.50 
±     5.72 7.33 6.96 6.99 7.34 2.57 12.24 7.56 
ES 0 0 0 0 2.79 2.28 -1.31 -2.33 1.66 7.71 1.59 3.16 
p     0.0296 0.0641 0.0343 0.0463 0.1045 0.0005 0.3037 0.1509 
FDR     0.2370 0.3207 0.0762 0.1607 0.6967 0.0185 0.5853 0.3018 
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Table S4.6. Main metabolite variations in polar extracts of HaCaT cells exposed to IC20 and IC50 of 
Cit30 AgNPs, Ag+, and H2O2, for 24 or 48 h, in relation to controls, expressed as % variation (%var) 
and respective error (±), effect size (ES), p-value (p), and FDR-adjusted (FDR) p-value. The 
variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|) were considered 
null. For metabolite codes, vide legend of Figure 4.7. 
  Cit30 Ag+ H2O2 
 IC20 IC50 IC20 IC50 IC20 IC50 
Time (h) 24 48 24 48 24 48 24 48 24 48 24 48 
Pyruvate 
%var -9.54 -9.66 0 -20.02 -20.12 0 -18.41 -20.92 -21.41 -26.84 -34.66 -53.07 
± 6.00 4.52  3.14 6.80  10.22 10.52 7.39 11.02 13.66 6.65 
ES -0.92 -1.53 0 -4.62 -2.15 0 -1.04 -1.58 -2.12 -1.84 -2.18 -5.22 
p 0.1309 0.1549  0.0061 0.0506  0.0878 0.1076 0.0398 0.0572 0.1282 0.0093 
FDR 0.3846 0.3932  0.0405 0.2681  0.3219 0.3227 0.2795 0.3514 0.2350 0.1537 
Lactate 
%var 0 0 0 0 0 0 0 0 -20.20 -17.52 -22.18 -31.99 
±         5.35 15.15 11.99 13.59 
ES 0 0 0 0 0 0 0 0 -2.75 -0.83 -1.64 -1.41 
p         0.0140 0.2836 0.2507 0.1027 
FDR         0.2795 0.5856 0.4136 0.2407 
Succinate 
%var 0 0 10.24 15.34 0 0 0 0 0 0 30.94 28.83 
±   4.03 9.84       23.96 24.41 
ES 0 0 1.25 0.95 0 0 0 0 0 0 0.84 0.89 
p   0.0439 0.2213       0.3908 0.4654 
FDR   0.1530 0.3652       0.5373 0.5296 
Gln 
%var -13.08 -25.65 -13.94 -24.46 0 -8.35 0 0 18.86 0 45.30 26.48 
± 5.59 8.00 5.82 6.20  4.11   6.24  7.19 2.72 
ES -1.63 -2.25 -1.63 -2.94 0 -1.39 0 0 1.80 0 3.67 4.71 
p 0.0562 0.0450 0.0464 0.0286  0.1013   0.0508  0.0329 0.0064 
FDR 0.2152 0.3702 0.1530 0.0857  0.4179   0.2795  0.1207 0.1537 
Glu 
%var -10.88 -16.39 -12.08 -21.08 -20.45 -14.73 -10.85 0 -18.76 -11.11 -28.90 -28.83 
± 6.76 12.65 7.06 11.02 5.17 3.47 3.99  5.70 8.22 4.39 5.25 
ES -1.10 -0.83 -1.14 -1.40 -2.88 -2.99 -1.42 0 -2.37 -0.93 -3.83 -4.46 
p 0.1487 0.2611 0.1212 0.1354 0.0160 0.0105 0.0243  0.0227 0.2682 0.0171 0.0344 
FDR 0.3846 0.5386 0.3333 0.2642 0.1411 0.1145 0.1393  0.2795 0.5856 0.0978 0.2407 
Asp 
%var -28.04 -37.87 -25.79 -49.62 0 -31.56 -27.48 0 -22.12 -24.65 -60.23 -67.96 
± 9.88 15.03 8.91 12.42  5.90 5.24  14.71 13.90 41.86 22.78 
ES -2.24 -1.95 -2.50 -3.47 0 -4.15 -3.40 0 -1.10 -1.32 -1.65 -3.40 
p 0.0244 0.0797 0.0399 0.0128  0.0100 0.0007  0.2056 0.1492 0.3012 0.1249 
FDR 0.2013 0.3702 0.1530 0.0543  0.1145 0.0110  0.4730 0.5470 0.4518 0.2407 
Gly 
%var -21.77 -35.45 -28.29 -35.26 -21.85 -25.93 -30.18 -33.61 0 0 0 -23.22 
± 8.05 12.44 8.33 12.46 6.79 8.11 8.45 8.22    12.10 
ES -2.15 -1.76 -2.86 -2.24 -2.36 -2.40 -2.02 -3.60 0 0 0 -1.40 
p 0.0406 0.0636 0.0196 0.0726 0.0624 0.0606 0.0048 0.0174    0.1532 
FDR 0.2152 0.3702 0.1077 0.1711 0.2681 0.3333 0.0393 0.2181    0.2407 
Ala 
%var -12.44 0 -10.90 0 0 0 -19.52 -24.50 0 0 13.72 -24.56 
± 7.87  7.41    8.43 12.96   4.81 10.50 
ES -1.09 0 -1.05 0 0 0 -1.39 -1.44 0 0 1.41 -1.54 
p 0.1515  0.1909    0.0375 0.0899   0.1040 0.0817 
FDR 0.3846  0.4534    0.1619 0.3077   0.2244 0.2407 
β-Ala 
%var -8.59 8.48 -14.57 0 8.86 0 0 0 0 -17.05 19.49 -11.46 
± 6.16 4.35 7.42  3.21     10.10 4.99 6.66 
ES -0.95 0.98 -1.25 0 1.73 0 0 0 0 -1.21 2.88 -0.94 
p 0.2065 0.1902 0.0702  0.0640     0.1396 0.1238 0.2013 
FDR 0.4867 0.4184 0.2106  0.2681     0.5470 0.2350 0.3019 
Ile 
%var 0 5.70 0 14.44 6.95 6.67 0 10.71 17.06 0 52.11 43.41 
±  2.05  1.99 2.36 3.20  2.66 4.86  3.01 9.02 
ES 0 1.69 0 4.41 1.86 1.32 0 2.84 2.11 0 11.95 3.63 
p  0.0799  0.0025 0.0731 0.1643  0.0529 0.0765  0.0303 0.1497 
FDR  0.3702  0.0322 0.2681 0.6026  0.2181 0.3156  0.1207 0.2407 
Leu 
%var 0 4.48 0 15.08 5.30 0 0 13.09 18.78 0 54.68 47.90 
±  1.27  1.44 3.66   4.05 4.34  4.79 9.53 
ES 0 1.85 0 6.35 0.92 0 0 2.30 2.58 0 8.04 3.75 
p  0.0555  0.0008 0.2741   0.0932 0.0479  0.0573 0.1479 
FDR  0.3702  0.0272 0.7320   0.3077 0.2795  0.1718 0.2407 
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  Cit30 Ag+ H2O2 
 IC20 IC50 IC20 IC50 IC20 IC50 
Time (h) 24 48 24 48 24 48 24 48 24 48 24 48 
  
            
Val 
%var 0 5.04 0 10.61 0 0 0 7.73 17.89 0 43.41 39.34 
±  1.46  1.55    3.21 5.49  1.82 6.98 
ES 0 2.05 0 4.24 0 0 0 1.73 1.95 0 16.65 4.32 
p  0.0455  0.0029    0.1354 0.0933  0.0178 0.1272 
FDR  0.3702  0.0322    0.3575 0.3422  0.0978 0.2407 
Tyr 
%var 0 8.15 0 11.68 0 0 0 8.88 17.89 0 41.64 31.07 
±  2.15  2.40    2.47 6.25  8.12 4.37 
ES 0 2.40 0 3.00 0 0 0 2.44 1.72 0 3.31 4.62 
p  0.0507  0.0132    0.0472 0.0616  0.0776 0.0373 
FDR  0.3702  0.0543    0.2181 0.2904  0.2135 0.2407 
Phe 
%var 0 3.07 0 7.52 0 0 0 8.48 9.74 -7.69 40.70 25.52 
±  2.19  1.75    2.28 5.88 1.65 2.53 6.38 
ES 0 1.09 0 2.71 0 0 0 2.21 1.03 -3.17 7.48 3.08 
p  0.3537  0.0255    0.0170 0.2151 0.0386 0.0018 0.1519 
FDR  0.6143  0.0857    0.2181 0.4730 0.3514 0.0535 0.2407 
Lys 
%var 0 0 0 10.17 0 0 0 -13.36 0 -7.68 0 0 
±    5.76    4.49  6.09   
ES 0 0 0 1.10 0 0 0 -1.78 0 -0.86 0 0 
p    0.1851    0.0415  0.2865   
FDR    0.3214    0.2181  0.5856   
Met 
%var 16.11 17.17 29.69 22.69 0 11.81 0 8.85 0 0 0 12.20 
± 8.75 5.65 7.44 2.63  8.93  3.18    5.40 
ES 0.91 2.16 1.90 5.07 0 0.82 0 1.67 0 0 0 1.32 
p 0.1323 0.1458 0.0109 0.0049  0.3018  0.0481    0.1251 
FDR 0.3846 0.3932 0.0897 0.0403  0.6860  0.2181    0.2407 
Cr 
%var -31.70 0 -31.02 0 -37.73 -25.32 -36.69 0 -26.71 -19.65 -53.60 -37.43 
± 8.09  11.47  5.10 4.29 7.55  8.50 6.19 5.46 7.44 
ES -2.43 0 -1.61 0 -5.95 -4.42 -2.75 0 -2.37 -2.30 -8.19 -4.50 
p 0.0017  0.0153  0.0008 0.0025 0.0012  0.0441 0.0364 0.0032 0.0537 
FDR 0.0268  0.1007  0.0138 0.0831 0.0130  0.2795 0.3514 0.0535 0.2407 
PCr 
%var -27.25 -12.61 -41.19 -30.69 -18.27 20.79 -19.00 17.68 0 0 -55.60 -29.17 
± 5.83 5.58 5.42 5.99 15.99 4.76 7.84 7.34   18.03 18.83 
ES -2.61 -1.37 -4.72 -3.96 -0.82 2.59 -1.57 1.65 0 0 -2.22 -1.52 
p 0.0024 0.0979 0.0001 0.0077 0.2884 0.0213 0.0393 0.1517   0.0310 0.3182 
FDR 0.0268 0.3702 0.0042 0.0423 0.7320 0.1403 0.1619 0.3575   0.1207 0.3889 
GSH 
%var 79.91 60.20 92.85 50.18 78.19 49.41 73.52 20.10 0 9.95 -27.35 -9.33 
± 8.02 25.46 8.90 11.41 3.40 5.73 5.09 6.42  3.45 7.05 6.00 
ES 4.21 1.58 3.81 2.30 10.79 4.52 5.45 1.64 0 1.79 -3.55 -1.31 
p 0.0010 0.2776 0.0003 0.0265 0.0007 0.0139 1.7e-5 0.0404  0.0639 0.1088 0.3149 
FDR 0.0268 0.5389 0.0042 0.0857 0.0138 0.1145 0.0006 0.2181  0.3514 0.2244 0.3889 
PC 
%var -14.66 0 -18.06 -14.90 -11.78 0 -12.10 0 0 14.49 -29.30 0 
± 6.23  6.89 8.99 4.97  4.49   2.53 5.49  
ES -1.70 0 -1.81 -1.17 -1.64 0 -1.40 0 0 3.49 -3.74 0 
p 0.0576  0.0293 0.1644 0.0669  0.0253   0.0075 0.0113  
FDR 0.2152  0.1380 0.3013 0.2681  0.1393   0.2490 0.0978  
GPC 
%var -12.91 -33.03 -25.32 -42.81 -13.58 0 -10.01 0 -5.57 21.08 0 25.86 
± 5.76 21.38 6.43 20.39 3.06  5.99  2.78 4.87  2.70 
ES -1.44 -1.03 -2.71 -1.74 -3.11 0 -1.06 0 -1.35 2.56 0 7.60 
p 0.0502 0.1732 0.0029 0.0987 0.0171  0.1348  0.1461 0.0584  0.0676 
FDR 0.2152 0.4083 0.0315 0.2172 0.1411  0.3799  0.4018 0.3514  0.2407 
m-Ino 
%var 0 -14.83 0 -21.96 -16.25 -12.89 -11.91 0 -12.76 0 -21.70 -36.77 
±  6.28  6.92 10.28 8.08 7.53  7.30  9.75 13.95 
ES 0 -1.30 0 -2.33 -1.12 -1.11 -0.95 0 -1.22 0 -1.52 -2.13 
p  0.1234  0.0522 0.1609 0.1920 0.1403  0.1740  0.1016 0.0912 
FDR  0.3702  0.1437 0.4827 0.6336 0.3799  0.4417  0.2244 0.2407 
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Table S4.7. Main metabolite variations in lipophilic extracts of HaCaT cells exposed to IC20 and IC50 
of Cit30 AgNPs, Ag+, and H2O2, for 24 or 48 h, in relation to controls, expressed as % variation (%var) 
and respective error (±), effect size (ES), p-value (p), and FDR-adjusted (FDR) p-value. The 
variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|,) were considered 
null. For metabolite codes, vide legend of Figure 4.7. 
  Cit30 Ag+ H2O2 
 IC20 IC50 IC20 IC50 IC20 IC50 
Time (h) 24 48 24 48 24 48 24 48 24 48 24 48 
Total 
cholesterol 
%var 0 0 0 -20.04 0 -4.58 -33.45 0 0 -10.65 0 -16.79 
±    18.76  3.64 15.05   4.88  3.56 
ES 0 0 0 -0.98 0 -0.84 -1.42 0 0 -1.51 0 -4.00 
p    0.4042  0.3038 0.0338   0.1308  0.0804 
FDR    0.6246  0.8449 0.0912   0.5402  0.3689 
Free 
cholesterol 
%var 0 0 0 0 0 -2.99 -44.37 -33.59 0 -8.59 4.80 -11.15 
±      2.38 22.23 15.32  2.77 1.64 1.99 
ES 0 0 0 0 0 -0.83 -1.37 -1.58 0 -2.12 1.55 -4.84 
p      0.3201 0.0491 0.0335  0.0741 0.0766 0.0802 
FDR      0.8449 0.0928 0.1901  0.5402 0.2606 0.3689 
PTC 
%var 0 0 0 -19.68 0 0 -58.95 0 -11.90 -11.00 -31.34 -36.57 
±    15.14   28.21  9.42 9.10 13.51 10.36 
ES 0 0 0 -1.00 0 0 -1.58 0 -0.88 -0.84 -1.87 -3.43 
p    0.2714   0.0245  0.2507 0.3124 0.1270 0.1223 
FDR    0.6246   0.0912  0.7393 0.5402 0.2699 0.3689 
PTE 
%var 0 0 0 -33.00 0 -2.81 -47.51 0 0 10.64 0 -21.27 
±    25.16  1.57 19.03   1.94  1.65 
ES 0 0 0 -1.17 0 -1.18 -1.74 0 0 3.40 0 -7.48 
p    0.2572  0.1805 0.0123   0.0065  0.0025 
FDR    0.6246  0.8449 0.0912   0.1102  0.0426 
PUFA 
chains 
%var 0 0 0 -17.82 0 0 -44.51 0 0 2.81 -11.75 0 
±    14.29   20.96   1.51 4.85  
ES 0 0 0 -1.03 0 0 -1.53 0 0 1.20 -1.66 0 
p    0.3229   0.0209   0.1576 0.1050  
FDR    0.6246   0.0912   0.5402 0.2699  
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Chapter 5. Metabolomic analysis of human hepatoma cells 
(HepG2) exposed to citrate-coated and biogenic silver 
nanoparticles 
5.1. Background and aims 
This chapter describes the cytotoxic and metabolic effects of two types of silver 
nanoparticles (AgNPs) with diameters of 30 nm – citrate-coated (Cit30) and biogenic 
(phytosynthesised) AgNPs (GS30) – towards human liver cells. Liver is a major site of 
AgNPs accumulation following intravenous injection (Dziendzikowska et al., 2012; Xue et 
al., 2012). Moreover, whether exposure occurs through ingestion, inhalation or dermal 
contact, AgNPs may enter the central blood circulation and translocate to several organs, 
including the liver (Oberdorster et al., 2005; Johnston et al., 2010). As a major detoxification 
organ and the body’s metabolic hub, liver largely contributes to regulate metabolite levels 
in the blood and to supply energy to other peripheral organs (Rui, 2014). Thus, assessing 
the impact of AgNPs on the metabolism of liver cells is relevant to understand the toxicity 
and biological effects of these nanoparticles. Constituting about 80% of all liver cells, 
hepatocytes have been the focus of many toxicity studies (Wiśniewski et al., 2016). In 
particular, the human hepatocellular carcinoma HepG2 cell line has been often used as an 
in vitro model, since it is well characterised, easy to culture, and has a stable phenotype. 
Moreover, it maintains the antioxidant defences and several liver-specific metabolic 
functions normally present in hepatocytes (Alia et al., 2005; Maier et al., 2010). Previous 
studies have demonstrated the toxicity of AgNPs towards HepG2 cells based on the 
assessment of abnormal cell morphologies (Kawata et al., 2009), decreased mitochondrial 
function (Avalos et al., 2014; Xue et al., 2016), membrane leakage of lactate 
dehydrogenase (Avalos et al., 2014; Vrček et al., 2016), disturbance of the redox balance 
(Avalos et al., 2014; Vrček et al., 2016), multiple altered genes (Kawata et al., 2009; Sahu 
et al., 2015), induction of micronucleus (Kawata et al., 2009; Prasad et al., 2013; Sahu et 
al., 2016), apoptosis (Jain et al., 2009; Xue et al., 2016), and alterations in cell cycle 
dynamics (Bastos et al., 2016). However, biological effects at low, sub-toxic concentrations 
(more physiologically relevant) have been poorly documented.  
The green synthesis of metal nanoparticles using plant extracts has been growing 
as an alternative approach to the well-established chemical reduction methods (Iravani, 
2011; Santos et al., 2014). Besides mediating silver reduction, the plant components may 
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potentially stabilise the nanoparticles and reduce their toxicity, thus favouring biomedical 
applications (Iravani, 2011). In addition, by taking advantage of the synergism between 
AgNPs toxicity and the bioactivity of natural compounds, plant-derived biogenic AgNPs 
have shown interesting anticancer activity towards different cell lines, including liver cells 
(Guo et al., 2015; Krishnasamy et al., 2015). On the other hand, little is known about the 
mechanisms underlying the biological effects of biogenic AgNPs or the specific role of the 
biocapping agents. In this work, we have compared the impact on viability and metabolism 
of HepG2 cells exposed to citrate-coated AgNPs or to biogenic AgNPs. The latter were 
prepared by our collaborators through the reduction of silver nitrate with an aqueous extract 
of Eucalyptus globulus Labill. (EG) bark (Santos et al., 2014); this extract was composed 
mainly of polyphenolic compounds and sugars which were shown to play dominant roles in 
the metal-ion reduction and the NPs stabilisation, respectively (Santos et al., 2014). Cellular 
responses to coating agents (citrate and EG extract), ionic silver and hydrogen peroxide 
were also assessed. 
 
5.2. Physicochemical properties of the AgNPs tested 
In order to facilitate the comparison between the two types of AgNPs studied, the 
characterisation of Cit30 AgNPs, already shown in Chapter 4, is repeated in this section 
and presented along with the results obtained for the biogenic AgNPs (GS30). TEM showed 
that both nanoparticles presented an approximately spherical morphology, with average 
core diameters of 29.1±3.9 nm and 32.9±4.0 nm for Cit30 and GS30, respectively 
(Supplementary Figure S5.1). DLS measurements of AgNPs aqueous colloidal solutions 
(Table 5.1) indicated a higher hydrodynamic diameter for GS30 (76.1±3.3 nm, compared to 
43.3±0.5 nm for Cit30), which is consistent with the coating of the silver core by phenolic 
compounds and other biomolecules present in the bark extract used for synthesising GS30 
AgNPs (Santos et al., 2014). The negative zeta-potential value for these nanoparticles 
further indicates the presence of negatively charged capping compounds. In terms of 
soluble ionic silver (Ag+), the aqueous colloidal suspensions of Cit30 and GS30 were found 
to contain 3.32±0.04% and 1.68±0.01% Ag+, respectively. 
When placed in complete culture medium (DMEM containing 10% FBS), Cit30 
progressively increased their Dh to about 94 nm at 48 h likely due to the formation of a 
protein corona, as already explained in Chapter 4. On the other hand, the Dh of GS30 
increased immediately after dispersion in culture medium to over 100 nm and remained 
approximately constant up to 48 h incubation (Figure 5.1a). As suggested by others for 
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carbohydrate-coated AgNPs (Kennedy et al., 2014), this increase in hydrodynamic size may 
also relate to the adsorption of proteins at the nanoparticle surface. 
 
Table 5.1. Physicochemical properties of the citrate-coated AgNPs (Cit30) and the biogenic AgNPs 
obtained by green synthesis (GS30), dispersed in ultrapure distilled water. 
AgNP D (nm)a D (nm)b Dh (nm)c PdIc ζ (mV)d λmaxe 
(nm) 
%Ag+f 
 
Cit30 32.7±4.8 29.1±3.9 43.3±0.5 0.25-0.26 -42.7±2.7 408 3.32±0.04 
GS30 n.a. 32.9±4.0 76.1±3.3 0.20-0.22 -37.1±8.1 434 1.68±0.01 
aDiameter indicated by the manufacturer; bDiameter measured by TEM; cHydrodynamic diameter 
and polydispersity index (PdI) measured by DLS; dZeta potential assessed by electrophoretic 
mobility; eWavelength of maximum absorbance peak in the UV-Vis spectrum; fPercentage of ionic 
silver in the AgNPs suspension. Standard deviations calculated for Dh, ζ and %Ag+ correspond to 3 
replicate measurements. n.a. not available (NPs synthesised in-house). 
 
 
Figure 5.1. a) Hydrodynamic diameter (Dh) of Cit30 and GS30 AgNPs in water and in culture medium 
(DMEM + 10% FBS), at 0, 4, 24 and 48 h incubations. # PdI > 0.3 or poor quality of results (as 
reported by the DLS instrument); b) Amount (%) of ionic silver (Ag+) in suspensions of Cit30 and 
GS30 AgNPs in water and in culture medium (0, 4, 24 and 48 h incubations). 
 
Concerning the Ag+ release behaviour in culture medium, GS30 appeared to suffer 
more extensive dissolution upon incubation for 48 h than Cit30 (Figure 5.1b); indeed, the 
amount of silver in 48 h medium supernatants was about 8 and 14% of total silver for Cit30 
and GS30, respectively. This result underscores that, in spite of the reducing environment 
provided by the phenolic and sugar compounds present in the EG extract, the biocapping 
layer did not prevent AgNPs oxidation and dissolution. If, on one hand, this could have 
implications in toxicity, on the other, it may be viewed as a positive asset in regard to the 
therapeutic application of these particles. 
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5.3. Viability of HepG2 cells exposed to AgNPs, Ag+ and H2O2 
The dose-response curves of HepG2 cells exposed for 24 h to Cit30 or GS30 
AgNPs, obtained through the MTT assay, are shown in Figure 5.2a and 5.2b, respectively. 
Both nanoparticles decreased the viability of HepG2 cells in a dose-dependent way, 
inducing a significant decrease in cell viability at a concentration of 10 μg/mL or higher. The 
IC50 values calculated from these curves were 18.9 μg/mL and 26.0 μg/mL for Cit30 and 
GS30, respectively, indicating that GS30 were slightly less cytotoxic to HepG2 cells than 
Cit30. Previous studies have reported varying IC50 values for HepG2 cells exposed to 
AgNPs, ranging from as low as 5 μg/mL (Mishra et al., 2016) to over 200 μg/mL (Jain et al., 
2009). The different properties of the AgNPs evaluated, together with the different 
cytotoxicity assays used, certainly contributed for these discrepancies. In particular, the size 
of AgNPs was shown by others to be determinant to their toxicity towards HepG2 cells. For 
instance, citrate-coated AgNPs of 20 and 50 nm in diameter caused a 50 % decrease in the 
viability of HepG2 cells at approximately 5 and 50 μg/mL, respectively (Sahu et al., 2015; 
Sahu et al., 2016). Moreover, the IC50 concentrations of PVP-coated AgNPs of 5, 20 and 
50 nm in diameter were reported to be 0.6, 25 and 34 μg/mL, respectively (Liu et al., 2010) 
showing relatively good agreement with our results.  
 
Compared to AgNPs, Ag+ administered to cells as AgNO3 was much more cytotoxic, 
with a concentration as low as 0.75 μg/mL inducing a significant decrease in cell viability 
(Figure 5.2c). The calculated IC50 value of 1.19 μg/mL matches the value of 1.11 μg/mL 
reported in the literature for the same cell line using the MTT assay (Liu et al., 2010). This 
much larger toxicity of Ag+ compared to AgNPs agrees with other studies of HepG2 cells 
(Liu et al., 2010; Vrček et al., 2016; Sahu et al., 2016) and, as argued for HaCaT cells in 
Chapter 4, it may relate to the different ways by which AgNPs and free extracellular Ag+ 
interact with cells. It has been shown that AgNPs are readily internalised by HepG2 cells 
(Jain et al., 2009; Liu et al., 2010; Mishra et al., 2016) and release Ag+ intracellularly (Yu et 
al., 2013b), while Ag+ in the form of AgNO3 has a lower rate of cellular uptake (Prasad et 
al., 2013), acting mainly through membrane damage. 
 
The effect of exposure of HepG2 cells to H2O2 is illustrated in Figure 5.2d. Cell 
viability decreased with increasing H2O2 concentrations and the calculated IC50 was 3.08 
mM. This much larger value compared to the IC50 found for HaCaT cells (143 μM, Chapter 
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4) could mean that HepG2 cells are less sensitive to this stressor. However, another good 
explanation relates to the supplementation of the medium used to culture HepG2 cells with 
sodium pyruvate (1 mM). Pyruvate is known to be an excellent ROS scavenger, which 
neutralises H2O2 in a reaction that produces acetate, carbon dioxide and water (Kelts et al., 
2015). Thus, it is likely that the decrease in cell viability upon H2O2 exposure would be much 
stronger if pyruvate had not been added to the culture medium. Indeed, in a study where 
pyruvate was not used to supplement the culture medium, a much lower IC50 of 500 μM has 
been reported for the 24 h exposure of HepG2 cells to H2O2, as assessed by the MTT assay 
(Chen et al., 2011). 
 
 
 
Figure 5.2. Viability (%) of HepG2 cells, measured by MTT assay, after 24 h of exposure to: a) Cit30, 
b) GS30, c) Ag+ and d) H2O2. Data expressed as mean ± standard deviation of three independent 
assays with three replicates each (n 9). Statistically significant (p < 0.05) differences relatively to 
controls are indicated by *. 
 
 
Based on the dose response curves presented above, two concentration levels were 
selected for the metabolomics study of each AgNP type, as well as of Ag+ and H2O2; these 
were the concentrations that caused minimal (5%) and small (20%) decreases in cell 
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viability (Table 5.2). The choice of exposing cells to non-toxic or sub-toxic concentrations of 
each tested substance was based on the hypothesis that cell metabolism would sensitively 
respond even in the absence of major toxicity, as it was indeed observed for HaCaT cells 
(Chapter 4). 
 
Table 5.2. Concentrations of Cit30 AgNPs, GS30 AgNPs, Ag+ (from AgNO3) and H2O2 selected for 
the metabolomic analysis of HepG2 cells. 
 Cit30 GS30 Ag+ H2O2 
IC5 6.4 μg/mL 5.4 μg/mL 0.35 μg/mL 0.58 mM 
IC20 11.0 μg/mL 14.0 μg/mL 0.64 μg/mL 1.38 mM 
 
 
Assuming that citrate and the phenolic/sugar compounds used to stabilise the 
nanoparticles could also influence the cellular responses, the cell viability and metabolomic 
effects were also determined upon exposure of HepG2 cells to citrate or the EG extract. 
The concentrations used for these exposures were calculated to reflect the maximum 
amounts present when IC5 and IC20 concentrations of AgNPs were administered to cells. 
As shown in Figure 5.3, neither citrate nor the EG extract affected cell viability at the 
concentrations tested. The impact on the cellular metabolic profiles will be presented in the 
next section.  
 
 
Figure 5.3. Viability (%) of HepG2 cells, measured by MTT assay, after 24 h of exposure to: a) citrate 
and b) the Eucalyptus globulus Labill. (EG) bark extract used in the green synthesis of GS30 AgNPs. 
Data expressed as mean ± standard deviation of three independent assays with three replicates 
each (n 9). 
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5.4. Generation of reactive oxygen species 
In addition to cell viability, intracellular ROS generation was measured in HepG2 
cells exposed to Cit30 or GS30 AgNPs at IC20 concentrations, as well as in cells exposed 
to the EG extract at the maximum concentration possibly present upon incubation with 
GS30. The results are presented in Figure 5.4. Intracellular ROS levels did not appear to 
vary upon exposure to IC20 concentrations of either Cit30 or GS30. On the other hand, the 
EG extract caused a significant increase in ROS production. It has been reported that 
certain polyphenolic and other food derived antioxidants added to cell culture medium 
undergo redox cycling and induce extracellular formation of H2O2 (Halliwell, 2008; Babich 
et al., 2009; Long et al., 2010). Thus, it is possible that the polyphenol-rich EG extract used 
in this work also led to increased H2O2 levels in the culture medium, which in turn resulted 
in higher intracellular ROS production.  
ROS generation upon exposure to Ag+ (from AgNO3) and to H2O2, at IC20 and IC50 
concentrations, was also assessed (Figure 5.4). Exposure to Ag+ did not significantly alter 
ROS levels, although there was a trend for increase at the IC50 concentration. In the 
literature, intracellular ROS have been shown to increase in HepG2 cells exposed to Ag+ 
(at the IC50), especially for shorter incubation times (2-3 h) (Liu et al., 2010; Vrček et al., 
2016). In regard to H2O2, the IC50 concentration caused a significant increase in intracellular 
ROS generation, in agreement with other studies (Alia et al., 2005; Chen et al., 2011; Jiang 
et al., 2014). 
 
 
Figure 5.4. Intracellular generation of reactive oxygen species (ROS), at 24 h exposure to Cit30, 
GS30, EG extract, Ag+ or H2O2. 1 In the case of EG extract, the concentration used matched the 
maximum amount estimated to be present when GS30 AgNPs were administered to cells at the IC20. 
Data is expressed as mean ± standard deviation of three independent assays with three replicates 
each (n 9). Statistically significant (p < 0.05) differences relatively to controls are indicated by *. 
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5.5. Metabolic variations induced by AgNPs in HepG2 cells 
As explained above, the metabolic effects of citrate-stabilised (Cit30) and biogenic 
AgNPs (GS30) on HepG2 cells were evaluated upon 24 h exposures to the IC5 and IC20 
concentrations of these nanoparticles. NMR profiling of culture medium supernatants was 
performed to assess the metabolic activity of control and nanoparticle exposed cells (in 
terms of substrate consumption and metabolite excretion), while analysis of cell extracts 
(polar and lipophilic) was conducted to assess the variations in the cellular metabolic 
composition. 
 
The metabolic variations in culture medium supernatants of AgNPs-exposed cells 
relatively to control cells are summarised in Figure 5.5a and Supplementary Table S5.1. 
Most changes were concentration-dependent, with the low IC5 concentration generally 
inducing fewer changes in the medium composition. Another general observation is that the 
extracellular metabolic signatures of the two AgNP types compared were relatively similar. 
Both nanoparticles induced a higher consumption of pyruvate (as indicated by decreased 
levels compared to the medium of control cells), although in the case of GS30 this decrease 
was only relevant at the IC20 concentration. Moreover, the excretion of lactate and of the 
TCA cycle intermediates citrate and fumarate increased. In this respect, it should be noted 
that while in the case of exposure to Cit30, the increased citrate levels in the medium could 
be partially due to citrate release from the nanoparticles surface, this should not be the case 
for GS30 as no citrate was expected in the bioacapping layer; thus, some citrate excretion 
must have originated from the cells altered metabolic activity. Nanoparticle exposure also 
induced alterations in the extracellular levels of several amino acids. Changes common to 
the two nanoparticle types comprised increased excretion of glutamate and decreased 
consumption of the amino acids phenylalanine, leucine and isoleucine. This variation in 
branched chain amino acids was in turn highly correlated to decreased release of their 
catabolic products 2-oxoisoleucine and α-ketovaline (|r| > 0.9, p < 0.001). Interestingly, 
GS30, but not Cit30, caused a higher consumption of glutamine at the IC5 concentration (as 
compared to non-exposed control cells). Furthermore, both AgNPs induced decreased 
formate excretion and choline consumption, this latter change being clearly more marked 
upon exposure to GS30. Finally, the medium of GS30-exposed cells, but not of Cit30-
exposed cells, showed significantly higher acetate levels than the medium of control cells. 
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Figure 5.5. Heatmap of the main metabolite variations in a) culture media, b) polar extracts, and c) 
lipophilic extracts, from HepG2 cells exposed to Cit30 and GS30 AgNPs, both at the IC5 and IC20 
concentrations, and to citrate and EG extract (at concentrations that reflected the maximum amounts 
present when IC20 concentrations of AgNPs were administered to cells), coloured according to % 
variation in relation to controls, from maximum decrease (dark blue) to maximum increase (dark red). 
* Uncorrected p-value < 0.05; ** FDR-corrected p-value < 0.05. Three letter code used for amino 
acids; NAA, N-acetylaspartate; Un. NAaa, unidentified N-acetylated amino acid; Cr, creatine; PCr, 
phosphocreatine; ADP/ATP, adenosine di/triphosphate; NAD+, nicotinamide adenine dinucleotide; 
GSH, reduced glutathione; PC, phosphocholine; UDP/UTP, uridine di/triphosphate; PTC, 
phosphatidylcholine; PTE, phosphatidylethanolamine; FA, fatty acyl. 
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Cell incubations with citrate (stabiliser of Cit30) and the Eucalyptus globulus (EG) 
extract used to prepare the GS30 AgNPs were also performed to assess the possible 
influence of these capping substances on the metabolic responses. As shown in Figure 
5.5a (5th column), addition of citrate to the cell culture did not produce changes in the 
medium composition other than the expected increase in citrate. On the other hand, the 
incubation of cells with the EG extract induced a few significant changes in the 
exometabolome (Figure 5.5a, 6th column). These included decreased pyruvate 
consumption and increased formate release, as compared to control cells, variations which 
were actually in the opposite sense to those induced by GS30 AgNPs. Additionally, the 
medium of cells incubated with the EG extract showed increased levels of lactate (although 
not statistically significant), citrate and acetate. As mentioned before, acetate may be 
formed from the reaction between pyruvate (present in the medium) and H2O2. Thus, the 
higher acetate levels in the medium of cells exposed to the EG extract corroborates the 
generation of extracellular H2O2 suggested to arise from redox reactions involving the EG 
extract compounds. A similar effect may be postulated to explain the increase in 
extracellular acetate caused by GS30 AgNPs. 
 
Analysis of the intracellular metabolic composition of HepG2 cells exposed to AgNPs 
allowed the impact of nanoparticle exposure on cell metabolism to be further investigated. 
The scores scatter plot resulting from applying principal component analysis (PCA) to the 
1H NMR spectra of polar extracts readily showed the separation between control and 
AgNPs-exposed cells along the first principal component (PC1) (Figure 5.6). Moreover, 
exposed samples showed grouping trends according to AgNP type and concentration, with 
cells exposed to the higher concentration (IC20) being more distant from controls than those 
exposed to the lower concentration (IC5). In order to assess the effects of each AgNP type 
in detail, multivariate analysis was applied separately to Cit30 and GS30-exposed samples. 
The results are presented in Figure 5.7. For both types of AgNPs, the PCA scores scatter 
plots maintained a clear dose-dependent separation between control and exposed samples 
(Figures 5.7a and 5.7d). Additionally, partial least squares discriminant analysis (PLS-DA, 
Figures 5.7b and 5.7e) allowed the two sample classes (control and exposed) to be 
discriminated with high robustness (Q2 0.8 and 0.7 for Cit30 and GS30 models, 
respectively), as confirmed through Monte Carlo cross validation and permutation testing 
(Supplementary Figure S5.2). The corresponding loadings (Figures 5.7c and 5.7f) showed 
that many of the metabolic features responsible for class discrimination were common to 
Chapter 5 
 
121 
 
the two nanoparticle types, although with varying importance (different VIP colouring of 
loadings).  
 
 
Figure 5.6. Scores scatter plot obtained by PCA of 1H NMR spectra from polar extracts of HepG2 
control cells and cells exposed to Cit30 and GS30 AgNPs at respective IC5 and IC20 concentrations. 
 
Spectral integration of individual metabolite signals further allowed the magnitude of 
those changes to be studied in detail. The more relevant variations (absolute effect size > 
0.8) were expressed as the percentage variation in relation to controls and are presented 
in Figure 5.5b and Supplementary Table S5.2. 
The variation of most intracellular polar metabolites was clearly dependent on the 
nanoparticle concentration, showing higher magnitude at the higher concentration of 
exposure. Additionally, while Cit30 significantly altered the levels of several metabolites 
already at the IC5 concentration, the impact of an equivalent concentration of GS30 on the 
metabolic profile was smaller (19 vs. 9 metabolites with relevant variations); at the IC20 
concentration, however, the overall impact of the two nanoparticle types was qualitatively 
similar (23 metabolite levels consistently affected upon exposure to either Cit30 or GS30). 
On the other hand, in quantitative terms, there are some differences to point out, as 
described in the next paragraphs. 
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Figure 5.7. Multivariate analysis of 1H NMR spectra from polar extracts of HepG2 control cells and 
cells exposed to a-c) Cit30, and d-f) GS30 AgNPs: a, d) PCA; b, e) PLS-DA scores scatter plots; and 
c, f) LV1 loadings w, coloured as a function of variable importance to the projection (VIP). BCAA, 
branched chain amino acids; AXP, ADP+ATP; UXP, UDP+UTP; for other metabolite codes, vide 
legend of Figure 5.5. 
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The increase in intracellular lactate was especially prominent in cells exposed to 
GS30 (15-28%), while Cit30 caused a smaller increase (9%) in lactate levels, seen only at 
the IC5 concentration. On the other hand, fumarate was more markedly decreased upon 
exposure to Cit30 (-46% vs. -25% for GS30). In regard to amino acids, the two nanoparticle 
types induced distinct variations in the levels of intracellular glutamine: cells exposed to the 
IC20 concentration of Cit30 contained significantly higher glutamine levels (10% more in 
relation to controls) while exposure to GS30 caused a significant decrease (-14%) in 
glutamine at the IC5 concentration (and no change at the IC20). As for other amino acids, 
both nanoparticle types induced significant decreases in glutamate, aspartate, N-
acetylaspartate and glycine and significant increases in isoleucine, leucine, valine, 
phenylalanine, methionine and an unassigned N-acetylated amino acid; these changes 
were generally more prominent upon exposure to Cit30 (Figure 5.5b and Supplementary 
Table S5.2). Moreover, the Cit30 particles additionally caused significant increases in 
tyrosine and histidine, not seen upon exposure to GS30 AgNPs. 
Nanoparticle exposure also affected the levels of several metabolites known to be 
involved in energy generation and transfer processes, namely creatine, phosphocreatine, 
ADP and NAD+ (decreased in relation to control cells), along with ATP and UTP (increased 
compared to control cells). Also of notice was the specific increase in UDP and the relatively 
larger increases in ATP and UTP upon exposure to GS30 (near 40% increases vs. 17-21% 
increases with Cit30). The intracellular levels of reduced glutathione (GSH) increased 17-
19% upon exposure to the IC5 of either Cit30 or GS30, and 23-25% in cells exposed to the 
IC20 of each nanoparticle type; thus, this variation showed little dependency on either the 
concentration or type of AgNPs. Finally, upon exposure to AgNPs, the endometabolome of 
HepG2 cells showed significantly decreased levels of phosphocholine (-24 and -32% in 
Cit30 and GS30-exposed cells, respectively) and of taurine (-22 and -31% in Cit30 and 
GS30-exposed cells, respectively). 
 
The intracellular metabolic changes induced by citrate and the EG extract used to 
prepare/stabilise the AgNPs were also assessed. As seen in Figure 5.5b (5th column), citrate 
(20 μM) did not induce any significant changes in the endometabolome of HepG2 cells. On 
the other hand, the EG extract (at 0.5 mg/mL) caused relevant changes in several 
metabolites (Figure 5.5b, 6th column). Among these, some were common to the effects 
observed in cells exposed to either Cit30 or GS30, namely the increases in lactate, an N-
acetylated amino acid and UTP, together with the decreases in phosphocholine and taurine. 
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Hence, it may be postulated that these variations reflected common cellular responses to 
certain exogenous stimuli rather than nanoparticle-specific effects. Additionally, the 
increase in UDP, seen only in cells exposed to GS30 or the EG extract (not to Cit30) could 
possibly reflect the specific interaction of plant extract compounds with the cells. On the 
other hand, a number of alterations seen upon exposure to AgNPs were not observed in 
cells exposed to the EG extract; for instance, fumarate, glutamine, glutamate, creatine and 
phosphocreatine levels were unaffected in those cells, and the variation of several other 
metabolites was in the opposite direction between cells exposed to AgNPs and the EG 
extract. To cite a few examples, cells exposed to the EG extract showed increased levels 
of aspartate, glycine and NAD+, compared to control cells, and decreased levels of ATP and 
GSH. This latter change is consistent with the induction of oxidative stress, also suggested 
by the significantly increased intracellular ROS generation observed upon exposure to the 
EG extract (Figure 5.4).  
 
Analysis of lipophilic extracts further revealed a few changes in the intracellular lipid 
composition (Figure 5.5c and Supplementary Table S5.3), most of which were common to 
cells exposed to Cit30 and GS30. These included increased levels of esterified cholesterol 
and decreased levels of unsaturated fatty acyl chains and phosphatidylcholine. Additionally, 
cells exposed to Cit30 presented significantly lower levels of total cholesterol, while cells 
exposed to GS30 showed a non-significant decrease in phosphatidylethanolamine. 
Exposure to citrate alone did not alter the lipid profile, whereas the EG extract caused 
decreases in total and esterified cholesterol and a slight but significant increase in 
phosphatidylethanolamine, again exhibiting a mode of action different from the 
nanoparticles.  
 
5.6. Metabolic variations induced by Ag+ in HepG2 cells 
Following a similar strategy to that presented above for the AgNPs, the impact of 
Ag+ (from AgNO3) on cell metabolism has been evaluated by NMR analysis of culture 
medium supernatants, as well as of polar and lipophilic extracts. Sub-toxic concentrations 
of Ag+ (IC5 and IC20) were selected to produce an impact on cell viability similar to that of 
AgNPs. 
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The changes in the culture medium arising from cell exposure to Ag+ are 
summarised in Figure 5.8a (and in Supplementary Table S5.4), where the results for Cit30 
are also included to aid comparative analysis. Similarly to AgNPs, Ag+ enhanced the 
consumption of pyruvate, downregulated the consumption of branched chain amino acids 
and choline, and increased the excretion of lactate, fumarate and glutamate. Unlike for 
AgNPs, citrate levels were not altered, whereas non-significant decreases in alanine and 
acetate and a significant increase in allantoin were noted. 
 
The polar extract profiles of Ag+-treated cells also showed evident differences from 
control cells, as readily seen through multivariate analysis. Indeed, the PCA scores scatter 
plot (Figure 5.9a) showed a clear dose-dependent separation between control and exposed 
samples, further evidenced by PLS-DA (Figure 5.9b, and Supplementary Figure S5.3). The 
joint analysis of the corresponding loadings (Figure 5.9c) and individual metabolite integrals 
allowed the most relevant variations to be highlighted and compared to those induced by 
the AgNPs. 
As it can be seen in Figure 5.8b (with support from Supplementary Table S5.5), the 
intracellular metabolic signature of Ag+ in HepG2 cells was remarkably similar to that of 
Cit30 AgNPs. Still, a few differences could be noted. These included larger increases of 
branched chain and aromatic amino acids, histidine, methionine and threonine, especially 
at the IC20 concentration, along with a less expressive non-significant decrease in NAD+ 
and smaller increases in GSH (less than 10%, as compared to ~20% induced by Cit30). 
Additionally, UTP levels were not increased upon exposure to Ag+ while pantothenate 
registered a non-significant increase, not seen with AgNPs. 
 
In what concerns the lipid profile, the most marked effects were the increase in 
cholesterol esters and the decrease in phosphatidylcholine (Figure 5.8c and Supplementary 
Table S5.6), similarly to the observations made for AgNPs. However, Ag+ seemed to 
produce lesser effects on total cholesterol and unsaturated fatty acyl chains. 
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Figure 5.8. Heatmap of the main metabolite variations in a) culture media, b) polar extracts, and c) 
lipophilic extracts, from HepG2 cells exposed to Cit30, Ag+, and H2O2, at the IC5 and IC20, coloured 
according to % variation in relation to controls, from maximum decrease (dark blue) to maximum 
increase (dark red). * Uncorrected p-value < 0.05; ** FDR-corrected p-value < 0.05. Three letter code 
used for amino acids; NAA, N-acetylaspartate; Un. NAaa, unidentified N-acetylated amino acid; Cr, 
creatine; PCr, phosphocreatine; ADP/ATP, adenosine di/triphosphate; NAD+, nicotinamide adenine 
dinucleotide; GSH, reduced glutathione; PC, phosphocholine; UTP, uridine triphosphate; PTC, 
phosphatidylcholine; FA, fatty acyl. 
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Figure 5.9. Multivariate analysis of 1H NMR spectra from polar extracts of control and Ag+-exposed 
HepG2 cells: a) PCA, b) PLS-DA scores scatter plots, and c) LV1 loadings w, coloured as a function 
of variable importance to the projection (VIP). BCAA, branched chain amino acids; AXP, ADP+ATP; 
for other metabolite codes, vide legend of Figure 5.8. 
 
5.7. Metabolic variations induced by H2O2 in HepG2 cells 
The metabolic impact resulting from exposure of HepG2 cells to IC5 and IC20 
concentrations of H2O2 was also investigated. Analysis of culture medium supernatants 
showed that, similarly to AgNPs/Ag+, H2O2 downregulated the consumption of branched 
chain amino acids and choline, and increased the excretion of glutamate (Figure 5.8a and 
Supplementary Table S5.4). However, H2O2 did not stimulate the release of citrate nor 
fumarate to significant extent, while the excretion of lactate and alanine were decreased in 
H2O2-exposed cells relatively to control cells. Another marked variation in the extracellular 
medium of H2O2-treated cells was the increase in acetate levels, which was highly 
correlated with the pyruvate decrease (r -0.89, p < 0.005). This corroborates the known 
reaction of pyruvate with H2O2 whereby acetate is produced. Thus, it is possible that 
decreased pyruvate levels in the medium of H2O2-exposed cells mainly reflected H2O2 
neutralisation rather than the increased consumption by cells suggested to take place upon 
exposure to AgNPs/Ag+. 
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The changes on the intracellular metabolic composition of H2O2-exposed cells were 
revealed based on multivariate analysis and integration of spectral signals from polar 
extracts. The PCA separation between controls and H2O2-exposed cells (Figure 5.10a) was 
not as clear for the low concentration (IC5) samples, thus rendering a less robust 
discrimination by PLS-DA (Figure 5.10b, and Supplementary Figure S5.4). Still, a number 
of relevant effects in polar metabolites could be identified (Figures 5.8b and 5.8c, and 
Supplementary Table S5.5). Many of these effects were common to those induced by 
AgNPs/Ag+, namely the increased intracellular levels of several amino acids and of ATP 
(although non-significantly in the latter case), along with significantly reduced levels of N-
acetylaspartate, creatine, phosphocreatine, phosphocholine and taurine. On the other 
hand, the intracellular composition of HepG2 cells was differently affected by H2O2 in the 
following aspects: lactate showed a non-significant decrease (while it increased in 
AgNPs/Ag+-exposed cells); fumarate showed a lower, non-significant decrease; glutamate 
and aspartate (seen to decrease upon exposure to AgNPs/Ag+) did not vary significantly; 
glycine and serine increased; NAD+, UTP or GSH levels remained largely unaffected; 
pantothenate showed a significant increase not seen in AgNPs/Ag+-treated cells. 
 
 
Figure 5.10. Multivariate analysis of 1H NMR spectra from polar extracts of control and H2O2-
exposed HepG2 cells: a) PCA, b) PLS-DA scores scatter plots, and c) LV1 loadings w, coloured as 
a function of variable importance to the projection (VIP). BCAA, branched chain amino acids; for 
other metabolite codes, vide legend of Figure 5.8. 
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As for the lipid composition (Figure 5.8c and Supplementary Table S5.6), H2O2-
exposed cells showed increased levels of both total and esterified cholesterol and a non-
significant decrease in phosphatidylcholine. 
 
5.8. Discussion of metabolic variations in HepG2 cells 
Exposure of HepG2 cells to silver nanoparticles with a metallic core diameter of 30 
nm and coated with either citrate or a plant-derived phenolic/sugar layer, at sub-toxic 
concentrations, was found to induce profound changes in the cellular metabolome, 
reflecting metabolic adaptations within different pathways.  
Based on the integrated analysis of the metabolite changes described above (Figure 
5.5), Cit30 and GS30 AgNPs may be proposed to significantly affect HepG2 cells energy 
production processes, as summarised schematically in Figure 5.11. A first interesting 
observation is that cells increased their intracellular ATP production in the presence of 
AgNPs. The opposite effect, i.e. ATP depletion, has been implicated in the cytotoxicity of 
AgNPs (Zhang et al., 2014b), as well as of other nanoparticles (Dong et al., 2009; 
Bhattacharjee et al., 2013; Yu et al., 2013a). In particular, a low ATP yield in human 
fibroblasts and glioblastoma cells exposed to AgNPs has been associated to mitochondrial 
dysfunction caused by structural damage induced by nanoparticle deposition and/or the 
induction of oxidative stress (AshaRani et al., 2009). Furthermore, it has been demonstrated 
that AgNPs can directly inhibit the activity of liver mitochondrial ATPase, thus reducing ATP 
synthesis (Chichova et al., 2014), and that AgNPs can impair oxidative phosphorylation in 
liver mitochondria (Costa et al., 2010; Teodoro et al., 2011). Thus, the fact that, in the 
present work, AgNPs did not reduce ATP levels can be interpreted as an indicator of low 
cytotoxicity, in consonance with the small decreases (5-20%) in MTT-assessed cell viability.  
Our results are also in contrast with those reported by Chen and co-workers whereby 
HepG2 cells (and other cell types) exposed to non-cytotoxic concentrations of AgNPs (up 
to 8 μg/mL) decreased intracellular ATP (Chen et al., 2014). In that work, the ATP depletion 
was related to a shift in energy metabolism from oxidative phosphorylation and fatty acid 
oxidation to glycolysis, based on increased intracellular pyruvate, lactate, triglyceride and 
cholesterol levels. Contrastingly, our data suggest an intensification of pyruvate use, down 
to the TCA cycle and oxidative phosphorylation, as supported by increased pyruvate 
consumption from the culture medium and decreased intracellular levels of several TCA 
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cycle anaplerotic substrates (glycine, N-acetylaspartate, aspartate and glutamate) (Figure 
5.11). 
 
Figure 5.11. Schematic diagram of the putative effects of Cit30 (red arrows), GS30 (purple arrows), 
Ag+ (green arrows), and H2O2 (blue arrows), on glycolysis and the TCA cycle. Dashed arrows indicate 
|% variation| < 10%. 
 
Additionally, the decrease in unsaturated fatty acyl chains, possibly reflecting their 
oxidation for energy production, together with decreased intracellular fumarate and 
increased release of citrate and fumarate, further support the enhanced activity of the TCA 
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cycle. Altogether, our results suggest a metabolic response of HepG2 cells to AgNPs 
distinct from that reported by (Chen et al., 2014). It may be hypothesised that the different 
physicochemical properties of the AgNPs used account for this discrepancy; the cited 
authors used PVP-coated AgNPs with a core diameter of 25 nm and a 76 nm hydrodynamic 
diameter in water, sizes which are actually comparable to those of the AgNPs used in this 
work (Table 5.1). Another possible explanation could relate to the supplementation of the 
culture medium used in this work with sodium pyruvate, according to the specific 
recommendations for culturing HepG2 cells (vide experimental section). Sheline and co-
authors reported that adding pyruvate to the medium of neuronal cells attenuated the toxic 
effects induced by zinc ions, namely by mitigating ATP loss and cell death (Sheline et al., 
2000). This effect was attributed to the ability of pyruvate to serve as an energy substrate 
and to regenerate NAD+ through conversion into lactate. Indeed, we have also seen 
increased production of lactate accompanying intensified pyruvate metabolism. Importantly, 
in the specific case of hepatocytes, the medium supplementation with pyruvate should 
better match the in vivo situation, as the liver is largely responsible for pyruvate recycling 
(produced from lactate by other organs) and gluconeogenesis. 
Another literature report has shown that HepG2 cells exposed to 5 nm AgNPs for a 
short period (1-6 hours) at concentrations inducing 10-40% decreases in cell viability 
displayed decreased glucose consumption and lactate release (Lee et al., 2016a); this 
effect was found to be size-dependent as it was not observed for 100 nm AgNPs. Also, the 
authors have shown that this alteration in glucose metabolism was tightly dependent on 
ROS production. Specifically, the downregulation of lactate release was accompanied by a 
progressive increase in ROS generation right from 1 h of exposure, while normal lactate 
release was restored in the presence of a ROS scavenger. Excessive ROS production has 
often been highlighted as a main mechanism through which AgNPs exert cytotoxicity; in 
HepG2 and other liver cells, exposure to AgNPs at cytotoxic concentrations was reported 
to induce increased intracellular ROS, along with decreased levels of reduced glutathione 
(GSH), postulated to reflect persistent oxidative stress (Piao et al., 2011; Vrček et al., 2016; 
Avalos et al., 2014). Interestingly, in the present work, intracellular ROS did not increase 
under the exposure conditions tested (IC20, 24h – Figure 5.4), while intracellular GSH was 
significantly increased in AgNPs-treated cells. These results agree with earlier works where 
HepG2 cells (Jain et al., 2009) or primary mouse liver cells (Arora et al., 2009) increased 
GSH levels (~1.1 fold), along with superoxide dismutase activity, upon exposure to AgNPs 
at ½ IC50 (corresponding to ~10 % decrease in cell viability). 
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Our results further showed significantly decreased levels of creatine and 
phosphocreatine, possibly reflecting reprogramming of energy storage and transmission. A 
similar observation has been made for HepG2 cells exposed to graphene nanosheets (Jiao 
et al., 2014). 
Additionally, AgNPs-treated cells showed significant increases in branched chain 
amino acids, aromatic amino acids, histidine and methionine, which were especially 
pronounced with Cit30. Increases in those amino acids (and some others) have been 
previously identified as part of the metabolic signature of drug-induced autophagy in tumour 
cells (Lin et al., 2016). Autophagy is a catabolic process by which unnecessary or 
dysfunctional cellular components are sequestered into double-membrane vesicles 
(autophagosomes) and targeted for lysosomal degradation (Jiang and Mizushima, 2014). 
Recently, a variety of nanoparticles have been shown to induce autophagy, leading either 
to increased cell death or, paradoxically, to promotion of cell survival (Zabirnyk et al., 2007). 
PVP-coated silver nanoparticles were shown to induce a size-dependent autophagic 
response in HepG2 cells, even at relatively low or non-cytotoxic doses. Furthermore, 
AgNPs-induced autophagy was shown to play a cytoprotective role at sub-toxic 
concentrations in HepG2 (Mishra et al., 2016) and HeLa cells (Lin et al., 2014). Thus, we 
may hypothesise that the observed increase in several amino acids could relate to an 
autophagic response, thus providing additional substrates for energy production and aiding 
cell survival. 
Phospholipid metabolism also seemed to be affected upon exposure to both 
nanoparticle types, as suggested by decreased choline consumption from the medium 
along with decreased levels of phosphocholine and phosphatidylcholine. 
Phosphatidylcholines are major components of cellular membranes, synthesised mainly 
through the CDP-choline pathway, which is part of the Kennedy pathway (Chang and 
Carman, 2008). The CDP-choline pathway begins with the uptake of exogenous choline 
into the cell and proceeds with the phosphorylation of choline to form phosphocholine 
(Figure 5.12a). In AgNPs-treated cells, we found a significant negative correlation between 
choline uptake and phosphatidylcholine (Figure 5.12b), suggesting the downregulation of 
phospholipid synthesis. This effect was especially pronounced in GS30-treated cells, where 
significant correlations were found between several compounds of the CDP-choline 
pathway (Figure 5.12b). Also, in GS30-treated cells, the intermediates of this pathway 
additionally showed a strong correlation with the increase in UTP, possibly reflecting its role 
as a CTP precursor (Figure 5.12a). Furthermore, cholesterol esters increased in exposed 
cells, which could reflect a form of biologically inert storage (detoxification) of fatty acids. 
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Figure 5.12. a) Schematic diagram of phosphatidylcholine biosynthesis via the CDP-choline 
pathway. Arrows indicate effects caused by Cit30 (red arrows), GS30 (purple arrows), Ag+ (green 
arrows), and H2O2 (blue arrows); dashed arrows indicate |% variation| < 10%; thick arrows indicate 
|% variation| > 50%. b) Pearson correlation coefficients (r) between metabolites involved in 
phosphatidylcholine biosynthesis, found to vary after HepG2 exposure to Cit30 (red) or GS30 
(purple) AgNPs. ext, extracellular; * p < 0.05; ** p-value < 0.005. 
 
Although the putative AgNP-induced biochemical events described above were 
largely common to both nanoparticle types, the different extent of some variations suggests 
that Cit30 had a greater impact on the TCA cycle and protein degradation, whereas GS30 
induced a stronger downregulation of phospholipid synthesis. Moreover, HepG2 cells 
appeared to use glutamine differently depending on exposure to Cit30 or GS30; while this 
amino acid increased in Cit30-treated cells (eventually reflecting the autophagic response 
seen for other amino acids), GS30 induced a higher glutamine consumption from the 
medium and decreased intracellular glutamine levels, suggesting higher glutaminolytic 
activity. Interestingly, the metabolic effects of the EG extract used to prepare and stabilise 
the GS30 were strikingly different from those of the nanoparticles themselves. For instance, 
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ATP and GSH decreased, most amino acids varied to a lesser extent and in opposite sense, 
creatine and phosphocreatine remained unaltered, and so did the levels of unsaturated fatty 
acyl chains and phosphatidylcholine, while cholesterol esters decreased. This could reflect 
not only the modified chemical nature of the compounds coating the GS30 AgNPs (and 
eventually released into the medium) compared to those present in the EG extract, but also 
the expectedly different uptake and interaction of nanoparticles and soluble organic 
compounds with cells. 
Based on the high similarity between the AgNPs metabolic signature and the effects 
induced by Ag+, described in section 5.6, it may be argued that the release of Ag+ from 
AgNPs largely explains the interaction of nanoparticles with cells at the biochemical level. 
However, differences like the higher increase in several amino acids (possibly reflecting 
protein degradation), the less pronounced increases in ATP or GSH in Ag+-exposed cells, 
together with the increase in the oxidative stress marker allantoin (product of uric acid 
oxidation) suggest that cells are less able to cope with the amount of ionic silver 
administered at once than with the gradual intracellular release from AgNPs. Indeed, this is 
consistent with the much larger cytotoxicity of Ag+ compared to AgNPs (IC50 1.19 and 18.9 
μg/mL, respectively). 
 
The H2O2 metabolic signature revealed a similar impact to AgNPs/Ag+ in regard to 
putative autophagy-related protein degradation and phospholipid metabolism. On the other 
hand, some ROS-specific effects may be proposed. For instance, unlike AgNPs/Ag+, H2O2 
reduced lactate intra- and extracellular levels, as well as alanine excretion, suggesting 
downregulation of fermentative glycolysis, in agreement with other studies (Brand et al., 
1999; Colussi et al., 2000; Kuehne et al., 2015). On the other hand, H2O2 had a lesser 
impact on TCA cycle intermediates and anaplerotic substrates, and did not alter GSH levels. 
In liver cells, the enzyme catalase is an especially effective system to detoxify H2O2, 
therefore, similarly to the observations of others (Alia et al., 2005), it is possible that little 
GSH was dedicated to H2O2 reduction under the exposure conditions tested. In addition, 
H2O2 induced a significant increase in pantothenate (vitamin B5), not seen upon exposure 
to AgNPs/Ag+. This metabolite is a precursor of coenzyme A (CoA), which has a crucial role 
in the synthesis and oxidation of fatty acids, the biosynthesis of cholesterol, and pyruvate 
oxidation through the TCA cycle (Leonardi et al., 2005; Snyder et al., 2015). As mammals 
do not synthesise pantothenate de novo, its intracellular increase should reflect increased 
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consumption from the medium (not confirmed due to spectral overlap) and/or reduced 
intracellular use in the processes mentioned above. 
 
Overall, the metabolic signature of AgNPs/Ag+ in HepG2 cells suggests that, under 
the conditions tested, these cells were able to activate metabolism-mediated protective 
mechanisms. Notably, a protective response has also been found in vivo in the liver of mice 
intravenously injected with PEG-coated AgNPs (core diameter of 30 nm) (paper submitted 
by our group). Specifically, the liver of treated mice displayed upregulated synthesis of 
glycogen, lipolysis, fatty acid oxidation and production of antioxidative molecules (including 
GSH). Thus, our results demonstrate that in vitro metabolomics shows good potential in 
aiding to explain and predict the in vivo outcomes of nanoparticle exposure. 
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Supplementary information to Chapter 5 
 
 
Figure S5.1. TEM images (left) and particle size histograms (right) of a) Cit30 and b) GS30 AgNPs. 
Data acquired at CICECO (UA) by Dr A. L. Daniel-da-Silva (Cit30) and Dr R. Pinto (GS30). 
 
 
 
Figure S5.2. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models of polar extracts, corresponding to exposure to: a) Cit30 (sensitivity 98.3%, 
specificity 100%, classification rate 99.1%), and b) GS30 (sensitivity 77.0%, specificity 100%, 
classification rate 87.9%). TPR: true positive rate; FPR: false positive rate. 
 
Chapter 5 
 
137 
 
 
 
 
Figure S5.3. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models of polar extracts, corresponding to Ag+ exposure (sensitivity 84.1%, specificity 
97.8%, classification rate 90.6%). TPR: true positive rate; FPR: false positive rate. 
 
 
 
Figure S5.4. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models of polar extracts, corresponding to H2O2 exposure (sensitivity 74.5%, 
specificity 92.4%, classification rate 83.0%). TPR: true positive rate; FPR: false positive rate. 
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Table S5.1. Main metabolite variations in culture medium of HepG2 cells exposed to Cit30 and GS30 
AgNPs at respective IC5 and IC20 concentrations, and to citrate and EG extract (at the maximum 
amounts present when IC20 concentrations of AgNPs were administered to cells), in relation to culture 
medium of control cells, expressed as % variation (%var) and respective error (±), effect size (ES), 
p-value (p), and FDR-adjusted p-value (FDR). The variations with |ES| < 0.8 (or standard error > 
|ES|, or mean error > |% variation|) were considered null. 
  Cit30 GS30 Citrate EG 
extract 
  IC5 IC20 IC5 IC20 
Pyruvate 
%var -13.81 -17.27 0 -14.32 0 15.30 
± 5.21 4.75  5.29  4.56 
ES -1.66 -2.38 0 -1.66 0 1.74 
p 0.0239 0.0054  0.0227  0.0187 
FDR 0.1122 0.0207  0.0576  0.1187 
Lactate 
%var 20.23 0 18.75 16.62 0 21.24 
± 6.43  7.01 8.01  7.62 
ES 1.66 0 1.31 1.02 0 1.34 
p 0.0259  0.0584 0.1172  0.0553 
FDR 0.1122  0.4437 0.1856  0.1910 
Citrate 
%var 13.19 16.54 10.33 5.80 16.36 9.99 
± 1.17 0.98 3.52 3.53 3.09 3.45 
ES 5.79 8.71 1.64 0.95 2.52 1.63 
p 3.93E-05 1.65E-06 0.0285 0.1572 0.0017 0.0302 
FDR 0.0007 0.0001 0.4437 0.2297 0.0652 0.1273 
Fumarate 
%var 11.19 13.95 4.65 13.43 0 0 
± 2.72 3.78 3.52 3.34   
ES 2.61 2.01 0.81 2.36 0 0 
p 0.0285 0.0113 0.2556 0.0144   
FDR 0.1122 0.0308 0.8274 0.0395   
Glutamine 
%var -3.93 0 -7.41 0 0 0 
± 2.57  2.71    
ES -0.89 0 -1.52 0 0 0 
p 0.1628  0.0402    
FDR 0.3701  0.4437    
Glutamate 
%var 22.17 21.72 13.38 24.59 0 0 
± 1.63 2.01 2.59 3.19   
ES 7.23 5.49 2.59 3.62 0 0 
p 9.11E-06 3.02E-05 0.0049 0.0015   
FDR 0.0003 0.0006 0.1857 0.0125   
Phenylalanine 
%var 3.50 6.56 0 5.19 0 0 
± 0.88 0.69  1.02   
ES 2.13 5.11 0 2.93 0 0 
p 0.0092 0.0001  0.0019   
FDR 0.0639 0.0008  0.0125   
Leucine 
%var 2.36 7.83 0 8.76 0 0 
± 1.16 1.13  1.30   
ES 1.11 3.67 0 3.41 0 0 
p 0.0913 0.0005  0.0023   
FDR 0.2676 0.0036  0.0125   
Isoleucine 
%var 1.60 5.70 0 6.08 0 0 
± 0.80 0.81  0.91   
ES 1.11 3.79 0 3.54 0 0 
p 0.0916 0.0004  0.0008   
FDR 0.2676 0.0036  0.0125   
2-Oxoisoleucine 
%var 0 -10.95 0 -9.41 0 0 
±  3.06  3.02   
ES 0 -2.12 0 -1.76 0 0 
p  0.0081  0.0244   
FDR  0.0266  0.0579   
α-Ketovaline 
%var -4.46 -14.33 4.26 -12.99 0 0 
± 2.93 3.44 2.64 3.01   
ES -0.89 -2.54 0.84 -2.47 0 0 
p 0.1636 0.0032 0.1845 0.0081   
FDR 0.3701 0.0146 0.8274 0.0281   
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  Cit30 GS30 Citrate EG 
extract 
  IC5 IC20 IC5 IC20 
Choline 
%var 23.53 38.47 8.02 57.15 0 0 
± 5.07 4.45 3.86 3.81   
ES 2.23 3.88 1.14 6.31 0 0 
p 0.0082 0.0006 0.0872 2.13E-05   
FDR 0.0639 0.0036 0.4733 0.0008   
Acetate 
%var 0 0 0 16.65 0 27.19 
±    4.01  2.71 
ES 0 0 0 2.20 0 5.71 
p    0.0068  0.0012 
FDR    0.0281  0.0237 
Formate 
%var 0 -8.72 7.45 -6.52 0 11.31 
±  2.96 3.34 4.20  3.15 
ES 0 -1.67 1.22 -0.90 0 1.94 
p  0.0264 0.0701 0.1550  0.0118 
FDR  0.0627 0.4437 0.2297  0.0900 
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Table S5.2. Main metabolite variations in polar extracts of HepG2 cells exposed to Cit30 and GS30 
AgNPs at respective IC5 and IC20 concentrations, and to citrate and EG extract (at the maximum 
amounts present when IC20 concentrations of AgNPs were administered to cells), in relation to 
controls, expressed as % variation (%var) and respective error (±), effect size (ES), p-value (p), and 
FDR-adjusted p-value (FDR). The variations with |ES| < 0.8 (or standard error > |ES|, or mean error 
> |% variation|) were considered null. 
  Cit30 GS30 Citrate EG Extract 
  IC5 IC20 IC5 IC20 
Lactate 
%var 8.84 0 15.28 28.15 0 16.74 
± 1.72  3.72 2.90  4.33 
ES 2.81 0 2.14 4.91 0 1.95 
p 0.0014  0.0073 0.0001  0.0119 
FDR 0.0056  0.0642 0.0006  0.0374 
Fumarate 
%var -24.86 -45.63 0 -25.34 0 0 
± 9.14 9.63  20.04   
ES -1.77 -3.51 0 -0.83 0 0 
p 0.0167 0.0008  0.1869   
FDR 0.0324 0.0023  0.2337   
Glutamine 
%var 0 10.48 -14.51 -4.12 0 0 
±  2.51 2.79 2.18   
ES 0 2.27 -3.02 -1.04 0 0 
p  0.0071 0.0029 0.1100   
FDR  0.0138 0.0515 0.1481   
Glutamate 
%var -7.64 -15.43 0 -20.15 9.03 0 
± 1.70 1.86  3.73 5.53  
ES -2.67 -5.15 0 -3.44 0.83 0 
p 0.0030 4.29E-05  0.0006 0.1533  
FDR 0.0089 0.0002  0.0028 0.9712  
Aspartate 
%var -24.53 -25.13 -7.95 -18.31 0 13.05 
± 3.14 4.33 4.22 5.98  3.72 
ES -5.09 -3.80 -1.19 -1.93 0 1.98 
p 2.03E-05 0.0004 0.0944 0.0119  0.0164 
FDR 0.0002 0.0013 0.3004 0.0261  0.0410 
N-acetylaspartate 
%var 0 -21.15 9.83 -16.02 0 13.06 
±  6.68 5.60 5.70  4.49 
ES 0 -2.02 0.91 -1.71 0 1.52 
p  0.0089 0.1493 0.0203  0.0321 
FDR  0.0152 0.4020 0.0419  0.0512 
Glycine 
%var -8.88 -14.04 -2.45 -13.07 0 22.70 
± 2.24 2.51 1.37 3.10  2.50 
ES -2.37 -3.43 -0.98 -2.41 0 4.26 
p 0.0094 0.0022 0.1255 0.0089  0.0009 
FDR 0.0205 0.0051 0.3661 0.0208  0.0055 
Isoleucine 
%var 13.33 28.82 -4.10 17.05 0 -6.11 
± 2.61 2.31 1.25 2.47  2.11 
ES 2.74 6.23 -1.89 3.36 0 -1.61 
p 0.0017 1.66E-05 0.0130 0.0021  0.0301 
FDR 0.0061 0.0001 0.0757 0.0065  0.0512 
Leucine 
%var 18.93 35.56 -1.69 23.92 0 -5.13 
± 2.05 2.25 1.11 2.89  1.64 
ES 4.81 7.68 -0.84 3.86 0 -1.72 
p 3.04E-05 2.06E-06 0.1769 0.0015  0.0247 
FDR 0.0003 2.12E-05 0.4423 0.0060  0.0455 
Valine 
%var 9.23 20.68 -4.24 14.31 0 -5.89 
± 2.41 2.14 1.65 2.99  1.63 
ES 2.09 5.01 -1.45 2.36 0 -2.07 
p 0.0069 0.0001 0.0393 0.0089  0.0095 
FDR 0.0187 0.0002 0.1529 0.0208  0.0334 
Tyrosine 
%var 7.17 12.40 0 8.54 0 -5.80 
± 2.61 2.71  3.97  3.23 
ES 1.52 2.46 0 1.08 0 -0.98 
p 0.0292 0.0026  0.1069  0.1335 
FDR 0.0511 0.0058  0.1481  0.1947 
Phenylalanine 
%var 14.76 24.15 0 15.47 0 0 
± 2.84 3.63  4.68   
ES 2.77 3.39 0 1.65 0 0 
p 0.0014 0.0009  0.0260   
FDR 0.0056 0.0025  0.0479   
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  Cit30 GS30 Citrate EG Extract 
  IC5 IC20 IC5 IC20 
Histidine 
%var 17.73 25.32 0 0 0 0 
± 3.29 5.65     
ES 2.83 2.27 0 0 0 0 
p 0.0011 0.0087     
FDR 0.0056 0.0152     
Methionine 
%var 20.83 40.13 5.63 31.51 0 -7.52 
± 3.96 1.37 2.27 4.68  2.14 
ES 2.72 13.96 1.29 3.02 0 -1.97 
p 0.0075 1.53E-07 0.0643 0.0042  0.0149 
FDR 0.0187 5.36E-06 0.2251 0.0113  0.0402 
Unidentified 
N-acetylated 
amino acid 
%var 64.10 101.84 28.87 116.49 0 61.65 
± 2.84 3.82 2.61 3.40  7.28 
ES 9.78 10.09 5.96 11.44 0 3.36 
p 1.98E-07 1.14E-06 0.0002 9.51E-07  0.0020 
FDR 6.93E-06 2.00E-05 0.0071 3.33E-05  0.0088 
Creatine 
%var -11.73 -21.72 0 -17.18 0 0 
± 3.51 4.07  3.20   
ES -2.03 -3.42 0 -3.75 0 0 
p 0.0205 0.0010  0.0023   
FDR 0.0377 0.0025  0.0067   
Phosphocreatine 
%var -25.58 -37.39 -13.01 -43.62 0 0 
± 5.02 5.22 5.16 6.16   
ES -3.34 -5.03 -1.62 -5.61 0 0 
p 0.0007 4.95E-05 0.0317 0.0001   
FDR 0.0041 0.0002 0.1421 0.0006   
ADP 
%var 0 -14.10 0 -9.44 0 -52.82 
±  9.61  6.50  4.46 
ES 0 -0.90 0 -0.85 0 -11.14 
p  0.1679  0.1754  0.0002 
FDR  0.2176  0.2273  0.0018 
ATP 
%var 0 21.43 0 36.74 0 -64.69 
±  6.68  9.72  9.10 
ES 0 1.66 0 1.72 0 -6.98 
p  0.0222  0.0218  0.0001 
FDR  0.0324  0.0424  0.0013 
NAD+ 
%var -7.78 -16.51 0 -9.22 0 13.38 
± 1.83 2.38  3.92  2.58 
ES -2.53 -4.32 0 -1.38 0 2.83 
p 0.0030 0.0003  0.0456  0.0020 
FDR 0.0089 0.0011  0.0733  0.0088 
UDP 
%var 0 0 0 32.97 0 44.13 
±    10.68  12.95 
ES 0 0 0 1.51 0 1.52 
p    0.0349  0.0322 
FDR    0.0611  0.0512 
UTP 
%var 0 16.85 0 38.77 0 41.30 
±  4.89  4.02  3.14 
ES 0 1.81 0 4.46 0 6.29 
p  0.0133  0.0001  1.59E-05 
FDR  0.0202  0.0009  0.0003 
GSH 
%var 19.45 23.47 17.21 25.65 0 -13.75 
± 3.19 2.67 4.36 3.46  3.74 
ES 3.17 4.49 2.03 3.78 0 -2.41 
p 0.0005 0.0001 0.0095 0.0003  0.0068 
FDR 0.0038 0.0004 0.0666 0.0020  0.0264 
Phosphocholine 
%var -17.05 -24.35 -11.36 -31.52 0 -9.08 
± 1.68 2.29 2.06 2.79  2.88 
ES -6.33 -6.93 -3.85 -8.29 0 -1.92 
p 1.48E-05 2.42E-06 0.0049 8.41E-06  0.0128 
FDR 0.0002 2.12E-05 0.0571 0.0001  0.0374 
Taurine 
%var -15.46 -21.58 -10.99 -31.43 -4.71 -20.65 
± 4.64 6.05 4.00 5.89 2.99 3.36 
ES -2.06 -2.28 -1.58 -3.45 -0.86 -3.80 
p 0.0106 0.0091 0.0325 0.0018 0.1387 0.0005 
FDR 0.0218 0.0152 0.1421 0.0063 0.9712 0.0038 
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Table S5.3. Main metabolite variations in lipophilic extracts of HepG2 cells exposed to Cit30 and 
GS30 AgNPs at respective IC5 and IC20 concentrations, and to citrate and EG extract (at the 
maximum amounts present when IC20 concentrations of AgNPs were administered to cells), in 
relation to controls, expressed as % variation (%var) and respective error (±), effect size (ES), p-
value (p), and FDR-adjusted p-value (FDR). The variations with |ES| < 0.8 (or standard error > |ES|, 
or mean error > |% variation|) were considered null. 
  Cit30 GS30 Citrate EG 
extract 
  IC5 IC20 IC5 IC20 
Total cholesterol 
%var 0 -6.20 0 -4.27 0 -17.25 
±  2.34  2.53  1.37 
ES 0 -1.56 0 -1.06 0 -8.47 
p  0.0297  0.1589  7.78E-06 
FDR  0.0837  0.2393  0.0002 
Cholesterol ester 
%var 14.64 29.12 0 30.19 0 -18.08 
± 4.87 5.45  6.49  4.82 
ES 1.60 2.66 0 2.48 0 -2.35 
p 0.0326 0.0051  0.0180  0.0046 
FDR 0.4566 0.0837  0.0503  0.0214 
PTC 
%var 0 -17.84 0 -22.84 0 0 
±  6.54  6.94   
ES 0 -1.71 0 -2.28 0 0 
p  0.0207  0.0119   
FDR  0.0837  0.0503   
PTE 
%var 0 0 0 -6.25 0 9.28 
±    3.37  2.88 
ES 0 0 0 -1.18 0 1.73 
p    0.1140  0.0193 
FDR    0.1996  0.0599 
Total unsaturated 
fatty acyl chains 
%var 0 -8.35 0 -11.65 0 4.71 
±  2.61  2.25  1.67 
ES 0 -1.91 0 -3.39 0 1.57 
p  0.0129  0.0028  0.0289 
FDR  0.0837  0.0265  0.0809 
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Table S5.4. Main metabolite variations in culture medium of HepG2 cells exposed to Cit30 AgNPs, 
Ag+, and H2O2 at respective IC5 and IC20 concentrations, in relation to culture medium of control cells, 
expressed as % variation (%var) and respective error (±), effect size (ES), p-value (p), and FDR-
adjusted p-value (FDR). The variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% 
variation|) were considered null. 
  Cit30 Ag+ H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Pyruvate 
%var -13.81 -17.27 -10.04 -18.80 0 -11.43 
± 5.21 4.75 5.63 5.84  4.85 
ES -1.66 -2.38 -1.16 -2.18 0 -1.44 
p 0.0239 0.0054 0.1144 0.0140  0.0403 
FDR 0.1122 0.0207 0.3848 0.0686  0.1095 
Lactate 
%var 20.23 0 12.88 17.57 0 -12.10 
± 6.43  7.90 8.59  6.67 
ES 1.66 0 0.94 1.16 0 -1.07 
p 0.0259  0.1808 0.1180  0.1013 
FDR 0.1122  0.4404 0.2989  0.2238 
Citrate 
%var 13.19 16.54 0 0 9.54 0 
± 1.17 0.98   4.69  
ES 5.79 8.71 0 0 1.08 0 
p 3.93E-05 1.65E-06   0.0975  
FDR 0.0007 0.0001   0.2850  
Fumarate 
%var 11.19 13.95 11.48 14.25 6.38 0 
± 2.72 3.78 3.42 3.39 3.48  
ES 2.61 2.01 1.95 2.41 1.12 0 
p 0.0285 0.0113 0.0210 0.0087 0.1382  
FDR 0.1122 0.0308 0.2660 0.0662 0.3100  
Glutamate 
%var 22.17 21.72 14.76 26.44 12.77 11.32 
± 1.63 2.01 2.52 2.81 2.08 4.13 
ES 7.23 5.49 3.36 5.12 3.13 1.37 
p 9.11E-06 3.02E-05 0.0032 0.0009 0.0016 0.0562 
FDR 0.0003 0.0006 0.1205 0.0164 0.0262 0.1424 
Alanine 
%var 0 0 -6.13 0 -8.77 -15.95 
±   3.62  3.58 3.30 
ES 0 0 -1.07 0 -1.44 -3.01 
p   0.1316  0.0396 0.0012 
FDR   0.3848  0.1503 0.0092 
Phenylalanine 
%var 3.50 6.56 2.60 6.07 3.66 7.40 
± 0.88 0.69 1.05 0.55 0.95 1.27 
ES 2.13 5.11 1.51 6.58 2.29 3.16 
p 0.0092 0.0001 0.0730 4.31E-05 0.0091 0.0009 
FDR 0.0639 0.0008 0.3848 0.0016 0.0577 0.0087 
Leucine 
%var 2.36 7.83 0 5.29 0 8.75 
± 1.16 1.13  1.99  1.58 
ES 1.11 3.67 0 1.60 0 2.80 
p 0.0913 0.0005  0.0684  0.0053 
FDR 0.2676 0.0036  0.2150  0.0272 
Isoleucine 
%var 1.60 5.70 0 2.92 0 5.71 
± 0.80 0.81  1.76  1.11 
ES 1.11 3.79 0 1.01 0 2.68 
p 0.0916 0.0004  0.1904  0.0040 
FDR 0.2676 0.0036  0.3881  0.0251 
2-Oxoisoleucine 
%var 0 -10.95 -3.50 -8.62 0 -9.59 
±  3.06 2.46 2.48  2.57 
ES 0 -2.12 -0.89 -2.24 0 -2.12 
p  0.0081 0.2009 0.0120  0.0115 
FDR  0.0266 0.4491 0.0686  0.0437 
α-Ketoleucine 
%var -4.46 -14.33 0.00 -9.96 0 -10.61 
± 2.93 3.44 3.19 3.00  3.62 
ES -0.89 -2.54 -0.70 -2.15 0 -1.64 
p 0.1636 0.0032 0.3034 0.0144  0.0336 
FDR 0.3701 0.0146 0.5182 0.0686  0.0983 
Choline 
%var 23.53 38.47 0 36.07 17.99 52.73 
± 5.07 4.45  4.82 4.40 2.86 
ES 2.23 3.88 0 3.90 2.07 8.32 
p 0.0082 0.0006  0.0031 0.0089 2.11E-06 
FDR 0.0639 0.0036  0.0291 0.0577 0.0001 
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  Cit30 Ag+ H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Acetate 
%var 0 0 -12.24 0 232.53 465.93 
±   6.10  9.55 8.14 
ES 0 0 -1.31 0 5.60 8.41 
p   0.1082  0.0004 0.0001 
FDR   0.3848  0.0140 0.0015 
Formate 
%var 0 -8.72 3.88 -4.35 0 -11.53 
±  2.96 2.40 3.40  5.30 
ES 0 -1.67 0.98 -0.81 0 -1.27 
p  0.0264 0.1854 0.2679  0.0623 
FDR  0.0627 0.4404 0.4731  0.1479 
Allantoin 
%var 0 0 17.32 9.21 9.51 0 
±   5.33 5.84 5.24  
ES 0 0 1.84 0.93 0.93 0 
p   0.0384 0.1940 0.1469  
FDR   0.3651 0.3881 0.3100  
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Table S5.5. Main metabolite variations in polar extracts of HepG2 cells exposed to Cit30 AgNPs, 
Ag+, and H2O2 at respective IC5 and IC20 concentrations, in relation to controls, expressed as % 
variation (%var) and respective error (±), effect size (ES), p-value (p), and FDR-adjusted p-value 
(FDR). The variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|) were 
considered null. 
  Cit30 Ag+ H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Lactate 
%var 8.84 0 -3.67 5.35 0 -5.99 
± 1.72  1.95 1.99  2.71 
ES 2.81 0 -1.09 1.50 0 -1.45 
p 0.0014  0.0923 0.0306  0.0750 
FDR 0.0056  0.1424 0.0465  0.1193 
Fumarate 
%var -24.86 -45.63 -36.04 -38.25 0 -31.87 
± 9.14 9.63 8.64 13.42  17.52 
ES -1.77 -3.51 -2.91 -2.01 0 -1.28 
p 0.0167 0.0008 0.0032 0.0087  0.0628 
FDR 0.0324 0.0023 0.0124 0.0161  0.1046 
Glutamine 
%var 0 10.48 0 18.45 13.39 37.60 
±  2.51  2.74 3.91 2.80 
ES 0 2.27 0 3.52 1.68 5.90 
p  0.0071  0.0011 0.0307 0.0002 
FDR  0.0138  0.0029 0.0767 0.0008 
Glutamate 
%var -7.64 -15.43 0 -12.88 0 0 
± 1.70 1.86  1.78   
ES -2.67 -5.15 0 -4.42 0 0 
p 0.0030 4.29E-05  0.0002   
FDR 0.0089 0.0002  0.0007   
Aspartate 
%var -24.53 -25.13 -12.89 -18.93 0 -6.20 
± 3.14 4.33 4.16 4.04  4.08 
ES -5.09 -3.80 -1.89 -2.96 0 -0.96 
p 2.03E-05 0.0004 0.0150 0.0015  0.1664 
FDR 0.0002 0.0013 0.0404 0.0038  0.2240 
N-acetylaspartate 
%var 0 -21.15 0 -23.09 0 -25.66 
±  6.68  5.70  4.96 
ES 0 -2.02 0 -2.62 0 -3.45 
p  0.0089  0.0070  0.0005 
FDR  0.0152  0.0136  0.0016 
Glycine 
%var -8.88 -14.04 -7.82 -8.73 16.18 12.44 
± 2.24 2.51 1.42 1.92 0.95 3.81 
ES -2.37 -3.43 -3.27 -2.71 8.73 1.61 
p 0.0094 0.0022 0.0010 0.0045 2.44E-06 0.0362 
FDR 0.0205 0.0051 0.0087 0.0093 0.0001 0.0703 
Isoleucine 
%var 13.33 28.82 15.77 45.33 12.42 33.04 
± 2.61 2.31 3.24 3.43 1.67 2.04 
ES 2.74 6.23 2.58 6.16 3.78 7.33 
p 0.0017 1.66E-05 0.0021 1.67E-05 0.0007 0.0001 
FDR 0.0061 0.0001 0.0105 0.0001 0.0039 0.0005 
Leucine 
%var 18.93 35.56 18.89 53.07 15.23 42.80 
± 2.05 2.25 3.26 3.04 1.59 1.70 
ES 4.81 7.68 3.02 7.88 4.72 10.83 
p 3.04E-05 2.06E-06 0.0021 1.77E-05 0.0004 1.40E-05 
FDR 0.0003 2.12E-05 0.0105 0.0001 0.0030 0.0003 
Valine 
%var 9.23 20.68 12.29 36.36 10.87 25.90 
± 2.41 2.14 2.85 2.95 1.36 2.03 
ES 2.09 5.01 2.32 5.95 4.21 5.98 
p 0.0069 0.0001 0.0038 1.54E-05 0.0002 0.0001 
FDR 0.0187 0.0002 0.0134 0.0001 0.0024 0.0006 
Tyrosine 
%var 7.17 12.40 10.23 31.27 11.36 29.06 
± 2.61 2.71 2.71 3.61 2.58 2.10 
ES 1.52 2.46 2.05 4.28 2.19 6.33 
p 0.0292 0.0026 0.0071 0.0003 0.0124 0.0002 
FDR 0.0511 0.0058 0.0226 0.0011 0.0333 0.0007 
Phenylalanine 
%var 14.76 24.15 15.78 44.98 17.52 45.42 
± 2.84 3.63 4.02 3.20 2.88 3.13 
ES 2.77 3.39 2.08 6.56 3.19 6.44 
p 0.0014 0.0009 0.0113 1.79E-05 0.0009 1.73E-05 
FDR 0.0056 0.0025 0.0329 0.0001 0.0039 0.0003 
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  Cit30 Ag+ H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Histidine 
%var 17.73 25.32 22.90 50.73 21.97 46.56 
± 3.29 5.65 4.34 5.42 4.93 5.19 
ES 2.83 2.27 2.70 4.26 2.29 3.99 
p 0.0011 0.0087 0.0024 0.0005 0.0054 0.0003 
FDR 0.0056 0.0152 0.0105 0.0017 0.0189 0.0008 
Methionine 
%var 20.83 40.13 24.58 51.44 20.61 44.28 
± 3.96 1.37 2.81 4.60 2.10 2.71 
ES 2.72 13.96 4.44 5.08 4.70 6.95 
p 0.0075 1.53E-07 0.0008 0.0007 0.0004 0.0001 
FDR 0.0187 5.36E-06 0.0087 0.0021 0.0030 0.0006 
Serine 
%var 4.03 9.15 5.20 13.52 9.80 16.40 
± 1.85 2.57 2.65 2.90 1.46 1.54 
ES 1.22 1.95 1.09 2.49 3.93 5.83 
p 0.0788 0.0097 0.0935 0.0034 0.0009 3.94E-05 
FDR 0.1254 0.0155 0.1424 0.0074 0.0039 0.0005 
Threonine 
%var 0 0 -3.38 0 8.47 23.59 
±   2.22  3.25 4.46 
ES 0 0 -0.89 0 1.41 2.54 
p   0.1633  0.0427 0.0046 
FDR   0.2381  0.0996 0.0095 
Unidentified 
N-acetylated 
amino acid 
%var 64.10 101.84 70.36 157.03 31.02 153.84 
± 2.84 3.82 7.04 4.13 3.18 12.08 
ES 9.78 10.09 4.22 12.15 4.88 3.62 
p 1.98E-07 1.14E-06 0.0009 2.07E-06 0.0001 0.0021 
FDR 6.93E-06 2.00E-05 0.0087 3.62E-05 0.0013 0.0057 
Creatine 
%var -11.73 -21.72 -9.71 -25.93 -4.64 -16.80 
± 3.51 4.07 4.60 4.06 2.74 3.16 
ES -2.03 -3.42 -1.27 -4.20 -1.15 -3.72 
p 0.0205 0.0010 0.0577 0.0005 0.1637 0.0026 
FDR 0.0377 0.0025 0.0961 0.0017 0.3015 0.0066 
Phosphocreatine 
%var -25.58 -37.39 -13.58 -36.75 -17.80 -39.23 
± 5.02 5.22 5.15 4.44 4.55 5.86 
ES -3.34 -5.03 -1.62 -5.80 -2.73 -5.17 
p 0.0007 4.95E-05 0.0284 8.92E-06 0.0077 0.0001 
FDR 0.0041 0.0002 0.0523 0.0001 0.0247 0.0006 
ADP 
%var 0 -14.10 0 -12.68 0 -9.90 
±  9.61  6.85  4.72 
ES 0 -0.90 0 -1.13 0 -1.30 
p  0.1679  0.0865  0.0620 
FDR  0.2176  0.1081  0.1046 
ATP 
%var 0 21.43 0 13.79 0 19.82 
±  6.68  7.49  9.75 
ES 0 1.66 0 0.98 0 1.01 
p  0.0222  0.1301  0.1176 
FDR  0.0324  0.1570  0.1715 
NAD+ 
%var -7.78 -16.51 -3.54 -8.68 4.42 7.85 
± 1.83 2.38 1.33 3.51 2.71 3.19 
ES -2.53 -4.32 -1.55 -1.48 0.93 1.33 
p 0.0030 0.0003 0.0271 0.0515 0.1560 0.0518 
FDR 0.0089 0.0011 0.0523 0.0693 0.3015 0.0954 
UTP 
%var 0 16.85 0 0 -8.46 0 
±  4.89   5.28  
ES 0 1.81 0 0 -0.94 0 
p  0.0133   0.1394  
FDR  0.0202   0.2870  
GSH 
%var 19.45 23.47 9.00 8.03 0 0 
± 3.19 2.67 2.53 2.44   
ES 3.17 4.49 1.95 1.80 0 0 
p 0.0005 0.0001 0.0182 0.0291   
FDR 0.0038 0.0004 0.0454 0.0462   
Phosphocholine 
%var -17.05 -24.35 -11.85 -25.24 -12.12 -23.80 
± 1.68 2.29 2.20 2.00 2.16 2.32 
ES -6.33 -6.93 -3.27 -8.27 -3.85 -7.58 
p 1.48E-05 2.42E-06 0.0005 5.84E-07 0.0029 0.0002 
FDR 0.0002 2.12E-05 0.0087 2.04E-05 0.0112 0.0007 
Taurine 
%var -15.46 -21.58 -10.57 -24.07 0 -17.82 
± 4.64 6.05 4.01 5.23  3.83 
ES -2.06 -2.28 -1.59 -2.99 0 -2.80 
p 0.0106 0.0091 0.0279 0.0020  0.0031 
FDR 0.0218 0.0152 0.0523 0.0048  0.0072 
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  Cit30 Ag+ H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Pantothenate 
%var 0 0 8.15 9.05 14.17 18.58 
±   3.28 3.72 3.45 3.99 
ES 0 0 1.36 1.33 2.32 2.45 
p   0.0525 0.0614 0.0090 0.0040 
FDR   0.0919 0.0796 0.0264 0.0086 
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Table S5.6. Main metabolite variations in lipophilic extracts of HepG2 cells exposed to Cit30 AgNPs, 
Ag+, and H2O2 at respective IC5 and IC20 concentrations, in relation to controls, expressed as % 
variation (%var) and respective error (±), effect size (ES), p-value (p), and FDR-adjusted p-value 
(FDR). The variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|) were 
considered null. 
  Cit30 Ag+ H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Total cholesterol 
%var 0 -6.20 0 0 3.31 12.41 
±  2.34   1.60 1.57 
ES 0 -1.56 0 0 1.16 4.18 
p  0.0297   0.0819 1.75E-04 
FDR  0.0837   0.8730 0.0026 
Cholesterol ester 
%var 14.64 29.12 12.05 26.33 9.15 38.18 
± 4.87 5.45 3.83 3.68 4.74 4.02 
ES 1.60 2.66 1.70 3.61 1.02 4.35 
p 0.0326 0.0051 0.0210 0.0004 0.1143 1.87E-04 
FDR 0.4566 0.0837 0.2947 0.0125 0.8730 0.0026 
PTC 
%var 0 -17.84 0 -13.44 0 -12.49 
±  6.54  5.36  5.79 
ES 0 -1.71 0 -1.54 0 -1.34 
p  0.0207  0.0283  0.0537 
FDR  0.0837  0.1134  0.1252 
Total unsaturated 
fatty acyl chains 
%var 0 -8.35 0 -5.89 0 0 
±  2.61  2.68   
ES 0 -1.91 0 -1.29 0 0 
p  0.0129  0.0600   
FDR  0.0837  0.1681   
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Chapter 6. Metabolomic analysis of murine macrophages (RAW 
264.7 cells) exposed to citrate-coated silver nanoparticles 
6.1. Background and aims 
In this Chapter, the cytotoxic and metabolic responses of blood-derived cells, 
namely murine RAW 264.7 macrophages, to citrate-coated silver nanoparticles with an 
average diameter of 30 nm (Cit30) are presented and discussed. Macrophages are 
important phagocytic cells of the immune system which, among other functions, strongly 
determine the biological responses to foreign particles, including nanoparticles 
administered intravenously for therapeutic purposes or those entering the bloodstream after 
exposure via other routes (Aude-Garcia et al., 2016). Thus, knowledge on the interaction 
between macrophages and nanoparticles is important not only for toxicity assessments but 
also for the design of more effective nanomedicines. The murine cell line RAW 264.7 has 
emerged as a good in vitro model for assessing macrophages responses to various stimuli, 
since it retains representative characteristics of different macrophage types (Bordbar et al., 
2012). Thus, a number of reports comprising the effects of AgNPs in RAW 264.7 cells have 
been published. These studies have assessed the cytotoxic potential of AgNPs towards 
RAW 264.7 macrophages, for instance by looking at cell membrane damage (Park et al., 
2011; Suresh et al., 2012), uptake and intracellular localisation of the nanoparticles 
(Orlowski et al., 2013; Haase et al., 2014), alterations in cellular morphology (Kaur and 
Tikoo, 2013), induction of oxidative stress/ROS generation (Park et al., 2010; Nishanth et 
al., 2011; Kaur and Tikoo, 2013; Munusamy et al., 2015; Paul et al., 2015), metallothionein 
expression (Park et al., 2010; Zhang et al., 2015a) and inflammatory response (Park et al., 
2010; Nishanth et al., 2011; Park et al., 2011; Kaur and Tikoo, 2013; Haase et al., 2011; 
Aldossari et al., 2015; Giovanni et al., 2015; Paul et al., 2015). The influence of size, surface 
coating, and dissolution rate of AgNPs in the viability of RAW 264.7 cells has also been 
addressed (Pratsinis et al., 2013; Wang et al., 2014). 
Recent findings have established metabolic reprogramming as a key element of 
macrophages’ functional behaviour, rather than being simply involved in energy generation 
and biosynthesis (El Kasmi and Stenmark, 2015; Mills and O'Neill, 2016). In particular, the 
activation of macrophages with different environmental signals, namely lipopolysaccharide 
(LPS) and interferon-γ (IFN-γ) (resulting in classically activated or M1 macrophages), or 
interleukins IL-4, IL-10 and IL-13 (resulting in alternatively activated or M2 macrophages), 
has been shown to be associated with marked alterations in cellular metabolism 
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(Rodriguez-Prados et al., 2010; Biswas and Mantovani, 2012; Lamour et al., 2012; Jha et 
al., 2015). To our knowledge, however, the metabolic responses of macrophages to 
nanoparticles are poorly characterised. In this work, we use NMR metabolomics to assess 
the impact of AgNPs on macrophage metabolism, with a view to better describe the 
nanoparticle-induced activation profile, and to identify potential markers of macrophage 
response, as well as possible targets for modulation of macrophage metabolism. 
 
6.2. Physicochemical properties of the AgNPs tested 
The silver nanoparticles used for incubations with RAW 264.7 macrophages were 
stabilised in citrate and had a metallic core diameter of 30 nm (Cit30). Other 
physicochemical properties of these particles, as well as their aggregation and dissolution 
behaviour in culture medium, have already been described (Chapter 4, Table 4.1 and Figure 
4.1) and, thus, are not repeated here. 
 
6.3. Viability of RAW 264.7 cells exposed to AgNPs, Ag+ and H2O2 
The dose-response curve of RAW 264.7 cells exposed for 24 h to Cit30, obtained 
through the MTT assay, is shown in Figure 6.1a. At 40 μg/mL and above, cell viability was 
significantly reduced. The IC50 value calculated from this curve was 55.9 μg/mL, suggesting 
that these cells have a higher tolerance to AgNPs than HaCaT or HepG2 cells (results 
shown in Chapters 4 and 5, respectively). A similar result was obtained by Wang et al., who 
observed a 40% decrease in cell viability after 24 h of exposure to 50 μg/mL of citrate-
coated AgNPs, with diameters of 20 or 100 nm (Wang et al., 2014). Higher cytotoxicity 
towards RAW 264.7 cells was found for smaller (< 10 nm) AgNPs (IC50 value between 0.1- 
4.9 μg/mL, depending on the coating) (Suresh et al., 2012), 20 nm AgNPs supported on 
nanostructured SiO2 (20 μg/mL reduced cell viability in 50%) (Pratsinis et al., 2013), 33 nm 
AgNPs modified with tannic acid (IC50 value of 4.07 μg/mL) (Orlowski et al., 2013), and 35 
nm PVP-coated AgNPs (10 μg/mL reduced cell viability in 30%) (Giovanni et al., 2015). On 
the other hand, there were also reports showing higher resistance of RAW 264.7 cells to 
AgNPs, with high viability (> 80%) being observed after exposure to concentrations above 
50 μg/mL (Kaur and Tikoo, 2013; Munusamy et al., 2015; Zhang et al., 2015a).  
Ag+, administered as AgNO3, was more cytotoxic to RAW 264.7 cells than Cit30 
AgNPs, resulting in very low cell viability (< 5%) above 3.5 μg/mL (Figure 6.1b). The 
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calculated IC50 value was 2.94 μg/mL. This value represents a higher cytotoxicity of Ag+ 
towards RAW 264.7 macrophages than that determined by Park and co-workers (Park et 
al., 2011). In their work, a dose of 6.7 μg/mL Ag+ was found to inhibit only 20% of cellular 
activity. On the contrary, in a study where exposure to Ag+ was performed for 4 and 12 h, 
the IC50 value was 0.75 μg/mL (Suresh et al., 2012). Haase and colleagues also tested the 
influence of Ag+ in this cell line using a concentration of ~1 μg/mL (10 μM), which did not 
reduce cell viability (Haase et al., 2014), thus agreeing with our results.  
 
 
Figure 6.1. Viability (%) of RAW 264.7 cells, measured by MTT assay, after 24 h of exposure to: a) 
Cit30, b) Ag+, c) H2O2 and d) citrate. Data expressed as mean ± standard deviation of three 
independent assays with three replicates each (n 9). Statistically significant (p < 0.05) differences 
relatively to controls are indicated by *.  
 
Figure 6.1c shows the dose-response curve of the 24 h-exposure of RAW 264.7 
macrophages to H2O2. Cell viability decreased with increasing H2O2 concentrations, 
although the difference to controls was not statistically significant below 300 μM. The IC50 
value was calculated as 186 μM. Among the few literature studies assessing the cytotoxic 
effect of H2O2 towards RAW 264.7 cells, using the MTT assay, some authors reported a 
decrease to 50-60% viable cells with only 100 μM of H2O2 (Oh et al., 2006; Jung et al., 
2014), while others indicated higher values such as 400 μM of H2O2 (Chow et al., 2005). In 
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another report where RAW 264.7 cells were exposed to 500 μM of H2O2, for up to 24 h, cell 
viability was found to be lower at 12 h (about 59%), than at 24 h (around 70%) (Wen et al., 
2013). 
The effect of citrate on cell viability was also evaluated and the resulting dose-
response curve is presented in Figure 6.2d. There was no significant change in cell viability 
up to 300 μM. Thus, at the estimated maximum concentration present when cells were 
exposed to the IC20 concentration of AgNPs (69 μM of citrate), cells fully maintained their 
viability. 
 
Based on the dose response curves presented above, the IC5 and IC20 
concentrations of each substance (Cit30 AgNPs, Ag+ and H2O2) have been estimated and 
selected for further metabolomics studies (Table 6.1).  
 
Table 6.1. Concentrations of Cit30 AgNPs, Ag+ (from AgNO3) and H2O2, selected for the 
metabolomic analysis of RAW 264.7 cells. 
 Cit30 Ag+ H2O2 
IC5 23.2 μg/mL 2.29 μg/mL 67.5 μM 
IC20 35.3 μg/mL 2.62 μg/mL 115.7 μM 
 
6.4. Generation of reactive oxygen species 
Intracellular ROS generation was measured in RAW 264.7 cells exposed for 24 h to 
Cit30, Ag+, or H2O2, at IC20 concentrations, as well as in cells exposed to citrate at the 
maximum concentration possibly present upon incubation with Cit30 AgNPs (Figure 6.2). 
ROS levels showed a significant decrease with exposure to Cit30. A similar result has been 
reported in RAW 264.7 cells exposed to 100 μg/mL of AgNPs synthesised through chemical 
reduction with sodium borohydride (Kaur and Tikoo, 2013). However, an increase in ROS 
levels after exposure to AgNPs has been more commonly reported (Nishanth et al., 2011; 
Park et al., 2011; Orlowski et al., 2014).  
Upon exposure to Ag+, H2O2 or citrate, ROS generation increased, although not 
significantly in the case of Ag+. ROS levels have been previously reported to increase in 
human macrophages (THP-1 cells) exposed to Ag+ in the 0.66 to 1.35 μg/mL concentration 
range (Foldbjerg et al., 2009). This same study also measured ROS generation induced by 
PVP-coated AgNPs (30-50 nm), reporting an increase, followed by a decrease. The authors 
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suggested that the decrease in ROS levels could be due to the loss of dichlorofluorescein 
from dying cells. Regarding H2O2, the IC20 concentration caused a significant increase in 
intracellular ROS levels, in agreement with a previous report (Chow et al., 2005).  
 
 
Figure 6.2. Intracellular generation of reactive oxygen species (ROS) in RAW 264.7 cells, after 24 h 
exposure to the IC20 concentration of Cit30, Ag+ or H2O2, and to 69 μM of citrate (maximum 
concentration present in the AgNPs exposure). Data is expressed as mean ± standard deviation of 
three independent assays with two replicates each (n 6). Statistically significant (p < 0.05) differences 
relatively to controls are indicated by *. 
 
6.5. Metabolic variations induced by AgNPs in RAW 264.7 
macrophages 
The effects of Cit30 AgNPs on the metabolic profile of RAW 264.7 cells were 
assessed after 24 h exposure to the IC5 and IC20 concentrations. Analysis of culture medium 
supernatants from control and exposed cells allowed differences in extracellular metabolite 
balances to be evaluated. Furthermore, changes in intracellular metabolites were measured 
in polar and lipophilic cell extracts. 
The metabolic variations in culture medium supernatants of RAW 264.7 cells 
exposed to AgNPs relatively to control cells are summarised in Figure 6.3a and in 
Supplementary Table S6.1. Only a few changes in substrate consumption and metabolite 
excretion were noted. Glucose appeared to be more consumed from the culture medium 
when cells were exposed to the IC5 concentration, although this variation was not 
statistically significant. At the IC20 exposure, no alterations were found in substrate 
consumption. Regarding metabolite excretion, pyruvate levels were decreased after 
AgNPs-exposure, indicating that this metabolite was less excreted in exposed cells than in 
control cells. Increased excretion of citrate and of glutamate were observed with both 
concentrations. A non-significant increase in lactate levels was also observed in media from 
cells exposed to the IC5 concentration of AgNPs. 
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When citrate was added to cells, to assess the influence of its presence as a 
stabiliser for AgNPs, there were no changes in the extracellular metabolome, except of 
course for the expected increase in citrate levels (Figure 6.3a, 3rd column). 
 
Multivariate analysis of polar extracts indicated a strong impact of AgNPs on the 
intracellular composition of RAW 264.7 cells (Figure 6.4). A very clear separation between 
control and exposed cells was observed in the PCA scores scatter plot, along the first 
principal component (Figure 6.4a). This plot also showed that the concentration of AgNPs 
had little influence in class separation, since IC5 and IC20 samples largely overlapped. In 
addition, control and exposed samples were discriminated with high robustness (Q2 0.9) by 
PLS-DA (scores plot in Figure 6.4b), as confirmed through Monte Carlo Cross Validation 
and permutation testing (Supplementary Figure S6.1). 
The corresponding PLS-DA loadings (Figure 6.4c) showed many metabolic features 
responsible for class discrimination, including glucose, GSH, choline-containing 
compounds, several amino acids and ADP/ATP. Subsequently, these changes were 
thoroughly evaluated through spectral integration of individual signals and relevant 
variations (absolute effect size > 0.8) were represented as the percentage variation in 
relation to controls (Figure 6.3b and Supplementary Table S6.2). 
AgNPs caused marked alterations in 26 intracellular polar metabolites of RAW 264.7 
macrophages. Except for lactate levels, which were slightly more affected by the IC5 
concentration, the highest exposure concentration generally caused changes of larger 
magnitude. Some metabolites, however, had variations of similar magnitude (< 3% 
difference) at the IC5 and IC20 exposures (glutamate, aspartate, threonine, ATP, GSH, and 
pantothenate). Very high increases in the levels of glucose, itaconate, succinate, creatine 
and phosphocreatine were observed. Specifically, glucose levels were increased by 250% 
at the IC5, and by 396% at the IC20. Itaconate and creatine also had their levels increased 
by more than 200% upon exposure to AgNPs. Increases above 50% were observed for 
phosphocreatine, succinate and tyrosine (only at the IC20). Relevant increases below 10% 
were also noted for lactate, serine, GSH, choline, isoleucine, and valine. 
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Figure 6.3. Heatmap of the main variations in a) culture media, b) polar extracts, and c) lipophilic 
extracts, from RAW 264.7 cells exposed to Cit30, Ag+ and H2O2, at IC5 and IC20 concentrations, 
coloured according to % variation in relation to controls; metabolic changes resulting from exposure 
to citrate (69 μM) also shown. * Uncorrected p-value < 0.05; ** FDR-corrected p-value < 0.05. Three 
letter code used for amino acids; Cr, creatine; PCr, phosphocreatine; ADP/ATP, adenosine 
di/triphosphate; NAD+, nicotinamide adenine dinucleotide; GSH, reduced glutathione; PC, 
phosphocholine; GPC, glycerophosphocholine; PTC, phosphatidylcholine; PTE, 
phosphatidylethanolamine; SM, sphingomyelin; FA, fatty acyl; PUFA, polyunsaturated fatty acyl 
chains.  
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Figure 6.4. Multivariate analysis of 1H NMR spectra from polar extracts of control and Cit30-exposed 
RAW 264.7 cells: a) PCA, b) PLS-DA scores scatter plots, and c) LV1 loadings w, coloured as a 
function of variable importance to the projection (VIP). Pant, pantothenate; Un. 1.64, unidentified 
metabolite at 1.64 ppm; for other metabolite codes, vide legend of Figure 6.4. 
 
Significant decreases were found for several amino acids (glutamate, aspartate, 
glycine, alanine, β-alanine, and threonine), ATP, choline-containing compounds 
(phosphocholine and glycerophosphocholine), and others (myo-inositol, betaine, and 
pantothenate). Among these variations, aspartate, phosphocholine, and 
glycerophosphocholine, presented particularly high decreases, varying more than 44% in 
relation to controls. The highest concentration of AgNPs (IC20) caused additional decreases 
(although not significant) in the levels of fumarate and ADP, which did not vary upon 
exposure to the IC5.  
 
AgNPs appeared to cause very little effect on the lipid composition of RAW 264.7 
macrophages; the only significant change was the 7% decrease in 
phosphatidylethanolamine (Figure 6.3c). Nonetheless, other non-significant variations were 
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observed. Total unsaturated fatty acyl chains decreased by 8%, and free cholesterol was 
increased by 9%, upon exposure to the IC20 of AgNPs, in relation to controls. 
 
As citrate was used to coat and suspend the nanoparticles, its effect on the cells 
metabolome was also assessed, after 24 h exposure to 69 μM (the concentration estimated 
to be present when the IC20 concentration of Cit30 was administered to cells). As observed 
in Figure 6.3b, a few changes were noted in the intracellular composition of citrate-exposed 
cells in relation to controls. Interestingly, these variations were clearly different from AgNPs-
induced effects. Variations in opposite directions include fumarate (that was decreased 
upon AgNPs exposure, but increased with citrate), serine, GSH and choline (decreased 
upon citrate exposure). Metabolites varying in the same direction but to different extents in 
cells exposed to Cit30 AgNPs or citrate include lactate, succinate, itaconate, aspartate, 
glycine, glycerophosphocholine, myo-inositol and betaine. Concerning lipophilic extracts, 
there were hardly any changes, with a small (6%) non-significant decrease being noted for 
the plasmenyl form of phosphatidylethanolamine. 
 
6.6. Metabolic variations induced by Ag+ in RAW 264.7 macrophages 
The impact of Ag+ (from AgNO3) on the metabolism of RAW 264.7 macrophages 
has been evaluated through NMR analysis of culture medium supernatants, and of cell 
extracts (polar and lipophilic). 
The changes in the exometabolome of cells exposed for 24 h to Ag+ (at respective 
IC5 and IC20), are summarised in Figure 6.3a and Supplementary Table S6.1. Ag+ had a 
noticeable influence in substrate consumption and metabolite excretion. Specifically, 
several metabolites were less consumed by RAW 264.7 macrophages in the presence of 
Ag+ (glucose, glutamine, choline, methionine, and branched chain amino acids), while 
others, such as pyruvate, lactate, citrate, itaconate, fumarate, alanine, keto-acids (resulting 
from lower consumption of branched chain amino acids), and formate, were less released. 
Compared to the extracellular variations induced by AgNPs, Ag+ had a much stronger 
impact; also some qualitative differences could be noticed. For instance, while the 
consumption of glucose and the excretion of lactate and citrate were increased in AgNPs 
exposed cells, the opposite effect was seen in cells exposed to Ag+. It should also be noted 
that the above changes were not seen in acellular medium to which Ag+ was added, and 
are thus not expected to result from interactions between Ag+ and medium components. 
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The intracellular composition of RAW 264.7 macrophages was also greatly affected 
by Ag+. However, in this case, we found larger biological variability within the assays, as 
reflected on the multivariate analysis results (Figure 6.5a and b, showing high dispersion 
between exposed samples), and confirmed by the poorer validation achieved through 
MCCV and permutation testing (Supplementary Figure S6.2). Still, together with the PLS-
DA loadings (Figure 6.5c), individual metabolite integrals allowed the most relevant 
variations in polar compounds to be highlighted and compared to those induced by Cit30 
AgNPs (Figure 6.3b and Supplementary Table S6.2). 
 
 
Figure 6.5. Multivariate analysis of 1H NMR spectra from polar extracts of control and Ag+-exposed 
RAW 264.7 cells: a) PCA, b) PLS-DA scores scatter plots, and c) LV1 loadings w, coloured as a 
function of variable importance to the projection (VIP). Pant, pantothenate; for other metabolite 
codes, vide legend of Figure 6.4. 
 
Several consistent variations were identified in Ag+-exposed cells, in relation to 
controls. The largest variation was in glucose levels, with an increase of 475% in IC20-
exposed cells (170% at the IC5). Other marked increases were seen for lactate, succinate, 
serine, (phospho)creatine, GSH, choline and taurine. Interestingly, some of these increases 
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were clearly less intense than those induced by AgNPs, namely in the case of succinate 
and creatine/phosphocreatine. Additionally, while itaconate was markedly increased in 
AgNPs-exposed cells, it was decreased or unaltered in cells exposed to Ag+. On the other 
hand, fumarate was more markedly decreased upon exposure to Ag+ than to AgNPs. Other 
metabolites with decreased levels in exposed cells (compared to controls) included several 
amino acids, phosphocholine, myo-inositol and betaine, similarly to what has been found in 
AgNPs-exposed cells. Additionally, Ag+ caused significant decreases in NAD+, not seen 
with AgNPs, while the levels of ATP and glycerophosphocholine, significantly depleted upon 
exposure to AgNPs, remained unaltered in Ag+-treated cells. 
 
Analysis of lipophilic extracts showed that Ag+ had a greater influence on the lipid 
composition of RAW 264.7 macrophages than Cit30 AgNPs (Figure 6.3c). In addition to a 
significant and more pronounced decrease in total unsaturated fatty acyl chains, Ag+ caused 
decreases in cholesterol (total and free), phosphatidylcholine, and sphingomyelin. Other 
differences comprised the increased levels of polyunsaturated fatty acyl chains, and of 
phosphatidylethanolamine in the plasmenyl form. 
 
6.7. Metabolic variations induced by H2O2 in RAW 264.7 macrophages 
Exposure to H2O2 at concentrations causing approximately 5 and 20% reduction in 
cell viability (IC5 and IC20, respectively) had a much weaker impact on the RAW 264.7 cells 
metabolome than exposures to Cit30 AgNPs or Ag+. Indeed, few changes were noted in 
extracellular metabolites, most of which were dose-dependent (Figure 6.3a). Decreased 
consumption of glucose and of glutamine, together with decreased excretion of lactate, 
were seen in IC5-exposed cells, while increased excretion of glutamate and decreased 
consumption of leucine and choline were clearer at the IC20. 
 
The weaker impact of H2O2 in the metabolism of RAW 264.7 macrophages, in 
comparison to Cit30 or Ag+, was also clearly demonstrated through multivariate analysis of 
polar extracts (Figure 6.6). Even though there was a trend for class distinction in the PCA 
scores scatter plot (Figure 6.7a), and an apparent good separation between classes along 
LV1 in the PLS-DA scores plot (Figure 6.6b), MCCV and permutation testing failed to 
validate the results (Supplementary Figure S6.3). Nonetheless, the combined interpretation 
of the PLS-DA loadings plot and integration results (Figures 6.6c and 6.3b, respectively) 
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revealed relevant changes (with absolute effect size greater than 0.8) in 7 intracellular 
metabolites at the IC5 exposure and in 15 metabolites at the IC20 exposure. These 
comprised minor increases in β-alanine and betaine, only at the IC5, and moderate 
increases in lactate, itaconate, succinate, serine, creatine, phosphocreatine and taurine, 
only at the IC20. Both concentrations caused increased levels of glycine and alanine, and 
decreased levels of aspartate, phosphocholine and glycerophosphocholine. At the IC20 
exposure, further decreases were observed for GSH, myo-inositol, and pantothenate. It 
should also be noted that glycine, alanine, GSH and betaine presented opposite variations 
in H2O2-exposed cells in comparison to those observed after exposure to Cit30 or Ag+. 
 
 
Figure 6.6. Multivariate analysis of 1H NMR spectra from polar extracts of control and H2O2-exposed 
RAW 264.7 cells: a) PCA, b) PLS-DA scores scatter plots, and c) LV1 loadings w, coloured as a 
function of variable importance to the projection (VIP). BCAA, branched chain amino acids; for other 
metabolite codes, vide legend of Figure 6.4. 
 
The lipid composition of RAW 264.7 cells was only slightly affected by H2O2 (Figure 
6.3c). Main variations were below 10% and included decreased cholesterol levels and 
increased phosphatidylethanolamine (both forms, acyl and plasmenyl), in opposition to the 
effects induced by Cit30 AgNPs. 
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6.8. Discussion of metabolic variations in RAW 264.7 macrophages 
The basal metabolic activity and intracellular composition of RAW 264.7 
macrophages were clearly altered after exposure to 30 nm citrate-coated AgNPs (Cit30), 
even at non-toxic or sub-toxic concentrations. Interestingly, some effects were common to 
those induced by Ag+ (given to cells as AgNO3, at concentrations inducing equivalent 
decreases in cell viability), while others were clearly distinct, as discussed in the following 
paragraphs. 
The IC5 concentration of Cit30 (but not the IC20) appeared to induce an increase in 
the glycolytic activity of RAW 264.7 cells, as suggested by increased glucose consumption 
and increased lactate production and excretion. Increased glycolysis in macrophages has 
also been observed after exposure to ultrasmall superparamagnetic particles of iron oxide 
(Feng et al., 2011a), airborne particulate matter (Santini et al., 2004), or bacterial LPS 
(Meiser et al., 2016). On the other hand, opposite variations in glucose consumption and in 
lactate excretion, together with decreased excretion of alanine (glycolytic product), were 
apparent in cells exposed to the IC20 concentration of Ag+, suggesting downregulation of 
glycolysis. Furthermore, exposure to Ag+ reduced the consumption of several medium 
substrates, namely glutamine, methionine, branched chain amino acids, and choline. 
AgNPs and Ag+ also appeared to have distinct effects on the TCA cycle, as 
schematically illustrated in Figure 6.7. AgNPs-exposed cells displayed increased release of 
citrate and very high increases in intracellular itaconate and succinate. The latter 
metabolites have been found elevated in LPS-stimulated macrophages, and are considered 
markers of a pro-inflammatory (M1) state (Strelko et al., 2011; Meiser et al., 2016). LPS-
activated macrophages have been described to present mitochondrial dysfunction, 
associated with a defective TCA cycle, with breakpoints at isocitrate dehydrogenase (IDH), 
the enzyme that converts isocitrate to α-ketoglutarate, and at succinate dehydrogenase 
(SDH), the enzyme that catalyses the oxidation of succinate to fumarate (Jha et al., 2015). 
While the breakpoint at SDH could forthrightly explain the increased levels of succinate, the 
reduced IDH activity results in a redirection of the TCA cycle flow towards the 
decarboxylation of cis-aconitate, inducing increased itaconate synthesis, and avoiding 
isocitrate accumulation (Michelucci et al., 2013; Jha et al., 2015). Furthermore, inhibition of 
SDH can also affect energy production through oxidative phosphorylation, since this 
enzyme constitutes complex II of the respiratory chain (El Kasmi and Stenmark, 2015). In 
the event of impaired respiration, substrate-level phosphorylation has a critical role in 
preventing ATP depletion; however, it has been shown that excessive itaconate abolishes 
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mitochondrial substrate-level phosphorylation in LPS-activated macrophages (Németh et 
al., 2015). Hence, the decreased ATP levels observed in RAW 264.7 cells after exposure 
to AgNPs, may be the combined result of SDH inhibition and increased itaconate synthesis. 
Macrophages exposed to sub-toxic concentrations of Cit30 additionally showed significantly 
decreased levels of aspartate and glutamate. The decreased levels of these metabolites 
could indicate that they were used in the aspartate-argininosuccinate shunt, which has been 
proven to have an anaplerotic role to replenish the TCA cycle of M1 macrophages, and thus 
overcome the breakpoint at SDH (Jha et al., 2015). 
 
Figure 6.7. Schematic diagram of the putative effects of Cit30 (red arrows), Ag+ (green arrows), and 
H2O2 (blue arrows), on glycolysis and the TCA cycle. Dashed arrows indicate |% variation| < 10%; 
thick arrows indicate |% variation| > 50%. 
 
On the other hand, upon exposure to Ag+, cells decreased the release of citrate and 
the production and excretion of itaconate and fumarate. These variations are suggestive of 
a simple downregulation of the TCA cycle activity, distinct from the specific effects induced 
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by AgNPs. The observed decrease in NAD+ further supports the downregulation of 
glycolysis and the TCA cycle. Moreover, Ag+ did not alter intracellular ATP levels. 
The levels of several amino acids (glutamate, aspartate, glycine, alanine and 
threonine) were markedly decreased upon exposure to both Cit30 and Ag+. At the same 
time, intracellular glucose increased significantly in exposed macrophages, while the 
excretion of pyruvate decreased. A possible explanation to these observations could be the 
activation of gluconeogenesis (Figure 6.8). In fact, FBP1, the enzyme that catalyses the 
hydrolysis of fructose-1,6-bisphosphate to form fructose-6-phosphate, has been found 
upregulated in human macrophages differentiated under the influence of granulocyte 
macrophage colony-stimulating factor (GM-CSF), i.e. in M1-activated macrophages, but not 
in those exposed to macrophage colony-stimulating factor (M-CSF), i.e. in M2-activated 
macrophages (Reales-Calderon et al., 2014). In that study, the authors proposed FBP1 as 
a metabolic target for modulating macrophage polarisation, since it was one of the most 
differentially expressed proteins between M1 and M2 macrophages. 
 
Figure 6.8. Schematic diagram of the putative effects of Cit30 (red arrows), Ag+ (green arrows), and 
H2O2 (blue arrows), on gluconeogenesis and the TCA cycle. Thick arrows indicate |% variation| > 
50%. 
Metabolomic analysis of murine macrophages (RAW 264.7 cells) exposed to citrate-coated 
silver nanoparticles 
164 
 
Furthermore, we have observed increased levels of creatine and phosphocreatine 
in response to both Cit30 and Ag+, but with a much higher magnitude in the case of 
nanoparticle-exposed cells. These metabolites were also reported to increase in RAW 
264.7 cells exposed to other nanoparticles (Feng et al., 2011a; Saborano et al., 2016). It is 
known that differentiated macrophages contain a phosphocreatine pool that functions as a 
high energy phosphate reservoir to replenish ATP levels (Loike et al., 1984; Wallimann et 
al., 1992). As such, it is possible that the accumulation of creatine and phosphocreatine in 
RAW 264.7 cells after exposure to AgNPs, is a consequence of the increased energy 
requirements, to compensate for the decreased ATP levels. The maintenance of such 
phosphocreatine pool is likely dependent on the creatine available in the extracellular 
medium since macrophages have been reported to be incapable of synthesising creatine 
de novo (from guanidinoacetate and glycine) (Loike et al., 1984).  
Upon exposure to both Cit30 and Ag+, the levels of GSH increased in RAW 264.7 
cells. This is in contrast with the reported decrease in GSH levels of RAW 264.7 
macrophages exposed to 0.2-1.6 ppm of AgNPs sized ~69 nm (Park et al., 2010). 
Conversely, a proteomic study on the effects of copper-based nanoparticles in the same 
cell line, revealed increased glutathione biosynthesis, which was suggested to be a critical 
factor for cell survival under stress (Triboulet et al., 2013). The GSH-mediated cellular 
antioxidant capacity is modulated by different processes. Serine de novo biosynthesis has 
been recognised as one of these processes, namely in tumour cells (Amelio et al., 2014), 
according to the reactions schematically shown in Figure 6.9. A possible hypothesis is that 
exposed cells are synthesising serine de novo, through a glycolysis-diverting pathway, to 
sustain the production of GSH, needed to neutralise ROS. Correlation analysis between 
serine and GSH provided some support to this hypothesis (r 0.79, p < 0.05, for Ag+-treated 
cells). Additionally, significant negative correlations were found between serine and lactate 
(r -0.95, p < 0.005), and between serine and alanine (r -0.92, p < 0.005). Since lactate and 
alanine are glycolytic products, this observation supports the hypothesis of glycolysis 
diversion towards serine biosynthesis. 
Choline and choline-containing compounds were also greatly affected by the 
presence of Cit30 AgNPs; while choline was non-significantly increased by ~27-33%, 
phosphocholine (PC) and glycerophosphocholine (GPC) were significantly decreased by 
~44-58%, in nanoparticle-exposed cells, compared to controls. Similar decreases in these 
choline-containing metabolites have been observed in RAW 264.7 macrophages exposed 
to ultrasmall superparamagnetic particles of iron oxide (Feng et al., 2011a). These 
compounds are associated with the structural components of cell membranes and their 
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altered levels in exposed-macrophages are probably related to cell membrane modification. 
Interestingly, Ag+ induced similar changes in choline and PC but no change in GPC, while 
the lipid composition assessed by NMR of lipophilic extracts was found to be more greatly 
affected by Ag+ than by AgNPs. Indeed, in addition to the decreased consumption of choline 
(which was not altered in cells exposed to AgNPs), Ag+-treated cells showed decreased 
levels of sphingomyelin and phosphatidylcholine, not observed in nanoparticle-exposed 
cells. This could reflect direct membrane damage by silver ions. Also, previous studies have 
reported that, upon stimulation, macrophages produce lipid mediators, important in the 
response to inflammation, from polyunsaturated fatty acids present in membrane 
glycerophospholipids (Rouzer et al., 2007; Biswas and Mantovani, 2012). This process 
involves the hydrolysis of the ester bond linking the fatty acids to the glycerol backbone, 
leading to membrane remodelling. Thus, the observed decreases in sphingomyelin and 
phosphatidylcholine could also result from increased lipid mediator biosynthesis. 
 
 
Figure 6.9. Schematic diagram of glycolysis diversion into serine synthesis to support GSH 
production. Effects of Cit30, Ag+, and H2O2, are represented by red, green, and blue arrows, 
respectively. Thick arrows indicate |% variation| > 50%. 
 
Other effects common to Cit30 and Ag+ in RAW 264.7 cells were the decreased 
levels of myo-inositol and betaine. These two metabolites are important organic osmolytes 
that help cells to maintain their volume (Friedrich et al., 2006). Following cell swelling or 
shrinkage, volume regulatory mechanisms are activated so that intracellular osmolarity is 
either decreased, through osmolyte release, or increased, through osmolyte generation 
and/or accumulation. Cell swelling has been previously observed in RAW 264.7 cells upon 
AgNPs exposure (Hashimoto et al., 2014). Thus, the observed decreases in intracellular 
levels of myo-inositol and betaine could be related to their release in order to regulate 
osmolarity. Indeed, the osmoregulatory role of betaine in RAW 264.7 cells has been 
previously demonstrated (Warskulat et al., 1995). As for myo-inositol, the mRNA for the 
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sodium/myo-inositol co-transporter (SMIT) was not detected in these cells, questioning the 
role of this metabolite as an osmolyte in RAW 264.7 macrophages (Warskulat et al., 1997). 
It is also possible that myo-inositol variations reflect its role in cell signalling through the 
phosphatidylinositol cycle (Santini et al., 2004).  
 
The macrophage metabolome was much less affected by H2O2 than by AgNPs or 
Ag+, as immediately revealed in the heatmaps in Figure 6.3. In addition to having affected 
fewer metabolites, H2O2 caused an inverse or less pronounced effect in some pathways 
found to be disturbed by AgNPs/Ag+. For example, H2O2 caused reduced glucose 
consumption and lactate release, suggesting downregulation of glycolysis, contrarily to the 
effect suggested for AgNPs. As for TCA cycle intermediates, H2O2-exposed cells showed 
moderate increases in itaconate and succinate, in contrast with the huge increases in 
AgNPs-exposed cells. Thus, TCA cycle reprogramming does not seem to be exclusively 
mediated by ROS generation. Another clear difference in cells treated with H2O2 was that, 
unlike AgNPs/Ag+-exposed cells, there was no evidence for activated gluconeogenesis. 
Intracellular glucose did not increase and gluconeogenic substrates (e.g. alanine, glycine, 
threonine, glutamate) did not decrease after H2O2-exposure. Furthermore, GSH showed a 
distinct response in H2O2-exposed cells, by showing unaltered or decreased levels, which 
is in accordance with its greater utilisation, to detoxify the increased ROS levels (Figure 
6.2). 
 
Finally, the cellular response to the addition of citrate (used as a stabiliser for AgNPs) 
also deserves a comment. When exposing cells to excess citrate, it is possible that this 
metabolite is accumulated within the mitochondria, potentiating the TCA cycle and 
promoting pyruvate/citrate cycling (Figure 6.10) (Guay et al., 2007). The upregulation of the 
TCA cycle would explain the increased levels of itaconate and fumarate, and the decrease 
in aspartate. Furthermore, at excessive levels, mitochondrial citrate is exported into the 
cytosol, where it is converted to pyruvate, through oxaloacetate and malate. This could 
explain the increased levels of lactate.  
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Figure 6.10. Schematic diagram of the putative effects of excess citrate (full arrows) on 
pyruvate/citrate cycling. Adapted from (Guay et al., 2007). 
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Supplementary information to Chapter 6 
Table S6.1. Main metabolite variations in culture medium of RAW 264.7 cells exposed to Cit30, Ag+, 
and H2O2, at the IC5 and IC20, in relation to culture media from control cells, expressed as % variation 
(%var) and respective error (±), effect size (ES), p-value (p), and FDR-adjusted p-value (FDR). The 
variations with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|) were considered 
null. 
  Cit30 Citrate Ag+ H2O2 
  IC5 IC20  IC5 IC20 IC5 IC20 
Glucose 
%var -8.45 0 0 0 13.55 9.51 0 
± 5.27    6.32 6.62  
ES -0.97 0 0 0 1.33 0.91 0 
p 0.1497    0.1025 0.2313  
FDR 0.5952    0.1974 0.6397  
Pyruvate 
%var -34.35 -41.50 0 -43.71 -55.81 -21.80 -15.62 
± 4.87 4.74  10.52 15.18 20.81 5.55 
ES -3.84 -4.73 0 -3.29 -3.31 -0.86 -1.60 
p 2.17E-05 4.72E-06  0.0068 0.0128 0.3327 0.0183 
FDR 0.0007 0.0002  0.0666 0.0713 0.6397 0.2018 
Lactate 
%var 21.27 0 0 0 -36.85 -24.22 0 
± 12.49    19.64 20.26  
ES 0.93 0 0 0 -1.39 -0.87 0 
p 0.1656    0.0873 0.2554  
FDR 0.5952    0.1902 0.6397  
Citrate 
%var 34.90 45.26 57.22 0 -14.59 0 5.48 
± 2.66 2.60 2.44  8.54  2.54 
ES 6.97 8.99 12.00 0 -1.36 0 1.18 
p 3.84E-05 1.08E-05 4.58E-07  0.1617  0.0725 
FDR 0.0007 0.0002 1.79E-05  0.2426  0.2570 
Itaconate 
%var 0 0 0 -16.31 -28.81 0 0 
±    8.58 14.92   
ES 0 0 0 -1.08 -1.43 0 0 
p    0.0792 0.0927   
FDR    0.1715 0.1902   
Fumarate 
%var 0 0 0 -4.79 -6.50 0 0 
±    2.86 3.05   
ES 0 0 0 -1.00 -1.31 0 0 
p    0.1390 0.0754   
FDR    0.2710 0.1885   
Glutamine 
%var 0 0 0 19.75 32.15 16.23 0 
±    7.88 10.13 12.10  
ES 0 0 0 1.29 1.78 0.83 0 
p    0.0509 0.0367 0.2680  
FDR    0.1417 0.1300 0.6397  
Glutamate 
%var 20.45 20.49 0 7.42 0 0 13.10 
± 4.43 4.49  4.14   4.85 
ES 2.19 2.18 0 0.83 0 0 1.37 
p 0.0022 0.0025  0.1150   0.0327 
FDR 0.0290 0.0322  0.2361   0.2127 
Alanine 
%var -3.56 -3.63 0 -12.78 -15.20 0 3.86 
± 2.46 2.78  2.62 3.63  2.41 
ES -0.88 -0.84 0 -3.11 -3.00 0 0.95 
p 0.1961 0.2452  0.0031 0.0110  0.1706 
FDR 0.5952 0.4347  0.0666 0.0713  0.4436 
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  Cit30 Citrate Ag+ H2O2 
  IC5 IC20  IC5 IC20 IC5 IC20 
Methionine 
%var 4.23 4.97 0 19.11 14.27 0 4.63 
± 2.84 3.49  3.49 3.05  1.98 
ES 0.86 0.89 0 3.31 2.72 0 1.10 
p 0.1930 0.2230  0.0049 0.0059  0.0473 
FDR 0.5952 0.4142  0.0666 0.0464  0.2135 
Isoleucine 
%var 3.36 4.39 0 5.68 9.61 5.93 3.85 
± 1.85 2.10  1.73 2.10 3.02 1.31 
ES 1.02 1.24 0 1.78 2.69 1.31 1.36 
p 0.1198 0.0904  0.0143 0.0058 0.1273 0.0179 
FDR 0.5952 0.2287  0.0724 0.0464 0.6397 0.2018 
Leucine 
%var 0 5.38 0 8.71 11.83 5.57 5.52 
±  2.64  2.52 3.34 4.50 2.09 
ES 0 1.18 0 1.95 2.21 0.85 1.36 
p  0.0938  0.0149 0.0232 0.2953 0.0322 
FDR  0.2287  0.0724 0.0906 0.6397 0.2127 
Valine 
%var 3.25 4.40 0 3.58 7.54 4.57 4.52 
± 2.05 2.41  2.21 1.93 2.28 1.58 
ES 0.85 1.06 0 0.90 2.02 1.14 1.32 
p 0.1594 0.1238  0.1566 0.0053 0.0935 0.0207 
FDR 0.5952 0.2683  0.2909 0.0464 0.6397 0.2018 
2-Oxoisoleucine 
%var 0 -3.06 3.28 -6.76 -9.83 0 0 
±  0.75 1.99 2.39 4.49   
ES 0 -2.45 1.80 -2.21 -1.78 0 0 
p  0.0068 0.0672 0.0578 0.1063   
FDR  0.0666 0.6556 0.1456 0.1974   
α-Ketovaline 
%var 0 -4.45 0 -9.08 -15.82 0 0 
±  2.00  3.50 5.62   
ES 0 -1.17 0 -1.76 -2.17 0 0 
p  0.0524  0.0502 0.0483   
FDR  0.2043  0.1417 0.1480   
Choline 
%var 0 4.77 0 16.08 17.12 6.04 8.42 
±  2.96  4.03 3.01 4.10 3.27 
ES 0 0.84 0 2.35 2.93 0.89 1.40 
p  0.1524  0.0129 0.0009 0.2072 0.0423 
FDR  0.3062  0.0724 0.0352 0.6397 0.2135 
Allantoin 
%var 0 0 0 -8.58 0 9.95 0 
±    3.52  6.21  
ES 0 0 0 -1.26 0 1.03 0 
p    0.0335  0.1925  
FDR    0.1304  0.6397  
Formate 
%var 0 0 0 -16.40 -30.53 -15.01 0 
±    6.54 11.88 14.87  
ES 0 0 0 -1.87 -2.19 -0.82 0 
p    0.0597 0.0576 0.3609  
FDR    0.1456 0.1604 0.6397  
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Table S6.2. Main metabolite variations in polar extracts of RAW 264.7 cells exposed to Cit30, Ag+, 
and H2O2, at the IC5 and IC20, in relation to controls, expressed as % variation (%var) and respective 
error (±), effect size (ES), p-value (p), and FDR-adjusted p-value (FDR). The variations with |ES| < 
0.8 (or standard error > |ES|, or mean error > |% variation|) were considered null. 
  Cit30 Citrate Ag
+
 H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Glucose 
%var 250.47 396.40 0 170.12 474.51 0 0 
± 19.22 24.24  14.57 104.78   
ES 5.35 5.66 0 4.96 2.20 0 0 
p 0.0036 0.0049  0.0014 0.1867   
FDR 0.0164 0.0150  0.0214 0.3272   
Lactate 
%var 36.39 29.38 24.04 24.63 0 0 24.67 
± 17.66 20.87 11.05 12.35   13.25 
ES 1.13 0.84 0.89 0.91 0 0 0.89 
p 0.1262 0.2639 0.0739 0.0997   0.1339 
FDR 0.2149 0.3372 0.3356 0.1765   0.4734 
Itaconate 
%var 229.72 288.37 31.11 -23.86 0 0 33.62 
± 19.73 27.84 15.35 11.29   16.42 
ES 5.14 4.31 1.28 -1.14 0 0 1.35 
p 0.0053 0.0120 0.1566 0.0488   0.1612 
FDR 0.0188 0.0291 0.4879 0.1309   0.4734 
Succinate 
%var 63.39 77.53 9.28 11.52 0 0 34.16 
± 13.53 15.79 6.55 8.36   5.98 
ES 3.01 3.11 0.85 0.88 0 0 3.15 
p 0.0258 0.0266 0.2445 0.2514   0.0072 
FDR 0.0539 0.0510 0.6616 0.3212   0.0828 
Fumarate 
%var 0 -22.46 26.20 -29.49 -43.99 0 0 
±  11.32 6.24 12.69 27.47   
ES 0 -1.24 1.62 -1.56 -1.67 0 0 
p  0.0772 0.0035 0.0480 0.1961   
FDR  0.1262 0.0406 0.1309 0.3272   
Glutamate 
%var -26.33 -28.82 0 -18.15 -32.86 0 0 
± 5.86 6.00  6.41 11.94   
ES -2.30 -2.51 0 -1.52 -2.26 0 0 
p 0.0007 0.0004  0.0163 0.0637   
FDR 0.0034 0.0018  0.0831 0.3150   
Aspartate 
%var -57.79 -57.36 -32.52 -56.90 -65.01 -20.53 -43.07 
± 8.50 7.88 8.28 9.91 18.03 7.40 11.26 
ES -3.66 -3.70 -1.94 -3.44 -3.20 -1.30 -2.43 
p 8.19E-06 1.04E-05 0.0027 0.0001 0.0251 0.0141 0.0096 
FDR 0.0001 0.0001 0.0406 0.0026 0.2306 0.3232 0.0828 
Glycine 
%var -11.48 -18.50 -6.63 -2.90 -11.89 14.04 20.03 
± 1.65 1.51 2.99 2.19 6.85 1.17 3.86 
ES -4.15 -7.02 -1.90 -0.89 -1.87 5.62 4.65 
p 0.0004 3.97E-06 0.1303 0.2469 0.2099 1.50E-06 0.0319 
FDR 0.0026 0.0001 0.4626 0.3212 0.3307 0.0001 0.1834 
Alanine 
%var -22.95 -31.24 0 -33.87 -41.07 10.71 13.81 
± 6.76 6.75  9.52 16.38 5.87 7.11 
ES -1.97 -2.71 0 -2.51 -2.48 0.93 1.14 
p 0.0078 0.0011  0.0112 0.0890 0.1196 0.1384 
FDR 0.0238 0.0044  0.0738 0.3150 0.7862 0.4734 
β-Alanine 
%var 0 -14.16 0 -21.50 -34.24 5.36 0 
±  4.71  10.24 20.08 3.21  
ES 0 -1.92 0 -1.74 -1.99 0.84 0 
p  0.0247  0.0993 0.1968 0.1398  
FDR  0.0494  0.1765 0.3272 0.8037  
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  Cit30 Citrate Ag
+
 H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Threonine 
%var -12.43 -14.47 0 -17.76 -22.70 0 0 
± 3.69 3.19  3.75 8.21   
ES -1.99 -2.47 0 -2.85 -2.63 0 0 
p 0.0124 0.0016  0.0023 0.0829   
FDR 0.0300 0.0057  0.0263 0.3150   
Isoleucine 
%var 0 11.06 -3.92 0 0 0 0 
±  4.99 3.75     
ES 0 1.62 -0.83 0 0 0 0 
p  0.1115 0.3802     
FDR  0.1655 0.7680     
Valine 
%var 0 7.35 0 -6.86 -3.67 0 3.02 
±  5.06  5.53 1.38  1.77 
ES 0 1.16 0 -1.05 -1.83 0 1.34 
p  0.2488  0.2916 0.0717  0.2048 
FDR  0.3270  0.3626 0.3150  0.4797 
Serine 
%var 20.49 30.47 -17.42 32.00 39.04 0 12.62 
± 8.31 9.26 6.80 11.56 14.26  7.53 
ES 1.38 1.91 -1.32 1.74 2.12 0 0.92 
p 0.0664 0.0341 0.0348 0.0680 0.1117  0.1749 
FDR 0.1272 0.0627 0.2000 0.1563 0.3272  0.4734 
Tyrosine 
%var 18.50 64.66 0 0 0 0 0 
± 11.63 12.90      
ES 0.80 2.51 0 0 0 0 0 
p 0.1774 0.0088      
FDR 0.2632 0.0239      
Creatine 
%var 208.73 252.06 0 26.08 25.63 0 26.13 
± 4.79 4.53  7.02 12.99  12.71 
ES 18.91 22.37 0 2.47 1.85 0 1.92 
p 3.46E-05 2.10E-05  0.0307 0.1992  0.1873 
FDR 0.0004 0.0002  0.1179 0.3272  0.4787 
Phosphocreatine 
%var 117.06 124.88 0 13.61 0 0 12.03 
± 6.36 8.46  7.71   3.41 
ES 9.53 8.01 0 1.18 0 0 1.53 
p 0.0003 0.0011  0.1693   0.0090 
FDR 0.0025 0.0044  0.2686   0.0828 
ADP 
%var 0 -38.88 0 0 -31.80 0 0 
±  21.95   17.17   
ES 0 -1.07 0 0 -0.91 0 0 
p  0.0796   0.0773   
FDR  0.1262   0.3150   
ATP 
%var -26.89 -26.41 0 0 0 0 0 
± 8.45 9.79      
ES -1.66 -1.55 0 0 0 0 0 
p 0.0063 0.0196      
FDR 0.0209 0.0430      
NAD+ 
%var 0 0 0 -14.01 -16.37 0 0 
±    5.76 4.97   
ES 0 0 0 -1.48 -1.84 0 0 
p    0.0453 0.0181   
FDR    0.1309 0.2306   
GSH 
%var 31.42 29.49 -12.28 43.55 40.27 0 -6.31 
± 6.78 6.91 11.55 8.70 8.83  5.37 
ES 3.19 2.96 -1.11 3.46 4.03 0 -0.93 
p 0.0191 0.0240 0.3805 0.0191 0.0479  0.3297 
FDR 0.0439 0.0494 0.7680 0.0878 0.3147  0.5417 
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  Cit30 Citrate Ag
+
 H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Choline 
%var 26.67 33.20 -13.68 15.24 0 0 0 
± 12.60 11.63 5.90 7.54    
ES 1.34 1.73 -0.98 1.03 0 0 0 
p 0.1244 0.0602 0.0394 0.0952    
FDR 0.2149 0.1025 0.2016 0.1765    
Phosphocholine 
%var -44.18 -50.75 0 -38.90 -42.91 -5.57 -17.21 
± 3.58 3.11  7.62 11.86 2.97 4.73 
ES -7.46 -9.06 0 -4.25 -3.99 -0.96 -2.58 
p 6.64E-07 3.38E-09  0.0055 0.0478 0.0904 0.0291 
FDR 1.53E-05 1.55E-07  0.0424 0.3147 0.7862 0.1834 
Glycero- 
phosphocholine 
%var -51.61 -57.60 -28.26 0 0 -15.82 -16.04 
± 3.98 4.50 5.48   6.59 4.14 
ES -6.18 -6.74 -2.97 0 0 -1.51 -1.76 
p 6.16E-07 3.56E-08 0.0024   0.0493 0.0033 
FDR 1.53E-05 8.18E-07 0.0406   0.5665 0.0828 
myo-Inositol 
%var -28.49 -32.50 -15.27 -39.25 -39.22 0 -13.00 
± 5.84 6.13 7.18 9.73 10.67  7.55 
ES -2.47 -2.79 -1.22 -2.82 -2.83 0 -1.02 
p 0.0003 0.0002 0.0803 0.0053 0.0250  0.1445 
FDR 0.0025 0.0010 0.3356 0.0424 0.2306  0.4734 
Taurine 
%var 0 0 0 11.44 0 0 9.97 
±    5.24   2.95 
ES 0 0 0 1.24 0 0 1.25 
p    0.0848   0.0108 
FDR    0.1695   0.0828 
Betaine 
%var -26.93 -35.91 -19.51 -13.88 -17.03 6.51 -4.34 
± 3.87 3.78 3.25 3.90 4.16 2.33 3.44 
ES -4.74 -6.51 -3.78 -2.37 -3.03 1.36 -0.82 
p 0.0007 0.0001 0.0034 0.0155 0.0240 0.0244 0.2816 
FDR 0.0034 0.0007 0.0406 0.0831 0.2306 0.3741 0.4797 
Pantothenate 
%var -22.56 -23.84 0 -24.69 -22.04 0 -8.07 
± 5.27 3.14  3.34 4.19  3.51 
ES -3.29 -4.72 0 -4.75 -4.02 0 -1.55 
p 0.0112 0.0002  0.0003 0.0126  0.0929 
FDR 0.0286 0.0010  0.0072 0.2306  0.4734 
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Table S6.3. Main metabolite variations in lipophilic extracts of RAW 264.7 cells exposed to Cit30, 
Ag+, and H2O2, at the IC5 and IC20, in relation to controls, expressed as % variation (%var) and 
respective error (±), effect size (ES), p-value (p), and FDR-adjusted p-value (FDR). The variations 
with |ES| < 0.8 (or standard error > |ES|, or mean error > |% variation|) were considered null. 
  Cit30 Citrate Ag
+
 H2O2 
  IC5 IC20 IC5 IC20 IC5 IC20 
Total 
cholesterol 
%var 0 0 0 -20.23 -28.08 0 -6.10 
±    7.98 14.20  3.42 
ES 0 0 0 -1.84 -1.98 0 -0.81 
p    0.0503 0.1509  0.1064 
FDR    0.1417 0.3094  0.3800 
Free 
cholesterol 
%var 0 9.13 0 0 -12.45 -8.97 0 
±  4.55   6.12 5.71  
ES 0 0.87 0 0 -1.06 -0.80 0 
p  0.0896   0.0751 0.1390  
FDR  0.3201   0.3094 0.8539  
PTC 
%var 0 0 0 -15.35 -19.05 0 0 
±    6.69 8.90   
ES 0 0 0 -1.55 -1.80 0 0 
p    0.0624 0.1223   
FDR    0.1417 0.3094   
PTE 
%var -3.89 -7.40 0 2.75 0 0 5.20 
± 1.15 0.77  2.26   1.25 
ES -2.17 -5.19 0 0.89 0 0 2.97 
p 0.0202 7.52E-06  0.3064   0.0276 
FDR 0.5061 0.0002  0.3685   0.3445 
PTE 
plasmalogen 
%var 0 0 -5.78 13.38 0 0 9.19 
±   5.60 3.83   2.26 
ES 0 0 -0.96 2.37 0 0 2.50 
p   0.3944 0.0334   0.0191 
FDR   0.8805 0.1391   0.3445 
SM 
%var 0 0 0 -13.94 -25.27 0 0 
±    6.09 14.88   
ES 0 0 0 -1.57 -1.74 0 0 
p    0.0666 0.1991   
FDR    0.1417 0.3094   
Total unsaturated  
fatty acyl chains 
%var 0 -7.72 0 -16.29 -20.92 0 0 
±  6.05  5.71 10.00   
ES 0 -0.82 0 -1.82 -1.85 0 0 
p  0.2467  0.0254 0.1320   
FDR  0.6377  0.1391 0.3094   
Polyunsaturated  
fatty acyl chains 
%var 0 0 0 16.36 13.84 0 5.28 
±    4.21 7.63  3.72 
ES 0 0 0 2.32 1.52 0 0.85 
p    0.0154 0.2061  0.2342 
FDR    0.1281 0.3094  0.5458 
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Figure S6.1. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models of polar extracts, corresponding to Cit30 exposure (sensitivity 100%, 
specificity 100%, classification rate 100%). TPR: true positive rate; FPR: false positive rate. 
 
 
 
Figure S6.2. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models of polar extracts, corresponding to Ag+ exposure (sensitivity 70.0%, specificity 
100%, classification rate 86.0%). TPR: true positive rate; FPR: false positive rate. 
 
 
 
Figure S6.3. ROC space (left) and Q2 histogram (right) obtained by MCCV and permutation testing 
of the PLS-DA models of polar extracts, corresponding to H2O2 exposure (sensitivity 74.3%, 
specificity 72.5%, classification rate 73.3%). TPR: true positive rate; FPR: false positive rate. 
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Chapter 7. Integrated discussion and conclusions 
In this work, the metabolic responses of cultured mammalian cells to silver 
nanoparticles (AgNPs) were evaluated through NMR metabolomics, with a view to improve 
current knowledge on the (sub)toxic effects of these relevant and widely disseminated 
nanoparticles. The cell lines used were epidermis keratinocytes (HaCaT), liver hepatoma 
cells (HepG2) and blood macrophages (RAW 264.7), selected to represent important sites 
of AgNPs entry, accumulation and interaction within the organism. Purified, well-
characterised AgNPs were used to enable meaningful relationships between nanoparticle 
properties and biological outcomes to be established. The exposure conditions for 
metabolomic profiling of AgNPs-induced effects were chosen after careful dose-response 
studies of cell viability, conducted for each cell type. Furthermore, the metabolic signatures 
of cell exposures to ionic silver and hydrogen peroxide were also characterised to assess 
the role of silver ions and oxidative stress on the biological impact of AgNPs. 
 
Silver nanoparticles were found to elicit profound alterations in the metabolic activity 
and intracellular composition of the three cell types studied, even at concentrations causing 
minimal (≤ 20%) decreases in cell viability. By measuring consistent changes in metabolite 
levels upon exposure to AgNPs, multiple effects in pathways used by cells for purposes like 
energy production, biosynthesis, antioxidant protection, membrane remodelling or 
osmoregulation, could be proposed. The great advantage of this approach was that it 
enabled the simultaneous, comprehensive screening of unpredicted effects, without making 
a priori assumptions. Compared to conventional cytotoxicity studies typically based on a 
single pre-established endpoint, this achievement has great potential for providing new 
mechanistic insights. On the other hand, one should be aware that metabolite levels reflect 
pools resulting from the interplay between different biochemical processes, and as such, it 
is hard to derive definite information based only on metabolic variations. Instead, metabolic 
profiling can be viewed as an initial step in the quest for mechanistic answers, which should 
be followed by more targeted investigations to confirm the hypotheses generated. That said, 
this thesis is believed to represent an important contribute towards the revelation of a more 
complete picture of AgNPs biological effects. 
 
The three cell types tested showed both common and distinct responses to AgNPs-
exposure. To aid this comparative analysis, the main variations resulting from 24 h exposure 
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of each cell line to citrate-coated AgNPs with a core diameter of 30 nm at the IC20 
concentration are summarised in Figure 7.1. Overall, HaCaT cells showed the least altered 
metabolic profile under these exposure conditions. Note, however, that some effects (seen 
for the other cell types) were also noticed in HaCaT cells exposed to a higher AgNPs 
concentration (IC50) or for a longer period (48 h). Thus, the complete sets of data were taken 
into consideration for the integrated discussion presented in the following paragraphs.  
The uptake and conversion of glucose into lactate through glycolysis and lactic acid 
fermentation was suggested to be moderately intensified in HaCaT cells exposed to the 
smaller (10 nm) AgNPs and in RAW 264.7 macrophages exposed to the IC5 concentration. 
However, there were generally no strong evidences for altered glycolytic activity. In HepG2 
cells, the lack of effect could be influenced by the medium supplementation with pyruvate 
(used as the main substrate). Glutamine was another major substrate used by cells and its 
variations suggested increased glutaminolytic activity in AgNPs-exposed HaCaT cells and 
in HepG2 cells exposed to the biogenic GS30 AgNPs; again, this was a cell- and material-
dependent effect.  
The TCA cycle emerged as an important target of AgNPs effects in all tested cell 
lines. Common variations relating to intermediates of this pathway included increased 
citrate excretion, decreased levels of several anaplerotic substrates (mainly amino acids 
like glutamate or aspartate), and increased intracellular succinate and/or decreased 
fumarate. This latter effect suggests altered activity for the enzyme succinate 
dehydrogenase (SDH), which catalyses the oxidation of succinate to fumarate; thus, this is 
an example of a specific enzymatic step deserving further investigation. Exposed 
macrophages additionally showed very high levels of the metabolite itaconate, known to be 
produced from aconitate after a TCA cycle breakpoint at isocitrate dehydrogenase (IDH), in 
response to a pro-inflammatory stimulus. Overall, exposed cells seemed to maintain an 
active, reprogrammed TCA cycle, with RAW macrophages showing the more profound 
changes in this pathway.  
Another distinctive feature of the macrophages response to AgNPs, not seen in the 
other cell types, regarded the increase in intracellular glucose, which, together with 
decreased levels of gluconeogenic substrates, suggested activation of gluconeogenesis. 
Assessing the expression and/or activity of the enzymes involved in this pathway, such as 
the rate-limiting enzyme fructose-1,6-bisphosphatase 1 (FBP1), should be pursued to 
confirm this hypothesis and to evaluate the functional significance of this change.  
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Figure 7.1. Heatmap of the main variations in a) culture media, b) polar extracts, and c) lipophilic 
extracts, of HaCaT, HepG2, and RAW 264.7 cells exposed to Cit30 AgNPs, at IC20 concentrations, 
for 24 h, coloured according to % variation in relation to controls. * Uncorrected p-value < 0.05; ** 
FDR-corrected p-value < 0.05. Three letter code used for amino acids; NAA, N-acetylaspartate; Un. 
NAaa, unidentified N-acetylated amino acid; Cr, creatine; PCr, phosphocreatine; ADP/ATP, 
adenosine di/triphosphate; NAD+, nicotinamide adenine dinucleotide; GSH, reduced glutathione; PC, 
phosphocholine; GPC, glycerophosphocholine; UTP, uridine triphosphate; PTC, 
phosphatidylcholine; PTE, phosphatidylethanolamine; FA, fatty acyl. 
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TCA cycle reprogramming is expected to affect oxidative phosphorylation and 
energy production. Interestingly, the variation in ATP levels was clearly cell-dependent. 
Upon exposure to AgNPs, HaCaT cells maintained their ATP levels unchanged, HepG2 
cells presented an increased ATP pool and RAW 264.7 macrophages showed ATP 
depletion. We have hypothesised that HepG2 cells have enhanced their metabolic activity, 
including ATP production, as a protective mechanism to cope with the presence of AgNPs. 
As for the RAW 264.7 macrophages, the profound reprogramming of the TCA cycle could 
have directly resulted in ATP depletion, through inhibition of SDH (complex II of the 
respiratory chain) and downregulation of substrate-level phosphorylation (by excess 
itaconate). Another striking energy-related change regarded the levels of creatine and 
phosphocreatine; these metabolites decreased in HaCaT and HepG2 cells exposed to 
AgNPs (compared to their respective controls), while exposed macrophages displayed 
marked increases in both compounds. In times of high metabolic demand, cells use 
phosphocreatine to obtain ATP through an enzymatic reaction catalysed by creatine kinase, 
whereby creatine is formed. Thus, the decrease in phosphocreatine could reflect the higher 
energetic needs of AgNPs-exposed cells (namely HaCaT and HepG2 cells). This was 
however not accompanied by the expected increase in creatine, possibly indicating its use 
by another reaction. As for RAW 264.7 macrophages, the opposite effect was observed, 
with exposed cells building up a large pool of creatine and phosphocreatine. Whether this 
alteration reflects an attempt to compensate for inhibited ATP production or it has another 
functional significance remains to be clarified. In future studies, it would be interesting to 
assess the expression of creatine kinase isoforms and of creatine transporter molecules, 
as well as to evaluate the activation state and metabolic profile of macrophages upon 
blockage of the creatine/phosphocreatine shuttle system.  
The intracellular levels of the antioxidant tripeptide glutathione (GSH) were seen to 
increase in the three cell lines upon exposure to AgNPs, with the exception of HaCaT cells 
exposed to the smallest (10 nm) nanoparticles, which displayed unaltered or decreased 
GSH levels compared to controls. When comparing the same NP type and exposure 
conditions, HaCaT cells registered the largest increase in GSH levels, in agreement with 
the strong antioxidant capacity of skin keratinocytes. We have thus postulated that cells 
activated GSH de novo synthesis, as supported by decreased amounts of precursor amino 
acids and, in the case of macrophages, by the increased production of serine through a 
glycolysis-diverting pathway. This preservation of the GSH-mediated defence against 
reactive oxygen species generated in AgNPs-exposed cells could have played a crucial role 
in avoiding major oxidative damage. Future work should entail the assessment of enzymes 
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involved in GSH synthesis, namely glutamate cysteine ligase (GCL) and GSH synthetase, 
as well as the quantitative measurement of both GSH and GSSG by alternative biochemical 
methods.  
Based on the increased levels of several amino acids, autophagy was proposed as 
an additional protective mechanism which appeared to be activated mainly in HepG2 cells, 
and, to a lesser extent, in HaCaT cells. Further metabolic variations comprised prominent 
decreases in myo-inositol (HaCaT and RAW 264.7 cells), taurine (HepG2 cells) and betaine 
(RAW 264.7 cells), possibly in relation to the osmoregulatory role of these metabolites. 
Additionally, the significant decreases in phosphocholine (common to the three cell lines) 
and glycerophosphocholine (seen in HaCaT and RAW 264.7 cells), pointed to changes in 
cell membrane composition and/or turnover.  
 
Analysis of lipophilic extracts was expected to provide complementary insight into 
AgNPs-induced alterations in lipid composition. The NMR-derived lipophilic profiles showed 
dominant contributions from membrane components, such as cholesterol and different 
phospholipid classes (phosphatidylcholine, phosphatidylethanolamine and sphingomyelin), 
and smaller contributions from neutral lipids (especially noticeable in HepG2 cells). 
However, the impact of AgNPs on those lipid profiles was found to be much smaller than 
that observed for polar metabolites. The few AgNPs-induced alterations which could be 
suggested based on the lipid metabolome comprised downregulation of phospholipid 
synthesis and storage of fatty acids in the form of cholesterol esters in HepG2 cells, and 
membrane damage and/or the possible use of phospholipids for the production of 
inflammatory mediators in RAW 264.7 macrophages. However, these hypotheses were 
rather speculative, requiring further confirmation. The use of alternative analytical methods 
to characterise lipid components could be helpful in this respect. Indeed, the 1H NMR 
analysis of lipids has important limitations, such as the large signal width resulting from the 
lower molecular mobility of bigger molecules (thus giving rise to broad, poorly resolved 
signals), and the high degree of spectral overlap between different lipid species (e.g. 
phospholipids with different fatty acids in their composition). Thus, other methods like liquid 
chromatography coupled to mass spectrometry (LC/MS), more commonly used in lipidomic 
studies, would be recommended; this technique not only has the ability to provide more 
detailed information on lipids structural diversity, as it is more sensitive than NMR, 
potentially allowing changes in minor lipid metabolites, present at submicromolar 
concentrations, to be detected. 
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It has been widely reported that the different physicochemical properties of AgNPs 
(such as size or coating) can influence the way they interact with cells. As such, a panel of 
six AgNP types with different diameters (10, 30 or 60 nm) and coatings (citrate, polyethylene 
glycol (PEG) or bovine serum albumin (BSA)) were tested in HaCaT cells, to assess the 
influence of nanoparticle size and surface on the cytotoxic and metabolic effects produced. 
Although several metabolic variations were commonly seen across all tested AgNPs, the 
smallest (10 nm) particles, coated either with citrate or PEG, produced the most distinct 
effects, namely in regard to glycolysis and GSH production/utilisation. Additionally, in 
HepG2 cells, a comparison was established between citrate-stabilised (Cit30) and 
phytosynthesised (GS30) AgNPs. Again, the two nanoparticle types induced many common 
effects; still, Cit30 AgNPs, which were slightly more cytotoxic to liver cells than GS30 
AgNPs, appeared to produce a greater impact on the TCA cycle and protein degradation. 
On the other hand, GS30 AgNPs apparently elicited higher glutaminolytic activity and a 
stronger downregulation of phospholipid synthesis. The detection of such differences 
suggests that the fine tuning of AgNPs properties may be used to modulate the cellular 
metabolic responses and, thus, the biological outcomes achieved.  
 
The role of silver ion release in AgNPs-mediated effects has been addressed in this 
work by exposing cells to a soluble silver salt (AgNO3) at concentrations causing equivalent 
decreases in cell viability. Metabolic profiling revealed remarkably similar effects for AgNPs 
and Ag+, especially in HaCaT and HepG2 cells. Still, some differences could be noted. In 
HaCaT cells, extracellular Ag+ ions appeared to cause a lower impact on the TCA cycle and 
glutaminolysis and to differently affect phosphocreatine levels, possibly in relation to 
energetic recovery. Moreover, Ag+ elicited much stronger changes in cellular lipids, such as 
the more prominent decreases in cholesterol and membrane phospholipids. In the case of 
HepG2 cells, differences like the less pronounced increases in GSH and ATP and the 
release of allantoin, suggested that cells treated with extracellular Ag+ were less capable of 
dealing with oxidative stress than those exposed to AgNPs. As for the RAW 264.7 
macrophages, although there were common features in the metabolic responses to AgNPs 
and Ag+ (e.g. activated gluconeogenesis, upregulated GSH synthesis), several pathways 
appeared to be distinctly affected. For instance, the TCA cycle was suggested to be 
exquisitely reprogrammed in AgNPs-treated cells, likely to sustain an inflammatory 
response, while in Ag+-exposed cells it appeared to be simply downregulated; also, ATP 
depletion was not seen upon exposure to extracellular Ag+ and the build-up of a 
creatine/phosphocreatine pool was much less significant. On the other hand, Ag+ produced 
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a clearly stronger impact on cellular lipids, which could be related to cell membrane damage 
and/or the synthesis of inflammatory mediators. 
 
The excessive production of reactive oxygen species (ROS) has been advocated as 
a major cause of AgNPs damaging effects on cells. Thus, to assess the role of oxidative 
stress in the metabolic signature of AgNPs, exposure to hydrogen peroxide (H2O2) has been 
performed and the resulting effects on the cellular metabolome have been evaluated. 
Clearly, many of the effects attributed to AgNPs were not exclusively mediated by ROS. 
Comparatively to AgNPs, H2O2 (at concentrations causing similar decreases in cell viability) 
caused a lower impact on the TCA cycle and did not appear to upregulate glutaminolysis or 
GSH synthesis. Additionally, in RAW 264.7 macrophages, there was no evidence of 
activated gluconeogenesis as seen upon exposure to AgNPs/Ag+. Also, in HaCaT cells, 
H2O2 was suggested to cause membrane degradation, in contrast with the lower turnover 
postulated for AgNPs-exposed keratinocytes. Another contrasting effect regarded the 
inhibition of glycolysis, which emerged as a common response of the three cell lines to H2O2 
but not to AgNPs. On the other hand, in HaCaT and HepG2 cells, H2O2 induced similar or 
even more intense increases in some amino acids (as compared to AgNPs), suggesting 
that the proposed autophagic protein degradation was a ROS-mediated effect. 
  
As a final conclusion, we can state that metabolic reprogramming in cells exposed 
to AgNPs took place independently of direct cytotoxic effects. In fact, some of the observed 
changes were possibly linked to protective mechanisms that conferred cells functional 
advantages to cope with the presence of foreign particles (and/or the ions/molecules 
released from their surface). Other effects, on the other hand, were likely related to adverse 
outcomes, providing novel insights into toxicity mechanisms of AgNPs. 
 
Overall, the work hereby presented has proven that NMR metabolomics is a 
powerful tool for the untargeted screening of the biochemical effects of AgNPs in 
mammalian cells. It is believed that this approach can be extended for establishing the 
biosafety of other existing and new nanomaterials, providing an invaluable complementary 
platform for their tailored design and risk-benefit assessment.  
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